id	sid	tid	token	lemma	pos
ecj-10468	1	1	hrev_master	hrev_master	NOUN
ecj-10468	1	2	abstract	abstract	NOUN
ecj-10468	1	3	covid-19	covid-19	PROPN
ecj-10468	1	4	can	can	AUX
ecj-10468	1	5	affect	affect	VERB
ecj-10468	1	6	multiple	multiple	ADJ
ecj-10468	1	7	organs	organ	NOUN
ecj-10468	1	8	,	,	PUNCT
ecj-10468	1	9	including	include	VERB
ecj-10468	1	10	skin	skin	NOUN
ecj-10468	1	11	.	.	PUNCT
ecj-10468	2	1	a	a	DET
ecj-10468	2	2	wide	wide	ADJ
ecj-10468	2	3	range	range	NOUN
ecj-10468	2	4	of	of	ADP
ecj-10468	2	5	skin	skin	NOUN
ecj-10468	2	6	manifestations	manifestation	NOUN
ecj-10468	2	7	have	have	AUX
ecj-10468	2	8	been	be	AUX
ecj-10468	2	9	reported	report	VERB
ecj-10468	2	10	in	in	ADP
ecj-10468	2	11	literature	literature	NOUN
ecj-10468	2	12	.	.	PUNCT
ecj-10468	3	1	six	six	NUM
ecj-10468	3	2	main	main	ADJ
ecj-10468	3	3	phenotypes	phenotype	NOUN
ecj-10468	3	4	have	have	AUX
ecj-10468	3	5	been	be	AUX
ecj-10468	3	6	identified	identify	VERB
ecj-10468	3	7	:	:	PUNCT
ecj-10468	3	8	i	i	NOUN
ecj-10468	3	9	)	)	PUNCT
ecj-10468	3	10	urticarial	urticarial	ADJ
ecj-10468	3	11	rash	rash	NOUN
ecj-10468	3	12	,	,	PUNCT
ecj-10468	3	13	ii	ii	NOUN
ecj-10468	3	14	)	)	PUNCT
ecj-10468	3	15	confluent	confluent	ADJ
ecj-10468	3	16	erythematous	erythematous	ADJ
ecj-10468	3	17	/	/	SYM
ecj-10468	3	18	maculopapular	maculopapular	ADJ
ecj-10468	3	19	/	/	SYM
ecj-10468	3	20	morbilliform	morbilliform	NOUN
ecj-10468	3	21	rash	rash	NOUN
ecj-10468	3	22	,	,	PUNCT
ecj-10468	3	23	iii	iii	X
ecj-10468	3	24	)	)	PUNCT
ecj-10468	3	25	papulovesicular	papulovesicular	ADJ
ecj-10468	3	26	exanthem	exanthem	PROPN
ecj-10468	3	27	,	,	PUNCT
ecj-10468	3	28	iv	iv	X
ecj-10468	3	29	)	)	PUNCT
ecj-10468	3	30	a	a	DET
ecj-10468	3	31	chilblain	chilblain	NOUN
ecj-10468	3	32	-	-	PUNCT
ecj-10468	3	33	like	like	ADJ
ecj-10468	3	34	acral	acral	ADJ
ecj-10468	3	35	pattern	pattern	NOUN
ecj-10468	3	36	,	,	PUNCT
ecj-10468	3	37	v	v	NOUN
ecj-10468	3	38	)	)	PUNCT
ecj-10468	3	39	a	a	DET
ecj-10468	3	40	livedo	livedo	NOUN
ecj-10468	3	41	reticularis	reticularis	PROPN
ecj-10468	3	42	/	/	SYM
ecj-10468	3	43	racemosa	racemosa	NOUN
ecj-10468	3	44	-	-	PUNCT
ecj-10468	3	45	like	like	ADJ
ecj-10468	3	46	pattern	pattern	NOUN
ecj-10468	3	47	,	,	PUNCT
ecj-10468	3	48	and	and	CCONJ
ecj-10468	3	49	vi	vi	X
ecj-10468	3	50	)	)	PUNCT
ecj-10468	3	51	a	a	DET
ecj-10468	3	52	purpuric	purpuric	ADJ
ecj-10468	3	53	vasculitic	vasculitic	ADJ
ecj-10468	3	54	pattern	pattern	NOUN
ecj-10468	3	55	.	.	PUNCT
ecj-10468	4	1	the	the	DET
ecj-10468	4	2	pathogenetic	pathogenetic	ADJ
ecj-10468	4	3	mechanism	mechanism	NOUN
ecj-10468	4	4	is	be	AUX
ecj-10468	4	5	still	still	ADV
ecj-10468	4	6	not	not	PART
ecj-10468	4	7	completely	completely	ADV
ecj-10468	4	8	clear	clear	ADJ
ecj-10468	4	9	,	,	PUNCT
ecj-10468	4	10	but	but	CCONJ
ecj-10468	4	11	a	a	DET
ecj-10468	4	12	role	role	NOUN
ecj-10468	4	13	of	of	ADP
ecj-10468	4	14	hyperactive	hyperactive	ADJ
ecj-10468	4	15	immune	immune	ADJ
ecj-10468	4	16	response	response	NOUN
ecj-10468	4	17	,	,	PUNCT
ecj-10468	4	18	complement	complement	NOUN
ecj-10468	4	19	activation	activation	NOUN
ecj-10468	4	20	and	and	CCONJ
ecj-10468	4	21	microvascular	microvascular	ADJ
ecj-10468	4	22	injury	injury	NOUN
ecj-10468	4	23	have	have	AUX
ecj-10468	4	24	been	be	AUX
ecj-10468	4	25	postulated	postulate	VERB
ecj-10468	4	26	.	.	PUNCT
ecj-10468	5	1	the	the	DET
ecj-10468	5	2	only	only	ADJ
ecj-10468	5	3	correlation	correlation	NOUN
ecj-10468	5	4	between	between	ADP
ecj-10468	5	5	the	the	DET
ecj-10468	5	6	cutaneous	cutaneous	ADJ
ecj-10468	5	7	phenotype	phenotype	NOUN
ecj-10468	5	8	and	and	CCONJ
ecj-10468	5	9	the	the	DET
ecj-10468	5	10	severity	severity	NOUN
ecj-10468	5	11	of	of	ADP
ecj-10468	5	12	covid-19	covid-19	PROPN
ecj-10468	5	13	has	have	AUX
ecj-10468	5	14	been	be	AUX
ecj-10468	5	15	observed	observe	VERB
ecj-10468	5	16	in	in	ADP
ecj-10468	5	17	the	the	DET
ecj-10468	5	18	case	case	NOUN
ecj-10468	5	19	of	of	ADP
ecj-10468	5	20	chilblain	chilblain	NOUN
ecj-10468	5	21	-	-	PUNCT
ecj-10468	5	22	like	like	ADJ
ecj-10468	5	23	acral	acral	ADJ
ecj-10468	5	24	lesions	lesion	NOUN
ecj-10468	5	25	,	,	PUNCT
ecj-10468	5	26	that	that	PRON
ecj-10468	5	27	is	be	AUX
ecj-10468	5	28	generally	generally	ADV
ecj-10468	5	29	associated	associate	VERB
ecj-10468	5	30	with	with	ADP
ecj-10468	5	31	the	the	DET
ecj-10468	5	32	benign	benign	ADJ
ecj-10468	5	33	/	/	SYM
ecj-10468	5	34	subclinical	subclinical	ADJ
ecj-10468	5	35	course	course	NOUN
ecj-10468	5	36	of	of	ADP
ecj-10468	5	37	covid-19	covid-19	PROPN
ecj-10468	5	38	.	.	PUNCT
ecj-10468	5	39	herein	herein	PROPN
ecj-10468	5	40	,	,	PUNCT
ecj-10468	5	41	we	we	PRON
ecj-10468	5	42	report	report	VERB
ecj-10468	5	43	two	two	NUM
ecj-10468	5	44	cases	case	NOUN
ecj-10468	5	45	of	of	ADP
ecj-10468	5	46	sars	sar	NOUN
ecj-10468	5	47	-	-	PUNCT
ecj-10468	5	48	cov2	cov2	PROPN
ecj-10468	5	49	infection	infection	NOUN
ecj-10468	5	50	in	in	ADP
ecj-10468	5	51	patients	patient	NOUN
ecj-10468	5	52	who	who	PRON
ecj-10468	5	53	developed	develop	VERB
ecj-10468	5	54	cutaneous	cutaneous	ADJ
ecj-10468	5	55	manifestations	manifestation	NOUN
ecj-10468	5	56	that	that	PRON
ecj-10468	5	57	completely	completely	ADV
ecj-10468	5	58	solved	solve	VERB
ecj-10468	5	59	with	with	ADP
ecj-10468	5	60	systemic	systemic	ADJ
ecj-10468	5	61	steroids	steroid	NOUN
ecj-10468	5	62	and	and	CCONJ
ecj-10468	5	63	antihistamines	antihistamine	NOUN
ecj-10468	5	64	.	.	PUNCT
ecj-10468	6	1	the	the	DET
ecj-10468	6	2	first	first	ADJ
ecj-10468	6	3	case	case	NOUN
ecj-10468	6	4	is	be	AUX
ecj-10468	6	5	a	a	DET
ecj-10468	6	6	female	female	ADJ
ecj-10468	6	7	patient	patient	NOUN
ecj-10468	6	8	not	not	PART
ecj-10468	6	9	vaccinated	vaccinate	VERB
ecj-10468	6	10	for	for	ADP
ecj-10468	6	11	sars	sar	NOUN
ecj-10468	6	12	-	-	PUNCT
ecj-10468	6	13	cov-2	cov-2	NOUN
ecj-10468	6	14	with	with	ADP
ecj-10468	6	15	covid-19	covid-19	PROPN
ecj-10468	6	16	associated	associated	ADJ
ecj-10468	6	17	pneumonia	pneumonia	NOUN
ecj-10468	6	18	,	,	PUNCT
ecj-10468	6	19	while	while	SCONJ
ecj-10468	6	20	the	the	DET
ecj-10468	6	21	second	second	ADJ
ecj-10468	6	22	case	case	NOUN
ecj-10468	6	23	is	be	AUX
ecj-10468	6	24	a	a	DET
ecj-10468	6	25	vaccinated	vaccinated	ADJ
ecj-10468	6	26	female	female	ADJ
ecj-10468	6	27	patient	patient	NOUN
ecj-10468	6	28	with	with	ADP
ecj-10468	6	29	only	only	ADJ
ecj-10468	6	30	skin	skin	NOUN
ecj-10468	6	31	manifestations	manifestation	NOUN
ecj-10468	6	32	.	.	PUNCT
ecj-10468	7	1	case	case	NOUN
ecj-10468	7	2	reports	report	VERB
ecj-10468	7	3	case	case	NOUN
ecj-10468	7	4	1	1	NUM
ecj-10468	7	5	is	be	AUX
ecj-10468	7	6	an	an	DET
ecj-10468	7	7	87	87	NUM
ecj-10468	7	8	-	-	PUNCT
ecj-10468	7	9	year	year	NOUN
ecj-10468	7	10	-	-	PUNCT
ecj-10468	7	11	old	old	ADJ
ecj-10468	7	12	woman	woman	NOUN
ecj-10468	7	13	who	who	PRON
ecj-10468	7	14	was	be	AUX
ecj-10468	7	15	hospitalized	hospitalize	VERB
ecj-10468	7	16	in	in	ADP
ecj-10468	7	17	our	our	PRON
ecj-10468	7	18	emergency	emergency	NOUN
ecj-10468	7	19	department	department	NOUN
ecj-10468	7	20	(	(	PUNCT
ecj-10468	7	21	ed	ed	NOUN
ecj-10468	7	22	)	)	PUNCT
ecj-10468	7	23	for	for	ADP
ecj-10468	7	24	covid-19	covid-19	PROPN
ecj-10468	7	25	pneumonia	pneumonia	NOUN
ecj-10468	7	26	with	with	ADP
ecj-10468	7	27	acute	acute	ADJ
ecj-10468	7	28	respiratory	respiratory	ADJ
ecj-10468	7	29	failure	failure	NOUN
ecj-10468	7	30	requiring	require	VERB
ecj-10468	7	31	oxygen	oxygen	NOUN
ecj-10468	7	32	therapy	therapy	NOUN
ecj-10468	7	33	via	via	ADP
ecj-10468	7	34	nasal	nasal	PROPN
ecj-10468	7	35	cannulas	cannula	NOUN
ecj-10468	7	36	.	.	PUNCT
ecj-10468	8	1	high	high	ADJ
ecj-10468	8	2	-	-	PUNCT
ecj-10468	8	3	resolution	resolution	NOUN
ecj-10468	8	4	chest	chest	NOUN
ecj-10468	8	5	ct	ct	PROPN
ecj-10468	8	6	scan	scan	PROPN
ecj-10468	8	7	showed	show	VERB
ecj-10468	8	8	a	a	DET
ecj-10468	8	9	diffuse	diffuse	ADJ
ecj-10468	8	10	interstitial	interstitial	ADJ
ecj-10468	8	11	pattern	pattern	NOUN
ecj-10468	8	12	with	with	ADP
ecj-10468	8	13	subpleural	subpleural	ADJ
ecj-10468	8	14	bilateral	bilateral	ADJ
ecj-10468	8	15	consolidations	consolidation	NOUN
ecj-10468	8	16	with	with	ADP
ecj-10468	8	17	an	an	DET
ecj-10468	8	18	estimated	estimate	VERB
ecj-10468	8	19	visual	visual	ADJ
ecj-10468	8	20	score	score	NOUN
ecj-10468	8	21	of	of	ADP
ecj-10468	8	22	25	25	NUM
ecj-10468	8	23	%	%	NOUN
ecj-10468	8	24	.	.	PUNCT
ecj-10468	9	1	she	she	PRON
ecj-10468	9	2	had	have	AUX
ecj-10468	9	3	not	not	PART
ecj-10468	9	4	been	be	AUX
ecj-10468	9	5	vaccinated	vaccinate	VERB
ecj-10468	9	6	for	for	ADP
ecj-10468	9	7	sars	sar	NOUN
ecj-10468	9	8	-	-	PUNCT
ecj-10468	9	9	cov-2	cov-2	NOUN
ecj-10468	9	10	and	and	CCONJ
ecj-10468	9	11	her	her	PRON
ecj-10468	9	12	past	past	ADJ
ecj-10468	9	13	medical	medical	ADJ
ecj-10468	9	14	history	history	NOUN
ecj-10468	9	15	consisted	consist	VERB
ecj-10468	9	16	in	in	ADP
ecj-10468	9	17	hypertension	hypertension	NOUN
ecj-10468	9	18	,	,	PUNCT
ecj-10468	9	19	diabetes	diabetes	NOUN
ecj-10468	9	20	mellitus	mellitus	NOUN
ecj-10468	9	21	type	type	VERB
ecj-10468	9	22	2	2	NUM
ecj-10468	9	23	,	,	PUNCT
ecj-10468	9	24	overweight	overweight	ADJ
ecj-10468	9	25	,	,	PUNCT
ecj-10468	9	26	and	and	CCONJ
ecj-10468	9	27	a	a	DET
ecj-10468	9	28	previous	previous	ADJ
ecj-10468	9	29	femoral	femoral	ADJ
ecj-10468	9	30	fracture	fracture	NOUN
ecj-10468	9	31	.	.	PUNCT
ecj-10468	10	1	therapeutic	therapeutic	ADJ
ecj-10468	10	2	management	management	NOUN
ecj-10468	10	3	included	include	VERB
ecj-10468	10	4	dexamethasone	dexamethasone	NOUN
ecj-10468	10	5	6	6	NUM
ecj-10468	10	6	mg	mg	NOUN
ecj-10468	10	7	iv	iv	NUM
ecj-10468	10	8	daily	daily	ADV
ecj-10468	10	9	,	,	PUNCT
ecj-10468	10	10	low	low	ADJ
ecj-10468	10	11	molecular	molecular	ADJ
ecj-10468	10	12	weight	weight	NOUN
ecj-10468	10	13	heparin	heparin	NOUN
ecj-10468	10	14	at	at	ADP
ecj-10468	10	15	prophylaxis	prophylaxis	PROPN
ecj-10468	10	16	dose	dose	NOUN
ecj-10468	10	17	,	,	PUNCT
ecj-10468	10	18	remdesivir	remdesivir	VERB
ecj-10468	10	19	200	200	NUM
ecj-10468	10	20	mg	mg	NOUN
ecj-10468	10	21	iv	iv	NUM
ecj-10468	10	22	the	the	DET
ecj-10468	10	23	first	first	ADJ
ecj-10468	10	24	day	day	NOUN
ecj-10468	10	25	and	and	CCONJ
ecj-10468	10	26	100	100	NUM
ecj-10468	10	27	mg	mg	NOUN
ecj-10468	10	28	daily	daily	ADV
ecj-10468	10	29	for	for	ADP
ecj-10468	10	30	the	the	DET
ecj-10468	10	31	next	next	ADJ
ecj-10468	10	32	four	four	NUM
ecj-10468	10	33	days	day	NOUN
ecj-10468	10	34	,	,	PUNCT
ecj-10468	10	35	and	and	CCONJ
ecj-10468	10	36	subcutaneous	subcutaneous	ADJ
ecj-10468	10	37	insulin	insulin	NOUN
ecj-10468	10	38	to	to	PART
ecj-10468	10	39	control	control	VERB
ecj-10468	10	40	plasmatic	plasmatic	ADJ
ecj-10468	10	41	glucose	glucose	NOUN
ecj-10468	10	42	levels	level	NOUN
ecj-10468	10	43	.	.	PUNCT
ecj-10468	11	1	on	on	ADP
ecj-10468	11	2	day	day	NOUN
ecj-10468	11	3	2	2	NUM
ecj-10468	11	4	,	,	PUNCT
ecj-10468	11	5	she	she	PRON
ecj-10468	11	6	developed	develop	VERB
ecj-10468	11	7	red	red	ADJ
ecj-10468	11	8	macular	macular	NOUN
ecj-10468	11	9	slightly	slightly	ADV
ecj-10468	11	10	itching	itching	NOUN
ecj-10468	11	11	patches	patch	NOUN
ecj-10468	11	12	(	(	PUNCT
ecj-10468	11	13	wheals	wheal	NOUN
ecj-10468	11	14	)	)	PUNCT
ecj-10468	11	15	on	on	ADP
ecj-10468	11	16	the	the	DET
ecj-10468	11	17	skin	skin	NOUN
ecj-10468	11	18	of	of	ADP
ecj-10468	11	19	her	her	PRON
ecj-10468	11	20	abdomen	abdoman	NOUN
ecj-10468	11	21	and	and	CCONJ
ecj-10468	11	22	thighs	thigh	NOUN
ecj-10468	11	23	(	(	PUNCT
ecj-10468	11	24	figure	figure	NOUN
ecj-10468	11	25	1	1	NUM
ecj-10468	11	26	)	)	PUNCT
ecj-10468	11	27	that	that	PRON
ecj-10468	11	28	increased	increase	VERB
ecj-10468	11	29	in	in	ADP
ecj-10468	11	30	size	size	NOUN
ecj-10468	11	31	in	in	ADP
ecj-10468	11	32	the	the	DET
ecj-10468	11	33	next	next	ADJ
ecj-10468	11	34	2	2	NUM
ecj-10468	11	35	days	day	NOUN
ecj-10468	11	36	and	and	CCONJ
ecj-10468	11	37	progressively	progressively	ADV
ecj-10468	11	38	disappeared	disappear	VERB
ecj-10468	11	39	after	after	ADP
ecj-10468	11	40	a	a	DET
ecj-10468	11	41	week	week	NOUN
ecj-10468	11	42	.	.	PUNCT
ecj-10468	12	1	the	the	DET
ecj-10468	12	2	emergency	emergency	NOUN
ecj-10468	12	3	care	care	NOUN
ecj-10468	12	4	journal	journal	PROPN
ecj-10468	12	5	2022	2022	NUM
ecj-10468	12	6	;	;	PUNCT
ecj-10468	12	7	volume	volume	NOUN
ecj-10468	12	8	18:10468	18:10468	NUM
ecj-10468	12	9	correspondence	correspondence	NOUN
ecj-10468	12	10	:	:	PUNCT
ecj-10468	12	11	erika	erika	PROPN
ecj-10468	12	12	poggiali	poggiali	PROPN
ecj-10468	12	13	,	,	PUNCT
ecj-10468	12	14	emergency	emergency	NOUN
ecj-10468	12	15	department	department	NOUN
ecj-10468	12	16	,	,	PUNCT
ecj-10468	12	17	“	"	PUNCT
ecj-10468	12	18	guglielmo	guglielmo	PROPN
ecj-10468	12	19	da	da	PROPN
ecj-10468	12	20	saliceto	saliceto	VERB
ecj-10468	12	21	”	"	PUNCT
ecj-10468	12	22	hospital	hospital	NOUN
ecj-10468	12	23	,	,	PUNCT
ecj-10468	12	24	via	via	ADP
ecj-10468	12	25	giuseppe	giuseppe	PROPN
ecj-10468	12	26	taverna	taverna	PROPN
ecj-10468	12	27	49	49	NUM
ecj-10468	12	28	,	,	PUNCT
ecj-10468	12	29	piacenza	piacenza	PROPN
ecj-10468	12	30	,	,	PUNCT
ecj-10468	12	31	italy	italy	PROPN
ecj-10468	12	32	.	.	PUNCT
ecj-10468	13	1	tel	tel	PROPN
ecj-10468	13	2	.	.	PUNCT
ecj-10468	13	3	:	:	PUNCT
ecj-10468	14	1	+39.0523.303044	+39.0523.303044	X
ecj-10468	14	2	e	e	NOUN
ecj-10468	14	3	-	-	NOUN
ecj-10468	14	4	mail	mail	NOUN
ecj-10468	14	5	:	:	PUNCT
ecj-10468	14	6	poggiali.erika@gmail.com	poggiali.erika@gmail.com	X
ecj-10468	14	7	key	key	ADJ
ecj-10468	14	8	words	word	NOUN
ecj-10468	14	9	:	:	PUNCT
ecj-10468	14	10	covid-19	covid-19	PROPN
ecj-10468	14	11	;	;	PUNCT
ecj-10468	14	12	sars	sar	NOUN
ecj-10468	14	13	-	-	PUNCT
ecj-10468	14	14	cov-2	cov-2	NUM
ecj-10468	14	15	;	;	PUNCT
ecj-10468	14	16	skin	skin	NOUN
ecj-10468	14	17	manifestations	manifestation	NOUN
ecj-10468	14	18	;	;	PUNCT
ecj-10468	14	19	coronavirus	coronaviru	NOUN
ecj-10468	14	20	;	;	PUNCT
ecj-10468	14	21	angioedema	angioedema	ADV
ecj-10468	14	22	;	;	PUNCT
ecj-10468	14	23	urticaria	urticaria	NOUN
ecj-10468	14	24	.	.	PUNCT
ecj-10468	15	1	contributions	contribution	NOUN
ecj-10468	15	2	:	:	PUNCT
ecj-10468	15	3	db	db	ADJ
ecj-10468	15	4	,	,	PUNCT
ecj-10468	15	5	gb	gb	ADJ
ecj-10468	15	6	,	,	PUNCT
ecj-10468	15	7	pr	pr	NOUN
ecj-10468	15	8	and	and	CCONJ
ecj-10468	15	9	ep	ep	PROPN
ecj-10468	15	10	drafted	draft	VERB
ecj-10468	15	11	the	the	DET
ecj-10468	15	12	manuscript	manuscript	NOUN
ecj-10468	15	13	.	.	PUNCT
ecj-10468	16	1	db	db	PROPN
ecj-10468	16	2	,	,	PUNCT
ecj-10468	16	3	gb	gb	ADJ
ecj-10468	16	4	,	,	PUNCT
ecj-10468	16	5	pr	pr	NOUN
ecj-10468	16	6	and	and	CCONJ
ecj-10468	16	7	ep	ep	PROPN
ecj-10468	16	8	cared	care	VERB
ecj-10468	16	9	for	for	ADP
ecj-10468	16	10	the	the	DET
ecj-10468	16	11	patient	patient	NOUN
ecj-10468	16	12	.	.	PUNCT
ecj-10468	17	1	ep	ep	PROPN
ecj-10468	17	2	,	,	PUNCT
ecj-10468	17	3	am	be	AUX
ecj-10468	17	4	e	e	AUX
ecj-10468	17	5	av	av	PROPN
ecj-10468	17	6	critically	critically	ADV
ecj-10468	17	7	revised	revise	VERB
ecj-10468	17	8	the	the	DET
ecj-10468	17	9	manuscript	manuscript	NOUN
ecj-10468	17	10	.	.	PUNCT
ecj-10468	18	1	all	all	DET
ecj-10468	18	2	authors	author	NOUN
ecj-10468	18	3	approved	approve	VERB
ecj-10468	18	4	the	the	DET
ecj-10468	18	5	final	final	ADJ
ecj-10468	18	6	version	version	NOUN
ecj-10468	18	7	and	and	CCONJ
ecj-10468	18	8	stated	state	VERB
ecj-10468	18	9	the	the	DET
ecj-10468	18	10	integrity	integrity	NOUN
ecj-10468	18	11	of	of	ADP
ecj-10468	18	12	the	the	DET
ecj-10468	18	13	whole	whole	ADJ
ecj-10468	18	14	work	work	NOUN
ecj-10468	18	15	.	.	PUNCT
ecj-10468	19	1	conflicts	conflict	NOUN
ecj-10468	19	2	of	of	ADP
ecj-10468	19	3	interest	interest	NOUN
ecj-10468	19	4	:	:	PUNCT
ecj-10468	19	5	the	the	DET
ecj-10468	19	6	authors	author	NOUN
ecj-10468	19	7	declare	declare	VERB
ecj-10468	19	8	no	no	DET
ecj-10468	19	9	conflict	conflict	NOUN
ecj-10468	19	10	of	of	ADP
ecj-10468	19	11	interest	interest	NOUN
ecj-10468	19	12	.	.	PUNCT
ecj-10468	20	1	ep	ep	PROPN
ecj-10468	20	2	is	be	AUX
ecj-10468	20	3	member	member	NOUN
ecj-10468	20	4	of	of	ADP
ecj-10468	20	5	the	the	DET
ecj-10468	20	6	editorial	editorial	ADJ
ecj-10468	20	7	board	board	NOUN
ecj-10468	20	8	of	of	ADP
ecj-10468	20	9	emergency	emergency	NOUN
ecj-10468	20	10	care	care	NOUN
ecj-10468	20	11	journal	journal	NOUN
ecj-10468	20	12	.	.	PUNCT
ecj-10468	21	1	availability	availability	NOUN
ecj-10468	21	2	of	of	ADP
ecj-10468	21	3	data	datum	NOUN
ecj-10468	21	4	and	and	CCONJ
ecj-10468	21	5	materials	material	NOUN
ecj-10468	21	6	:	:	PUNCT
ecj-10468	21	7	all	all	DET
ecj-10468	21	8	data	datum	NOUN
ecj-10468	21	9	underlying	underlie	VERB
ecj-10468	21	10	the	the	DET
ecj-10468	21	11	findings	finding	NOUN
ecj-10468	21	12	are	be	AUX
ecj-10468	21	13	fully	fully	ADV
ecj-10468	21	14	available	available	ADJ
ecj-10468	21	15	upon	upon	SCONJ
ecj-10468	21	16	reasonable	reasonable	ADJ
ecj-10468	21	17	request	request	NOUN
ecj-10468	21	18	to	to	ADP
ecj-10468	21	19	erika	erika	PROPN
ecj-10468	21	20	poggiali	poggiali	PROPN
ecj-10468	21	21	,	,	PUNCT
ecj-10468	21	22	poggiali.erika@gmail.com	poggiali.erika@gmail.com	X
ecj-10468	21	23	.	.	PUNCT
ecj-10468	22	1	ethics	ethic	NOUN
ecj-10468	22	2	approval	approval	NOUN
ecj-10468	22	3	and	and	CCONJ
ecj-10468	22	4	consent	consent	NOUN
ecj-10468	22	5	to	to	PART
ecj-10468	22	6	participate	participate	VERB
ecj-10468	22	7	:	:	PUNCT
ecj-10468	22	8	as	as	SCONJ
ecj-10468	22	9	this	this	PRON
ecj-10468	22	10	was	be	AUX
ecj-10468	22	11	a	a	DET
ecj-10468	22	12	descriptive	descriptive	ADJ
ecj-10468	22	13	case	case	NOUN
ecj-10468	22	14	report	report	NOUN
ecj-10468	22	15	and	and	CCONJ
ecj-10468	22	16	data	datum	NOUN
ecj-10468	22	17	was	be	AUX
ecj-10468	22	18	collected	collect	VERB
ecj-10468	22	19	without	without	ADP
ecj-10468	22	20	patient	patient	ADJ
ecj-10468	22	21	identifiers	identifier	NOUN
ecj-10468	22	22	,	,	PUNCT
ecj-10468	22	23	ethics	ethic	NOUN
ecj-10468	22	24	approval	approval	NOUN
ecj-10468	22	25	was	be	AUX
ecj-10468	22	26	not	not	PART
ecj-10468	22	27	required	require	VERB
ecj-10468	22	28	under	under	ADP
ecj-10468	22	29	our	our	PRON
ecj-10468	22	30	hospital	hospital	NOUN
ecj-10468	22	31	’s	’s	PART
ecj-10468	22	32	institutional	institutional	PROPN
ecj-10468	22	33	review	review	NOUN
ecj-10468	22	34	board	board	NOUN
ecj-10468	22	35	guidelines	guideline	NOUN
ecj-10468	22	36	.	.	PUNCT
ecj-10468	23	1	informed	informed	ADJ
ecj-10468	23	2	consent	consent	NOUN
ecj-10468	23	3	:	:	PUNCT
ecj-10468	23	4	the	the	DET
ecj-10468	23	5	patients	patient	NOUN
ecj-10468	23	6	provided	provide	VERB
ecj-10468	23	7	consent	consent	NOUN
ecj-10468	23	8	for	for	ADP
ecj-10468	23	9	the	the	DET
ecj-10468	23	10	access	access	NOUN
ecj-10468	23	11	to	to	ADP
ecj-10468	23	12	medical	medical	ADJ
ecj-10468	23	13	records	record	NOUN
ecj-10468	23	14	at	at	ADP
ecj-10468	23	15	the	the	DET
ecj-10468	23	16	time	time	NOUN
ecj-10468	23	17	of	of	ADP
ecj-10468	23	18	admission	admission	NOUN
ecj-10468	23	19	.	.	PUNCT
ecj-10468	24	1	received	receive	VERB
ecj-10468	24	2	for	for	ADP
ecj-10468	24	3	publication	publication	NOUN
ecj-10468	24	4	:	:	PUNCT
ecj-10468	24	5	18	18	NUM
ecj-10468	24	6	march	march	NOUN
ecj-10468	24	7	2022	2022	NUM
ecj-10468	24	8	.	.	PUNCT
ecj-10468	25	1	revision	revision	NOUN
ecj-10468	25	2	received	receive	VERB
ecj-10468	25	3	:	:	PUNCT
ecj-10468	25	4	15	15	NUM
ecj-10468	25	5	april	april	PROPN
ecj-10468	25	6	2022	2022	NUM
ecj-10468	25	7	.	.	PUNCT
ecj-10468	26	1	accepted	accept	VERB
ecj-10468	26	2	for	for	ADP
ecj-10468	26	3	publication	publication	NOUN
ecj-10468	26	4	:	:	PUNCT
ecj-10468	26	5	19	19	NUM
ecj-10468	26	6	april	april	PROPN
ecj-10468	26	7	2022	2022	NUM
ecj-10468	26	8	.	.	PUNCT
ecj-10468	27	1	this	this	DET
ecj-10468	27	2	work	work	NOUN
ecj-10468	27	3	is	be	AUX
ecj-10468	27	4	licensed	license	VERB
ecj-10468	27	5	under	under	ADP
ecj-10468	27	6	a	a	DET
ecj-10468	27	7	creative	creative	ADJ
ecj-10468	27	8	commons	common	NOUN
ecj-10468	27	9	attribution	attribution	NOUN
ecj-10468	27	10	4.0	4.0	NUM
ecj-10468	27	11	license	license	NOUN
ecj-10468	27	12	(	(	PUNCT
ecj-10468	27	13	by	by	ADP
ecj-10468	27	14	-	-	PUNCT
ecj-10468	27	15	nc	nc	PROPN
ecj-10468	27	16	4.0	4.0	NUM
ecj-10468	27	17	)	)	PUNCT
ecj-10468	27	18	.	.	PUNCT
ecj-10468	28	1	©	©	PROPN
ecj-10468	28	2	copyright	copyright	NOUN
ecj-10468	28	3	:	:	PUNCT
ecj-10468	28	4	the	the	DET
ecj-10468	28	5	author(s	author(s	PROPN
ecj-10468	28	6	)	)	PUNCT
ecj-10468	28	7	,	,	PUNCT
ecj-10468	28	8	2022	2022	NUM
ecj-10468	28	9	licensee	licensee	NOUN
ecj-10468	28	10	pagepress	pagepress	NOUN
ecj-10468	28	11	,	,	PUNCT
ecj-10468	28	12	italy	italy	PROPN
ecj-10468	28	13	emergency	emergency	PROPN
ecj-10468	28	14	care	care	PROPN
ecj-10468	28	15	journal	journal	PROPN
ecj-10468	28	16	2022	2022	NUM
ecj-10468	28	17	;	;	PUNCT
ecj-10468	28	18	18:10468	18:10468	NUM
ecj-10468	28	19	doi:10.4081	doi:10.4081	NOUN
ecj-10468	28	20	/	/	SYM
ecj-10468	28	21	ecj.2022.10468	ecj.2022.10468	NOUN
ecj-10468	28	22	publisher	publisher	NOUN
ecj-10468	28	23	's	's	PART
ecj-10468	28	24	note	note	NOUN
ecj-10468	28	25	:	:	PUNCT
ecj-10468	28	26	all	all	DET
ecj-10468	28	27	claims	claim	NOUN
ecj-10468	28	28	expressed	express	VERB
ecj-10468	28	29	in	in	ADP
ecj-10468	28	30	this	this	DET
ecj-10468	28	31	article	article	NOUN
ecj-10468	28	32	are	be	AUX
ecj-10468	28	33	solely	solely	ADV
ecj-10468	28	34	those	those	PRON
ecj-10468	28	35	of	of	ADP
ecj-10468	28	36	the	the	DET
ecj-10468	28	37	authors	author	NOUN
ecj-10468	28	38	and	and	CCONJ
ecj-10468	28	39	do	do	AUX
ecj-10468	28	40	not	not	PART
ecj-10468	28	41	necessarily	necessarily	ADV
ecj-10468	28	42	represent	represent	VERB
ecj-10468	28	43	those	those	PRON
ecj-10468	28	44	of	of	ADP
ecj-10468	28	45	their	their	PRON
ecj-10468	28	46	affiliated	affiliated	ADJ
ecj-10468	28	47	organizations	organization	NOUN
ecj-10468	28	48	,	,	PUNCT
ecj-10468	28	49	or	or	CCONJ
ecj-10468	28	50	those	those	PRON
ecj-10468	28	51	of	of	ADP
ecj-10468	28	52	the	the	DET
ecj-10468	28	53	publisher	publisher	NOUN
ecj-10468	28	54	,	,	PUNCT
ecj-10468	28	55	the	the	DET
ecj-10468	28	56	editors	editor	NOUN
ecj-10468	28	57	and	and	CCONJ
ecj-10468	28	58	the	the	DET
ecj-10468	28	59	reviewers	reviewer	NOUN
ecj-10468	28	60	.	.	PUNCT
ecj-10468	29	1	any	any	DET
ecj-10468	29	2	product	product	NOUN
ecj-10468	29	3	that	that	PRON
ecj-10468	29	4	may	may	AUX
ecj-10468	29	5	be	be	AUX
ecj-10468	29	6	evaluated	evaluate	VERB
ecj-10468	29	7	in	in	ADP
ecj-10468	29	8	this	this	DET
ecj-10468	29	9	article	article	NOUN
ecj-10468	29	10	or	or	CCONJ
ecj-10468	29	11	claim	claim	NOUN
ecj-10468	29	12	that	that	PRON
ecj-10468	29	13	may	may	AUX
ecj-10468	29	14	be	be	AUX
ecj-10468	29	15	made	make	VERB
ecj-10468	29	16	by	by	ADP
ecj-10468	29	17	its	its	PRON
ecj-10468	29	18	manufacturer	manufacturer	NOUN
ecj-10468	29	19	is	be	AUX
ecj-10468	29	20	not	not	PART
ecj-10468	29	21	guaranteed	guarantee	VERB
ecj-10468	29	22	or	or	CCONJ
ecj-10468	29	23	endorsed	endorse	VERB
ecj-10468	29	24	by	by	ADP
ecj-10468	29	25	the	the	DET
ecj-10468	29	26	publisher	publisher	NOUN
ecj-10468	29	27	.	.	PUNCT
ecj-10468	30	1	[	[	X
ecj-10468	30	2	emergency	emergency	NOUN
ecj-10468	30	3	care	care	NOUN
ecj-10468	30	4	journal	journal	NOUN
ecj-10468	30	5	2022	2022	NUM
ecj-10468	30	6	;	;	PUNCT
ecj-10468	30	7	18:10468	18:10468	NUM
ecj-10468	30	8	]	]	X
ecj-10468	30	9	[	[	X
ecj-10468	30	10	page	page	NOUN
ecj-10468	30	11	9	9	NUM
ecj-10468	30	12	]	]	X
ecj-10468	30	13	covid-19	covid-19	PROPN
ecj-10468	30	14	and	and	CCONJ
ecj-10468	30	15	cutaneous	cutaneous	ADJ
ecj-10468	30	16	manifestations	manifestation	NOUN
ecj-10468	30	17	:	:	PUNCT
ecj-10468	30	18	two	two	NUM
ecj-10468	30	19	cases	case	NOUN
ecj-10468	30	20	and	and	CCONJ
ecj-10468	30	21	a	a	DET
ecj-10468	30	22	review	review	NOUN
ecj-10468	30	23	of	of	ADP
ecj-10468	30	24	the	the	DET
ecj-10468	30	25	literature	literature	PROPN
ecj-10468	30	26	davide	davide	PROPN
ecj-10468	30	27	bastoni,1	bastoni,1	PROPN
ecj-10468	30	28	giorgia	giorgia	PROPN
ecj-10468	30	29	borio,2	borio,2	PROPN
ecj-10468	30	30	paola	paola	PROPN
ecj-10468	30	31	rienzo,2	rienzo,2	PROPN
ecj-10468	30	32	andrea	andrea	PROPN
ecj-10468	30	33	magnacavallo,1	magnacavallo,1	PROPN
ecj-10468	30	34	andrea	andrea	PROPN
ecj-10468	30	35	vercelli,1	vercelli,1	PROPN
ecj-10468	30	36	erika	erika	PROPN
ecj-10468	30	37	poggiali1	poggiali1	PROPN
ecj-10468	30	38	1emergency	1emergency	PROPN
ecj-10468	30	39	department	department	NOUN
ecj-10468	30	40	,	,	PUNCT
ecj-10468	30	41	guglielmo	guglielmo	PROPN
ecj-10468	30	42	da	da	PROPN
ecj-10468	30	43	saliceto	saliceto	PROPN
ecj-10468	30	44	hospital	hospital	NOUN
ecj-10468	30	45	,	,	PUNCT
ecj-10468	30	46	piacenza	piacenza	NOUN
ecj-10468	30	47	;	;	PUNCT
ecj-10468	30	48	2emergency	2emergency	NUM
ecj-10468	30	49	department	department	NOUN
ecj-10468	30	50	,	,	PUNCT
ecj-10468	30	51	san	san	PROPN
ecj-10468	30	52	raffaele	raffaele	PROPN
ecj-10468	30	53	hospital	hospital	PROPN
ecj-10468	30	54	irccs	irccs	PROPN
ecj-10468	30	55	,	,	PUNCT
ecj-10468	30	56	milano	milano	PROPN
ecj-10468	30	57	,	,	PUNCT
ecj-10468	30	58	italy	italy	PROPN
ecj-10468	30	59	highlights	highlight	VERB
ecj-10468	30	60	skin	skin	NOUN
ecj-10468	30	61	rash	rash	NOUN
ecj-10468	30	62	can	can	AUX
ecj-10468	30	63	be	be	AUX
ecj-10468	30	64	an	an	DET
ecj-10468	30	65	extrapulmonary	extrapulmonary	ADJ
ecj-10468	30	66	manifestation	manifestation	NOUN
ecj-10468	30	67	of	of	ADP
ecj-10468	30	68	covid-19	covid-19	PROPN
ecj-10468	30	69	.	.	PUNCT
ecj-10468	31	1	covid-19	covid-19	PROPN
ecj-10468	31	2	cutaneous	cutaneous	ADJ
ecj-10468	31	3	lesions	lesion	NOUN
ecj-10468	31	4	can	can	AUX
ecj-10468	31	5	be	be	AUX
ecj-10468	31	6	classified	classify	VERB
ecj-10468	31	7	in	in	ADP
ecj-10468	31	8	six	six	NUM
ecj-10468	31	9	main	main	ADJ
ecj-10468	31	10	clinical	clinical	ADJ
ecj-10468	31	11	patterns	pattern	NOUN
ecj-10468	31	12	:	:	PUNCT
ecj-10468	31	13	i	i	PRON
ecj-10468	31	14	)	)	PUNCT
ecj-10468	31	15	urticarial	urticarial	ADJ
ecj-10468	31	16	rash	rash	NOUN
ecj-10468	31	17	,	,	PUNCT
ecj-10468	31	18	ii	ii	NOUN
ecj-10468	31	19	)	)	PUNCT
ecj-10468	31	20	confluent	confluent	ADJ
ecj-10468	31	21	erythematous	erythematous	ADJ
ecj-10468	31	22	/	/	SYM
ecj-10468	31	23	maculopapular	maculopapular	ADJ
ecj-10468	31	24	/	/	SYM
ecj-10468	31	25	morbilliform	morbilliform	NOUN
ecj-10468	31	26	rash	rash	NOUN
ecj-10468	31	27	,	,	PUNCT
ecj-10468	31	28	iii	iii	X
ecj-10468	31	29	)	)	PUNCT
ecj-10468	31	30	papulovesicular	papulovesicular	ADJ
ecj-10468	31	31	exanthem	exanthem	PROPN
ecj-10468	31	32	,	,	PUNCT
ecj-10468	31	33	iv	iv	X
ecj-10468	31	34	)	)	PUNCT
ecj-10468	31	35	a	a	DET
ecj-10468	31	36	chilblain	chilblain	NOUN
ecj-10468	31	37	-	-	PUNCT
ecj-10468	31	38	like	like	ADJ
ecj-10468	31	39	acral	acral	ADJ
ecj-10468	31	40	pattern	pattern	NOUN
ecj-10468	31	41	,	,	PUNCT
ecj-10468	31	42	v	v	NOUN
ecj-10468	31	43	)	)	PUNCT
ecj-10468	31	44	a	a	DET
ecj-10468	31	45	livedo	livedo	NOUN
ecj-10468	31	46	reticularis	reticularis	PROPN
ecj-10468	31	47	/	/	SYM
ecj-10468	31	48	racemosa	racemosa	NOUN
ecj-10468	31	49	-	-	PUNCT
ecj-10468	31	50	like	like	ADJ
ecj-10468	31	51	pattern	pattern	NOUN
ecj-10468	31	52	,	,	PUNCT
ecj-10468	31	53	and	and	CCONJ
ecj-10468	31	54	vi	vi	X
ecj-10468	31	55	)	)	PUNCT
ecj-10468	31	56	a	a	DET
ecj-10468	31	57	purpuric	purpuric	ADJ
ecj-10468	31	58	vasculitic	vasculitic	ADJ
ecj-10468	31	59	pattern	pattern	NOUN
ecj-10468	31	60	.	.	PUNCT
ecj-10468	32	1	the	the	DET
ecj-10468	32	2	pathogenesis	pathogenesis	NOUN
ecj-10468	32	3	is	be	AUX
ecj-10468	32	4	not	not	PART
ecj-10468	32	5	completely	completely	ADV
ecj-10468	32	6	clear	clear	ADJ
ecj-10468	32	7	,	,	PUNCT
ecj-10468	32	8	but	but	CCONJ
ecj-10468	32	9	a	a	DET
ecj-10468	32	10	role	role	NOUN
ecj-10468	32	11	of	of	ADP
ecj-10468	32	12	hyperactive	hyperactive	ADJ
ecj-10468	32	13	immune	immune	ADJ
ecj-10468	32	14	response	response	NOUN
ecj-10468	32	15	,	,	PUNCT
ecj-10468	32	16	complement	complement	NOUN
ecj-10468	32	17	activation	activation	NOUN
ecj-10468	32	18	and	and	CCONJ
ecj-10468	32	19	microvascular	microvascular	ADJ
ecj-10468	32	20	injury	injury	NOUN
ecj-10468	32	21	have	have	AUX
ecj-10468	32	22	been	be	AUX
ecj-10468	32	23	postulated	postulate	VERB
ecj-10468	32	24	.	.	PUNCT
ecj-10468	33	1	therapy	therapy	NOUN
ecj-10468	33	2	is	be	AUX
ecj-10468	33	3	based	base	VERB
ecj-10468	33	4	on	on	ADP
ecj-10468	33	5	topical	topical	ADJ
ecj-10468	33	6	or	or	CCONJ
ecj-10468	33	7	systemic	systemic	ADJ
ecj-10468	33	8	corticosteroids	corticosteroid	NOUN
ecj-10468	33	9	with	with	ADP
ecj-10468	33	10	or	or	CCONJ
ecj-10468	33	11	without	without	ADP
ecj-10468	33	12	antihistamines	antihistamine	NOUN
ecj-10468	33	13	,	,	PUNCT
ecj-10468	33	14	or	or	CCONJ
ecj-10468	33	15	a	a	DET
ecj-10468	33	16	“	"	PUNCT
ecj-10468	33	17	wait	wait	VERB
ecj-10468	33	18	-	-	PUNCT
ecj-10468	33	19	and	and	CCONJ
ecj-10468	33	20	-	-	PUNCT
ecj-10468	33	21	see	see	VERB
ecj-10468	33	22	”	"	PUNCT
ecj-10468	33	23	strategy	strategy	NOUN
ecj-10468	33	24	,	,	PUNCT
ecj-10468	33	25	depending	depend	VERB
ecj-10468	33	26	on	on	ADP
ecj-10468	33	27	the	the	DET
ecj-10468	33	28	clinical	clinical	ADJ
ecj-10468	33	29	pattern	pattern	NOUN
ecj-10468	33	30	.	.	PUNCT
ecj-10468	34	1	non	non	ADJ
ecj-10468	34	2	-co	-co	PROPN
ecj-10468	34	3	mmerc	mmerc	PROPN
ecj-10468	34	4	ial	ial	PROPN
ecj-10468	34	5	us	us	PROPN
ecj-10468	34	6	e	e	NOUN
ecj-10468	34	7	o	o	NOUN
ecj-10468	34	8	nly	nly	ADV
ecj-10468	34	9	patient	patient	ADJ
ecj-10468	34	10	was	be	AUX
ecj-10468	34	11	discharged	discharge	VERB
ecj-10468	34	12	after	after	ADP
ecj-10468	34	13	10	10	NUM
ecj-10468	34	14	days	day	NOUN
ecj-10468	34	15	of	of	ADP
ecj-10468	34	16	recovery	recovery	NOUN
ecj-10468	34	17	in	in	ADP
ecj-10468	34	18	good	good	ADJ
ecj-10468	34	19	clinical	clinical	ADJ
ecj-10468	34	20	condition	condition	NOUN
ecj-10468	34	21	without	without	ADP
ecj-10468	34	22	oxygen	oxygen	NOUN
ecj-10468	34	23	need	need	NOUN
ecj-10468	34	24	.	.	PUNCT
ecj-10468	35	1	case	case	NOUN
ecj-10468	35	2	2	2	NUM
ecj-10468	35	3	is	be	AUX
ecj-10468	35	4	a	a	DET
ecj-10468	35	5	65	65	NUM
ecj-10468	35	6	-	-	PUNCT
ecj-10468	35	7	year	year	NOUN
ecj-10468	35	8	-	-	PUNCT
ecj-10468	35	9	old	old	ADJ
ecj-10468	35	10	woman	woman	NOUN
ecj-10468	35	11	with	with	ADP
ecj-10468	35	12	an	an	DET
ecj-10468	35	13	asymptomatic	asymptomatic	ADJ
ecj-10468	35	14	sarscov-2	sarscov-2	NUM
ecj-10468	35	15	infection	infection	NOUN
ecj-10468	35	16	,	,	PUNCT
ecj-10468	35	17	who	who	PRON
ecj-10468	35	18	was	be	AUX
ecj-10468	35	19	admitted	admit	VERB
ecj-10468	35	20	to	to	ADP
ecj-10468	35	21	our	our	PRON
ecj-10468	35	22	ed	ed	NOUN
ecj-10468	35	23	for	for	ADP
ecj-10468	35	24	acute	acute	ADJ
ecj-10468	35	25	onset	onset	NOUN
ecj-10468	35	26	of	of	ADP
ecj-10468	35	27	facial	facial	ADJ
ecj-10468	35	28	oedema	oedema	NOUN
ecj-10468	35	29	with	with	ADP
ecj-10468	35	30	pruritus	pruritus	PROPN
ecj-10468	35	31	,	,	PUNCT
ecj-10468	35	32	treated	treat	VERB
ecj-10468	35	33	by	by	ADP
ecj-10468	35	34	her	her	PRON
ecj-10468	35	35	general	general	ADJ
ecj-10468	35	36	practitioner	practitioner	NOUN
ecj-10468	35	37	with	with	ADP
ecj-10468	35	38	dexamethasone	dexamethasone	NOUN
ecj-10468	35	39	4	4	NUM
ecj-10468	35	40	mg	mg	NOUN
ecj-10468	35	41	i	i	PRON
ecj-10468	35	42	m	m	VERB
ecj-10468	35	43	and	and	CCONJ
ecj-10468	35	44	chlorphenamine	chlorphenamine	ADJ
ecj-10468	35	45	10	10	NUM
ecj-10468	35	46	mg	mg	PROPN
ecj-10468	36	1	i	i	PRON
ecj-10468	36	2	m	m	VERB
ecj-10468	36	3	with	with	ADP
ecj-10468	36	4	partial	partial	ADJ
ecj-10468	36	5	benefit	benefit	NOUN
ecj-10468	36	6	.	.	PUNCT
ecj-10468	37	1	she	she	PRON
ecj-10468	37	2	was	be	AUX
ecj-10468	37	3	vaccinated	vaccinate	VERB
ecj-10468	37	4	with	with	ADP
ecj-10468	37	5	3	3	NUM
ecj-10468	37	6	doses	dose	NOUN
ecj-10468	37	7	of	of	ADP
ecj-10468	37	8	tozinameran	tozinameran	NOUN
ecj-10468	37	9	,	,	PUNCT
ecj-10468	37	10	with	with	ADP
ecj-10468	37	11	no	no	DET
ecj-10468	37	12	adverse	adverse	ADJ
ecj-10468	37	13	reactions	reaction	NOUN
ecj-10468	37	14	.	.	PUNCT
ecj-10468	38	1	she	she	PRON
ecj-10468	38	2	denied	deny	VERB
ecj-10468	38	3	dyspnea	dyspnea	NOUN
ecj-10468	38	4	or	or	CCONJ
ecj-10468	38	5	fever	fever	NOUN
ecj-10468	38	6	.	.	PUNCT
ecj-10468	39	1	she	she	PRON
ecj-10468	39	2	had	have	VERB
ecj-10468	39	3	a	a	DET
ecj-10468	39	4	history	history	NOUN
ecj-10468	39	5	of	of	ADP
ecj-10468	39	6	alpha	alpha	NOUN
ecj-10468	39	7	1	1	NUM
ecj-10468	39	8	antitrypsin	antitrypsin	NOUN
ecj-10468	39	9	deficiency	deficiency	NOUN
ecj-10468	39	10	with	with	ADP
ecj-10468	39	11	chronic	chronic	ADJ
ecj-10468	39	12	obstructive	obstructive	ADJ
ecj-10468	39	13	pulmonary	pulmonary	ADJ
ecj-10468	39	14	disease	disease	NOUN
ecj-10468	39	15	,	,	PUNCT
ecj-10468	39	16	rheumatoid	rheumatoid	NOUN
ecj-10468	39	17	arthritis	arthritis	NOUN
ecj-10468	39	18	,	,	PUNCT
ecj-10468	39	19	and	and	CCONJ
ecj-10468	39	20	hypercholesterolemia	hypercholesterolemia	NOUN
ecj-10468	39	21	.	.	PUNCT
ecj-10468	40	1	her	her	PRON
ecj-10468	40	2	medications	medication	NOUN
ecj-10468	40	3	included	include	VERB
ecj-10468	40	4	alpha-1	alpha-1	NUM
ecj-10468	40	5	antitrypsin	antitrypsin	NOUN
ecj-10468	40	6	,	,	PUNCT
ecj-10468	40	7	adalimumab	adalimumab	NOUN
ecj-10468	40	8	and	and	CCONJ
ecj-10468	40	9	vitamin	vitamin	NOUN
ecj-10468	40	10	d.	d.	PROPN
ecj-10468	40	11	she	she	PRON
ecj-10468	40	12	was	be	AUX
ecj-10468	40	13	allergic	allergic	ADJ
ecj-10468	40	14	to	to	AUX
ecj-10468	40	15	pollen	pollen	VERB
ecj-10468	40	16	with	with	ADP
ecj-10468	40	17	cough	cough	NOUN
ecj-10468	40	18	and	and	CCONJ
ecj-10468	40	19	rhinitis	rhinitis	NOUN
ecj-10468	40	20	.	.	PUNCT
ecj-10468	41	1	during	during	ADP
ecj-10468	41	2	the	the	DET
ecj-10468	41	3	observation	observation	NOUN
ecj-10468	41	4	in	in	ADP
ecj-10468	41	5	the	the	DET
ecj-10468	41	6	emergency	emergency	NOUN
ecj-10468	41	7	room	room	NOUN
ecj-10468	41	8	,	,	PUNCT
ecj-10468	41	9	she	she	PRON
ecj-10468	41	10	developed	develop	VERB
ecj-10468	41	11	urticarial	urticarial	ADJ
ecj-10468	41	12	rash	rash	NOUN
ecj-10468	41	13	of	of	ADP
ecj-10468	41	14	the	the	DET
ecj-10468	41	15	trunks	trunk	NOUN
ecj-10468	41	16	and	and	CCONJ
ecj-10468	41	17	lower	low	ADJ
ecj-10468	41	18	limbs	limb	NOUN
ecj-10468	41	19	with	with	ADP
ecj-10468	41	20	itch	itch	NOUN
ecj-10468	41	21	and	and	CCONJ
ecj-10468	41	22	facial	facial	ADJ
ecj-10468	41	23	angioedema	angioedema	NOUN
ecj-10468	41	24	in	in	ADP
ecj-10468	41	25	absence	absence	NOUN
ecj-10468	41	26	of	of	ADP
ecj-10468	41	27	respiratory	respiratory	ADJ
ecj-10468	41	28	symptoms	symptom	NOUN
ecj-10468	41	29	(	(	PUNCT
ecj-10468	41	30	figure	figure	NOUN
ecj-10468	41	31	2	2	NUM
ecj-10468	41	32	)	)	PUNCT
ecj-10468	41	33	.	.	PUNCT
ecj-10468	42	1	chest	chest	NOUN
ecj-10468	42	2	ct	ct	PROPN
ecj-10468	42	3	scan	scan	PROPN
ecj-10468	42	4	excluded	exclude	VERB
ecj-10468	42	5	interstitial	interstitial	ADJ
ecj-10468	42	6	pneumoniae	pneumoniae	NOUN
ecj-10468	42	7	,	,	PUNCT
ecj-10468	42	8	confirming	confirm	VERB
ecj-10468	42	9	panacinar	panacinar	ADJ
ecj-10468	42	10	emphysema	emphysema	NOUN
ecj-10468	42	11	and	and	CCONJ
ecj-10468	42	12	bronchiectasis	bronchiectasis	NOUN
ecj-10468	42	13	.	.	PUNCT
ecj-10468	43	1	blood	blood	NOUN
ecj-10468	43	2	analysis	analysis	NOUN
ecj-10468	43	3	was	be	AUX
ecj-10468	43	4	normal	normal	ADJ
ecj-10468	43	5	,	,	PUNCT
ecj-10468	43	6	including	include	VERB
ecj-10468	43	7	procalcitonin	procalcitonin	ADJ
ecj-10468	43	8	,	,	PUNCT
ecj-10468	43	9	c	c	NOUN
ecj-10468	43	10	-	-	PUNCT
ecj-10468	43	11	reactive	reactive	ADJ
ecj-10468	43	12	protein	protein	NOUN
ecj-10468	43	13	and	and	CCONJ
ecj-10468	43	14	erythrocyte	erythrocyte	NOUN
ecj-10468	43	15	rate	rate	NOUN
ecj-10468	43	16	sedimentation	sedimentation	NOUN
ecj-10468	43	17	.	.	PUNCT
ecj-10468	44	1	il-6	il-6	NOUN
ecj-10468	44	2	resulted	result	VERB
ecj-10468	44	3	increased	increase	VERB
ecj-10468	44	4	(	(	PUNCT
ecj-10468	44	5	28.21	28.21	NUM
ecj-10468	44	6	pg	pg	NOUN
ecj-10468	44	7	/	/	SYM
ecj-10468	44	8	ml	ml	NOUN
ecj-10468	44	9	,	,	PUNCT
ecj-10468	44	10	normal	normal	ADJ
ecj-10468	44	11	value	value	NOUN
ecj-10468	44	12	<	<	X
ecj-10468	44	13	6.4	6.4	NUM
ecj-10468	44	14	)	)	PUNCT
ecj-10468	44	15	.	.	PUNCT
ecj-10468	45	1	she	she	PRON
ecj-10468	45	2	was	be	AUX
ecj-10468	45	3	treated	treat	VERB
ecj-10468	45	4	with	with	ADP
ecj-10468	45	5	systemic	systemic	ADJ
ecj-10468	45	6	corticosteroids	corticosteroid	NOUN
ecj-10468	45	7	(	(	PUNCT
ecj-10468	45	8	methylprednisolone	methylprednisolone	NOUN
ecj-10468	45	9	40	40	NUM
ecj-10468	45	10	mg	mg	NOUN
ecj-10468	45	11	bid	bid	NOUN
ecj-10468	45	12	)	)	PUNCT
ecj-10468	45	13	and	and	CCONJ
ecj-10468	45	14	antihistamines	antihistamine	NOUN
ecj-10468	45	15	(	(	PUNCT
ecj-10468	45	16	chlorphenamine	chlorphenamine	NOUN
ecj-10468	45	17	10	10	NUM
ecj-10468	45	18	mg	mg	NOUN
ecj-10468	45	19	daily	daily	ADV
ecj-10468	45	20	)	)	PUNCT
ecj-10468	45	21	with	with	ADP
ecj-10468	45	22	progressive	progressive	ADJ
ecj-10468	45	23	improvement	improvement	NOUN
ecj-10468	45	24	of	of	ADP
ecj-10468	45	25	the	the	DET
ecj-10468	45	26	cutaneous	cutaneous	ADJ
ecj-10468	45	27	lesions	lesion	NOUN
ecj-10468	45	28	,	,	PUNCT
ecj-10468	45	29	which	which	PRON
ecj-10468	45	30	completely	completely	ADV
ecj-10468	45	31	solved	solve	VERB
ecj-10468	45	32	after	after	ADP
ecj-10468	45	33	7	7	NUM
ecj-10468	45	34	days	day	NOUN
ecj-10468	45	35	.	.	PUNCT
ecj-10468	46	1	she	she	PRON
ecj-10468	46	2	did	do	AUX
ecj-10468	46	3	not	not	PART
ecj-10468	46	4	develop	develop	VERB
ecj-10468	46	5	respiratory	respiratory	ADJ
ecj-10468	46	6	failure	failure	NOUN
ecj-10468	46	7	during	during	ADP
ecj-10468	46	8	the	the	DET
ecj-10468	46	9	recovery	recovery	NOUN
ecj-10468	46	10	,	,	PUNCT
ecj-10468	46	11	and	and	CCONJ
ecj-10468	46	12	she	she	PRON
ecj-10468	46	13	was	be	AUX
ecj-10468	46	14	completely	completely	ADV
ecj-10468	46	15	asymptomatic	asymptomatic	ADJ
ecj-10468	46	16	at	at	ADP
ecj-10468	46	17	discharge	discharge	NOUN
ecj-10468	46	18	with	with	ADP
ecj-10468	46	19	a	a	DET
ecj-10468	46	20	negative	negative	ADJ
ecj-10468	46	21	rt	rt	ADJ
ecj-10468	46	22	-	-	PUNCT
ecj-10468	46	23	pcr	pcr	ADJ
ecj-10468	46	24	nasopharyngeal	nasopharyngeal	NOUN
ecj-10468	46	25	swab	swab	NOUN
ecj-10468	46	26	.	.	PUNCT
ecj-10468	47	1	discussion	discussion	NOUN
ecj-10468	47	2	since	since	SCONJ
ecj-10468	47	3	the	the	DET
ecj-10468	47	4	first	first	ADJ
ecj-10468	47	5	case	case	NOUN
ecj-10468	47	6	of	of	ADP
ecj-10468	47	7	covid-19	covid-19	PROPN
ecj-10468	47	8	in	in	ADP
ecj-10468	47	9	december	december	PROPN
ecj-10468	47	10	2020	2020	NUM
ecj-10468	47	11	,	,	PUNCT
ecj-10468	47	12	clinicians	clinician	NOUN
ecj-10468	47	13	have	have	AUX
ecj-10468	47	14	learned	learn	VERB
ecj-10468	47	15	that	that	SCONJ
ecj-10468	47	16	the	the	DET
ecj-10468	47	17	most	most	ADV
ecj-10468	47	18	common	common	ADJ
ecj-10468	47	19	clinical	clinical	ADJ
ecj-10468	47	20	manifestations	manifestation	NOUN
ecj-10468	47	21	of	of	ADP
ecj-10468	47	22	this	this	DET
ecj-10468	47	23	disease	disease	NOUN
ecj-10468	47	24	are	be	AUX
ecj-10468	47	25	flu	flu	NOUN
ecj-10468	47	26	-	-	PUNCT
ecj-10468	47	27	like	like	ADJ
ecj-10468	47	28	symptoms	symptom	NOUN
ecj-10468	47	29	,	,	PUNCT
ecj-10468	47	30	such	such	ADJ
ecj-10468	47	31	as	as	ADP
ecj-10468	47	32	cough	cough	NOUN
ecj-10468	47	33	,	,	PUNCT
ecj-10468	47	34	fever	fever	NOUN
ecj-10468	47	35	and	and	CCONJ
ecj-10468	47	36	fatigue	fatigue	NOUN
ecj-10468	47	37	,	,	PUNCT
ecj-10468	47	38	and	and	CCONJ
ecj-10468	47	39	respiratory	respiratory	ADJ
ecj-10468	47	40	symptoms	symptom	NOUN
ecj-10468	47	41	ranging	range	VERB
ecj-10468	47	42	from	from	ADP
ecj-10468	47	43	exertional	exertional	ADJ
ecj-10468	47	44	dyspnea	dyspnea	NOUN
ecj-10468	47	45	to	to	PART
ecj-10468	47	46	acute	acute	VERB
ecj-10468	47	47	respiratory	respiratory	ADJ
ecj-10468	47	48	distress	distress	NOUN
ecj-10468	47	49	syndrome	syndrome	NOUN
ecj-10468	47	50	.	.	PUNCT
ecj-10468	48	1	with	with	ADP
ecj-10468	48	2	the	the	DET
ecj-10468	48	3	worldwide	worldwide	ADJ
ecj-10468	48	4	spread	spread	NOUN
ecj-10468	48	5	of	of	ADP
ecj-10468	48	6	the	the	DET
ecj-10468	48	7	sars	sar	NOUN
ecj-10468	48	8	-	-	PUNCT
ecj-10468	48	9	cov-2	cov-2	NOUN
ecj-10468	48	10	,	,	PUNCT
ecj-10468	48	11	new	new	ADJ
ecj-10468	48	12	symptoms	symptom	NOUN
ecj-10468	48	13	are	be	AUX
ecj-10468	48	14	emerging	emerge	VERB
ecj-10468	48	15	,	,	PUNCT
ecj-10468	48	16	and	and	CCONJ
ecj-10468	48	17	an	an	DET
ecj-10468	48	18	increasing	increase	VERB
ecj-10468	48	19	number	number	NOUN
ecj-10468	48	20	of	of	ADP
ecj-10468	48	21	reports	report	NOUN
ecj-10468	48	22	are	be	AUX
ecj-10468	48	23	documenting	document	VERB
ecj-10468	48	24	extrapulmonary	extrapulmonary	ADJ
ecj-10468	48	25	manifestations	manifestation	NOUN
ecj-10468	48	26	of	of	ADP
ecj-10468	48	27	covid-19	covid-19	PROPN
ecj-10468	48	28	,	,	PUNCT
ecj-10468	48	29	including	include	VERB
ecj-10468	48	30	dermatological	dermatological	ADJ
ecj-10468	48	31	signs	sign	NOUN
ecj-10468	48	32	.	.	PUNCT
ecj-10468	49	1	it	it	PRON
ecj-10468	49	2	is	be	AUX
ecj-10468	49	3	well	well	ADV
ecj-10468	49	4	-	-	PUNCT
ecj-10468	49	5	known	know	VERB
ecj-10468	49	6	that	that	SCONJ
ecj-10468	49	7	most	most	ADJ
ecj-10468	49	8	viruses	virus	NOUN
ecj-10468	49	9	can	can	AUX
ecj-10468	49	10	cause	cause	VERB
ecj-10468	49	11	skin	skin	NOUN
ecj-10468	49	12	manifestations	manifestation	NOUN
ecj-10468	49	13	acting	act	VERB
ecj-10468	49	14	as	as	ADP
ecj-10468	49	15	foreign	foreign	ADJ
ecj-10468	49	16	particles	particle	NOUN
ecj-10468	49	17	in	in	ADP
ecj-10468	49	18	the	the	DET
ecj-10468	49	19	skin1,2	skin1,2	PROPN
ecj-10468	49	20	through	through	ADP
ecj-10468	49	21	an	an	DET
ecj-10468	49	22	inflammatory	inflammatory	ADJ
ecj-10468	49	23	process,3	process,3	NOUN
ecj-10468	49	24	and	and	CCONJ
ecj-10468	49	25	covid-19	covid-19	PROPN
ecj-10468	49	26	associated	associated	ADJ
ecj-10468	49	27	skin	skin	NOUN
ecj-10468	49	28	rashes	rash	NOUN
ecj-10468	49	29	can	can	AUX
ecj-10468	49	30	be	be	AUX
ecj-10468	49	31	a	a	DET
ecj-10468	49	32	manifestation	manifestation	NOUN
ecj-10468	49	33	of	of	ADP
ecj-10468	49	34	viremia,4	viremia,4	NOUN
ecj-10468	49	35	as	as	SCONJ
ecj-10468	49	36	firstly	firstly	ADV
ecj-10468	49	37	reported	report	VERB
ecj-10468	49	38	by	by	ADP
ecj-10468	49	39	recalcati	recalcati	NOUN
ecj-10468	49	40	et	et	PROPN
ecj-10468	49	41	al	al	PROPN
ecj-10468	49	42	.	.	PROPN
ecj-10468	50	1	in	in	ADP
ecj-10468	50	2	a	a	DET
ecj-10468	50	3	case	case	NOUN
ecj-10468	50	4	series	series	NOUN
ecj-10468	50	5	of	of	ADP
ecj-10468	50	6	18	18	NUM
ecj-10468	50	7	covid-19	covid-19	PROPN
ecj-10468	50	8	patients.5	patients.5	PROPN
ecj-10468	50	9	since	since	SCONJ
ecj-10468	50	10	2020	2020	NUM
ecj-10468	50	11	an	an	DET
ecj-10468	50	12	increasing	increase	VERB
ecj-10468	50	13	number	number	NOUN
ecj-10468	50	14	of	of	ADP
ecj-10468	50	15	reports	report	NOUN
ecj-10468	50	16	regarding	regard	VERB
ecj-10468	50	17	covid-19	covid-19	PROPN
ecj-10468	50	18	associated	associated	ADJ
ecj-10468	50	19	cutaneous	cutaneous	ADJ
ecj-10468	50	20	manifestations	manifestation	NOUN
ecj-10468	50	21	has	have	AUX
ecj-10468	50	22	been	be	AUX
ecj-10468	50	23	published,5	published,5	NOUN
ecj-10468	50	24	-	-	PUNCT
ecj-10468	50	25	10	10	NUM
ecj-10468	50	26	but	but	CCONJ
ecj-10468	50	27	the	the	DET
ecj-10468	50	28	real	real	ADJ
ecj-10468	50	29	incidence	incidence	NOUN
ecj-10468	50	30	of	of	ADP
ecj-10468	50	31	the	the	DET
ecj-10468	50	32	covid-19	covid-19	PROPN
ecj-10468	50	33	associated	associated	ADJ
ecj-10468	50	34	cutaneous	cutaneous	ADJ
ecj-10468	50	35	manifestations	manifestation	NOUN
ecj-10468	50	36	has	have	VERB
ecj-10468	50	37	yet	yet	ADV
ecj-10468	50	38	to	to	PART
ecj-10468	50	39	be	be	AUX
ecj-10468	50	40	estimated	estimate	VERB
ecj-10468	50	41	due	due	ADP
ecj-10468	50	42	to	to	ADP
ecj-10468	50	43	their	their	PRON
ecj-10468	50	44	heterogeneous	heterogeneous	ADJ
ecj-10468	50	45	spectrum	spectrum	NOUN
ecj-10468	50	46	of	of	ADP
ecj-10468	50	47	presentation	presentation	NOUN
ecj-10468	50	48	.	.	PUNCT
ecj-10468	51	1	a	a	DET
ecj-10468	51	2	difficulty	difficulty	NOUN
ecj-10468	51	3	in	in	ADP
ecj-10468	51	4	determining	determine	VERB
ecj-10468	51	5	the	the	DET
ecj-10468	51	6	actual	actual	ADJ
ecj-10468	51	7	prevalence	prevalence	NOUN
ecj-10468	51	8	has	have	AUX
ecj-10468	51	9	been	be	AUX
ecj-10468	51	10	mostly	mostly	ADV
ecj-10468	51	11	linked	link	VERB
ecj-10468	51	12	to	to	ADP
ecj-10468	51	13	the	the	DET
ecj-10468	51	14	fact	fact	NOUN
ecj-10468	51	15	that	that	SCONJ
ecj-10468	51	16	in	in	ADP
ecj-10468	51	17	some	some	DET
ecj-10468	51	18	countries	country	NOUN
ecj-10468	51	19	only	only	ADV
ecj-10468	51	20	patients	patient	NOUN
ecj-10468	51	21	with	with	ADP
ecj-10468	51	22	pneumoniae	pneumoniae	NOUN
ecj-10468	51	23	or	or	CCONJ
ecj-10468	51	24	requiring	require	VERB
ecj-10468	51	25	hospitalization	hospitalization	NOUN
ecj-10468	51	26	are	be	AUX
ecj-10468	51	27	screened	screen	VERB
ecj-10468	51	28	.	.	PUNCT
ecj-10468	52	1	in	in	ADP
ecj-10468	52	2	a	a	DET
ecj-10468	52	3	binational	binational	ADJ
ecj-10468	52	4	chinese	chinese	ADJ
ecj-10468	52	5	-	-	PUNCT
ecj-10468	52	6	italian	italian	ADJ
ecj-10468	52	7	cohort	cohort	NOUN
ecj-10468	52	8	of	of	ADP
ecj-10468	52	9	678	678	NUM
ecj-10468	52	10	hospitalized	hospitalize	VERB
ecj-10468	52	11	adults	adult	NOUN
ecj-10468	52	12	with	with	ADP
ecj-10468	52	13	laboratory	laboratory	NOUN
ecj-10468	52	14	confirmed	confirm	VERB
ecj-10468	52	15	disease	disease	NOUN
ecj-10468	52	16	,	,	PUNCT
ecj-10468	52	17	the	the	DET
ecj-10468	52	18	prevalence	prevalence	NOUN
ecj-10468	52	19	was	be	AUX
ecj-10468	52	20	7.8	7.8	NUM
ecj-10468	52	21	%	%	NOUN
ecj-10468	52	22	,	,	PUNCT
ecj-10468	52	23	but	but	CCONJ
ecj-10468	52	24	cutaneous	cutaneous	ADJ
ecj-10468	52	25	lesions	lesion	NOUN
ecj-10468	52	26	are	be	AUX
ecj-10468	52	27	likely	likely	ADJ
ecj-10468	52	28	to	to	PART
ecj-10468	52	29	have	have	AUX
ecj-10468	52	30	been	be	AUX
ecj-10468	52	31	underestimated	underestimate	VERB
ecj-10468	52	32	for	for	ADP
ecj-10468	52	33	many	many	ADJ
ecj-10468	52	34	other	other	ADJ
ecj-10468	52	35	reasons	reason	NOUN
ecj-10468	52	36	,	,	PUNCT
ecj-10468	52	37	including	include	VERB
ecj-10468	52	38	the	the	DET
ecj-10468	52	39	paucity	paucity	NOUN
ecj-10468	52	40	of	of	ADP
ecj-10468	52	41	dermatology	dermatology	NOUN
ecj-10468	52	42	consultations.11	consultations.11	VERB
ecj-10468	52	43	moreover	moreover	ADV
ecj-10468	52	44	,	,	PUNCT
ecj-10468	52	45	cutaneous	cutaneous	ADJ
ecj-10468	52	46	lesions	lesion	NOUN
ecj-10468	52	47	may	may	AUX
ecj-10468	52	48	be	be	AUX
ecj-10468	52	49	neglected	neglect	VERB
ecj-10468	52	50	as	as	SCONJ
ecj-10468	52	51	their	their	PRON
ecj-10468	52	52	duration	duration	NOUN
ecj-10468	52	53	can	can	AUX
ecj-10468	52	54	be	be	AUX
ecj-10468	52	55	very	very	ADV
ecj-10468	52	56	short	short	ADJ
ecj-10468	52	57	and	and	CCONJ
ecj-10468	52	58	local	local	ADJ
ecj-10468	52	59	symptoms	symptom	NOUN
ecj-10468	52	60	can	can	AUX
ecj-10468	52	61	be	be	AUX
ecj-10468	52	62	minimal	minimal	ADJ
ecj-10468	52	63	or	or	CCONJ
ecj-10468	52	64	absent	absent	ADJ
ecj-10468	52	65	.	.	PUNCT
ecj-10468	53	1	the	the	DET
ecj-10468	53	2	first	first	ADJ
ecj-10468	53	3	large	large	ADJ
ecj-10468	53	4	clinical	clinical	ADJ
ecj-10468	53	5	study	study	NOUN
ecj-10468	53	6	of	of	ADP
ecj-10468	53	7	375	375	NUM
ecj-10468	53	8	mini	mini	ADJ
ecj-10468	53	9	review	review	NOUN
ecj-10468	53	10	figure	figure	NOUN
ecj-10468	53	11	2	2	NUM
ecj-10468	53	12	.	.	PUNCT
ecj-10468	53	13	urticarial	urticarial	ADJ
ecj-10468	53	14	rash	rash	NOUN
ecj-10468	53	15	(	(	PUNCT
ecj-10468	53	16	a	a	NOUN
ecj-10468	53	17	)	)	PUNCT
ecj-10468	53	18	of	of	ADP
ecj-10468	53	19	the	the	DET
ecj-10468	53	20	trunk	trunk	NOUN
ecj-10468	53	21	(	(	PUNCT
ecj-10468	53	22	b	b	NOUN
ecj-10468	53	23	)	)	PUNCT
ecj-10468	53	24	and	and	CCONJ
ecj-10468	53	25	lower	low	ADJ
ecj-10468	53	26	limbs	limb	NOUN
ecj-10468	53	27	(	(	PUNCT
ecj-10468	53	28	c	c	NOUN
ecj-10468	53	29	)	)	PUNCT
ecj-10468	53	30	.	.	PUNCT
ecj-10468	54	1	figure	figure	NOUN
ecj-10468	54	2	1	1	NUM
ecj-10468	54	3	.	.	PUNCT
ecj-10468	54	4	urticarial	urticarial	ADJ
ecj-10468	54	5	rash	rash	NOUN
ecj-10468	54	6	involving	involve	VERB
ecj-10468	54	7	the	the	DET
ecj-10468	54	8	abdomen	abdoman	NOUN
ecj-10468	54	9	(	(	PUNCT
ecj-10468	54	10	a	a	X
ecj-10468	54	11	)	)	PUNCT
ecj-10468	54	12	and	and	CCONJ
ecj-10468	54	13	the	the	DET
ecj-10468	54	14	thighs	thigh	NOUN
ecj-10468	54	15	(	(	PUNCT
ecj-10468	54	16	b	b	NOUN
ecj-10468	54	17	)	)	PUNCT
ecj-10468	54	18	.	.	PUNCT
ecj-10468	55	1	[	[	X
ecj-10468	55	2	page	page	NOUN
ecj-10468	55	3	10	10	NUM
ecj-10468	55	4	]	]	PUNCT
ecj-10468	56	1	[	[	X
ecj-10468	56	2	emergency	emergency	NOUN
ecj-10468	56	3	care	care	NOUN
ecj-10468	56	4	journal	journal	NOUN
ecj-10468	56	5	2022	2022	NUM
ecj-10468	56	6	;	;	PUNCT
ecj-10468	56	7	18:10468	18:10468	NUM
ecj-10468	56	8	]	]	X
ecj-10468	56	9	non	non	ADJ
ecj-10468	56	10	-co	-co	PROPN
ecj-10468	56	11	mmerc	mmerc	PROPN
ecj-10468	56	12	ial	ial	PROPN
ecj-10468	56	13	us	us	PROPN
ecj-10468	56	14	e	e	NOUN
ecj-10468	56	15	o	o	NOUN
ecj-10468	56	16	nly	nly	ADV
ecj-10468	56	17	patients	patient	NOUN
ecj-10468	56	18	with	with	ADP
ecj-10468	56	19	covid-19	covid-19	PROPN
ecj-10468	56	20	associated	associate	VERB
ecj-10468	56	21	skin	skin	NOUN
ecj-10468	56	22	manifestations	manifestation	NOUN
ecj-10468	56	23	has	have	AUX
ecj-10468	56	24	been	be	AUX
ecj-10468	56	25	published	publish	VERB
ecj-10468	56	26	in	in	ADP
ecj-10468	56	27	2020	2020	NUM
ecj-10468	56	28	by	by	ADP
ecj-10468	56	29	galvan	galvan	PROPN
ecj-10468	56	30	casas	casas	PROPN
ecj-10468	56	31	et	et	PROPN
ecj-10468	56	32	al.12	al.12	VERB
ecj-10468	56	33	the	the	DET
ecj-10468	56	34	authors	author	NOUN
ecj-10468	56	35	recognized	recognize	VERB
ecj-10468	56	36	five	five	NUM
ecj-10468	56	37	clinical	clinical	ADJ
ecj-10468	56	38	patterns	pattern	NOUN
ecj-10468	56	39	of	of	ADP
ecj-10468	56	40	presentation	presentation	NOUN
ecj-10468	56	41	,	,	PUNCT
ecj-10468	56	42	as	as	SCONJ
ecj-10468	56	43	follows	follow	VERB
ecj-10468	56	44	:	:	PUNCT
ecj-10468	56	45	i	i	PRON
ecj-10468	56	46	)	)	PUNCT
ecj-10468	56	47	acral	acral	ADJ
ecj-10468	56	48	areas	area	NOUN
ecj-10468	56	49	of	of	ADP
ecj-10468	56	50	erythema	erythema	ADJ
ecj-10468	56	51	with	with	ADP
ecj-10468	56	52	vesicles	vesicle	NOUN
ecj-10468	56	53	or	or	CCONJ
ecj-10468	56	54	pustules	pustule	NOUN
ecj-10468	56	55	(	(	PUNCT
ecj-10468	56	56	pseudo	pseudo	NOUN
ecj-10468	56	57	-	-	NOUN
ecj-10468	56	58	chilblains	chilblain	NOUN
ecj-10468	56	59	)	)	PUNCT
ecj-10468	56	60	(	(	PUNCT
ecj-10468	56	61	19	19	NUM
ecj-10468	56	62	%	%	NOUN
ecj-10468	56	63	)	)	PUNCT
ecj-10468	56	64	,	,	PUNCT
ecj-10468	56	65	ii	ii	X
ecj-10468	56	66	)	)	PUNCT
ecj-10468	56	67	other	other	ADJ
ecj-10468	56	68	vesicular	vesicular	ADJ
ecj-10468	56	69	eruptions	eruption	NOUN
ecj-10468	56	70	(	(	PUNCT
ecj-10468	56	71	9	9	NUM
ecj-10468	56	72	%	%	NOUN
ecj-10468	56	73	)	)	PUNCT
ecj-10468	56	74	,	,	PUNCT
ecj-10468	56	75	iii	iii	X
ecj-10468	56	76	)	)	PUNCT
ecj-10468	56	77	urticarial	urticarial	ADJ
ecj-10468	56	78	lesions	lesion	NOUN
ecj-10468	56	79	(	(	PUNCT
ecj-10468	56	80	19	19	NUM
ecj-10468	56	81	%	%	NOUN
ecj-10468	56	82	)	)	PUNCT
ecj-10468	56	83	,	,	PUNCT
ecj-10468	56	84	iv	iv	X
ecj-10468	56	85	)	)	PUNCT
ecj-10468	56	86	maculopapular	maculopapular	ADJ
ecj-10468	56	87	eruptions	eruption	NOUN
ecj-10468	56	88	(	(	PUNCT
ecj-10468	56	89	47	47	NUM
ecj-10468	56	90	%	%	NOUN
ecj-10468	56	91	)	)	PUNCT
ecj-10468	56	92	,	,	PUNCT
ecj-10468	56	93	and	and	CCONJ
ecj-10468	56	94	v	v	NOUN
ecj-10468	56	95	)	)	PUNCT
ecj-10468	56	96	livedo	livedo	NOUN
ecj-10468	56	97	or	or	CCONJ
ecj-10468	56	98	necrosis	necrosis	NOUN
ecj-10468	56	99	(	(	PUNCT
ecj-10468	56	100	6	6	NUM
ecj-10468	56	101	%	%	NOUN
ecj-10468	56	102	)	)	PUNCT
ecj-10468	56	103	.	.	PUNCT
ecj-10468	57	1	vesicular	vesicular	ADJ
ecj-10468	57	2	eruptions	eruption	NOUN
ecj-10468	57	3	were	be	AUX
ecj-10468	57	4	found	find	VERB
ecj-10468	57	5	to	to	PART
ecj-10468	57	6	appear	appear	VERB
ecj-10468	57	7	early	early	ADV
ecj-10468	57	8	in	in	ADP
ecj-10468	57	9	the	the	DET
ecj-10468	57	10	course	course	NOUN
ecj-10468	57	11	of	of	ADP
ecj-10468	57	12	the	the	DET
ecj-10468	57	13	disease	disease	NOUN
ecj-10468	57	14	(	(	PUNCT
ecj-10468	57	15	before	before	ADP
ecj-10468	57	16	other	other	ADJ
ecj-10468	57	17	symptoms	symptom	NOUN
ecj-10468	57	18	in	in	ADP
ecj-10468	57	19	15	15	NUM
ecj-10468	57	20	%	%	NOUN
ecj-10468	57	21	of	of	ADP
ecj-10468	57	22	cases	case	NOUN
ecj-10468	57	23	)	)	PUNCT
ecj-10468	57	24	,	,	PUNCT
ecj-10468	57	25	chilblain	chilblain	NOUN
ecj-10468	57	26	-	-	PUNCT
ecj-10468	57	27	like	like	ADJ
ecj-10468	57	28	lesions	lesion	NOUN
ecj-10468	57	29	frequently	frequently	ADV
ecj-10468	57	30	appear	appear	VERB
ecj-10468	57	31	late	late	ADV
ecj-10468	57	32	over	over	ADP
ecj-10468	57	33	the	the	DET
ecj-10468	57	34	disease	disease	NOUN
ecj-10468	57	35	course	course	NOUN
ecj-10468	57	36	,	,	PUNCT
ecj-10468	57	37	whereas	whereas	SCONJ
ecj-10468	57	38	the	the	DET
ecj-10468	57	39	remaining	remain	VERB
ecj-10468	57	40	patterns	pattern	NOUN
ecj-10468	57	41	tend	tend	VERB
ecj-10468	57	42	to	to	PART
ecj-10468	57	43	develop	develop	VERB
ecj-10468	57	44	during	during	ADP
ecj-10468	57	45	the	the	DET
ecj-10468	57	46	illness	illness	NOUN
ecj-10468	57	47	phase	phase	NOUN
ecj-10468	57	48	.	.	PUNCT
ecj-10468	58	1	chilblain	chilblain	NOUN
ecj-10468	58	2	-	-	PUNCT
ecj-10468	58	3	like	like	ADJ
ecj-10468	58	4	lesions	lesion	NOUN
ecj-10468	58	5	also	also	ADV
ecj-10468	58	6	tend	tend	VERB
ecj-10468	58	7	to	to	PART
ecj-10468	58	8	have	have	VERB
ecj-10468	58	9	a	a	DET
ecj-10468	58	10	longer	long	ADJ
ecj-10468	58	11	duration	duration	NOUN
ecj-10468	58	12	as	as	SCONJ
ecj-10468	58	13	compared	compare	VERB
ecj-10468	58	14	to	to	ADP
ecj-10468	58	15	the	the	DET
ecj-10468	58	16	other	other	ADJ
ecj-10468	58	17	forms	form	NOUN
ecj-10468	58	18	.	.	PUNCT
ecj-10468	59	1	a	a	DET
ecj-10468	59	2	gradient	gradient	NOUN
ecj-10468	59	3	of	of	ADP
ecj-10468	59	4	severity	severity	NOUN
ecj-10468	59	5	of	of	ADP
ecj-10468	59	6	covid-19	covid-19	PROPN
ecj-10468	59	7	could	could	AUX
ecj-10468	59	8	be	be	AUX
ecj-10468	59	9	observed	observe	VERB
ecj-10468	59	10	ranging	range	VERB
ecj-10468	59	11	from	from	ADP
ecj-10468	59	12	less	less	ADV
ecj-10468	59	13	severe	severe	ADJ
ecj-10468	59	14	disease	disease	NOUN
ecj-10468	59	15	in	in	ADP
ecj-10468	59	16	acral	acral	ADJ
ecj-10468	59	17	lesions	lesion	NOUN
ecj-10468	59	18	to	to	ADP
ecj-10468	59	19	most	most	ADV
ecj-10468	59	20	severe	severe	ADJ
ecj-10468	59	21	in	in	ADP
ecj-10468	59	22	the	the	DET
ecj-10468	59	23	case	case	NOUN
ecj-10468	59	24	of	of	ADP
ecj-10468	59	25	livedo.12	livedo.12	PROPN
ecj-10468	59	26	subsequently	subsequently	ADV
ecj-10468	59	27	,	,	PUNCT
ecj-10468	59	28	marzano	marzano	PROPN
ecj-10468	59	29	et	et	PROPN
ecj-10468	59	30	al	al	PROPN
ecj-10468	59	31	.	.	PROPN
ecj-10468	59	32	identified	identify	VERB
ecj-10468	59	33	6	6	NUM
ecj-10468	59	34	main	main	ADJ
ecj-10468	59	35	phenotypes	phenotype	NOUN
ecj-10468	59	36	on	on	ADP
ecj-10468	59	37	the	the	DET
ecj-10468	59	38	basis	basis	NOUN
ecj-10468	59	39	of	of	ADP
ecj-10468	59	40	the	the	DET
ecj-10468	59	41	available	available	ADJ
ecj-10468	59	42	literature	literature	NOUN
ecj-10468	59	43	and	and	CCONJ
ecj-10468	59	44	direct	direct	ADJ
ecj-10468	59	45	clinical	clinical	ADJ
ecj-10468	59	46	experience	experience	NOUN
ecj-10468	59	47	,	,	PUNCT
ecj-10468	59	48	including	include	VERB
ecj-10468	59	49	:	:	PUNCT
ecj-10468	59	50	i	i	NOUN
ecj-10468	59	51	)	)	PUNCT
ecj-10468	59	52	urticarial	urticarial	ADJ
ecj-10468	59	53	rash	rash	NOUN
ecj-10468	59	54	,	,	PUNCT
ecj-10468	59	55	ii	ii	NOUN
ecj-10468	59	56	)	)	PUNCT
ecj-10468	59	57	confluent	confluent	ADJ
ecj-10468	59	58	erythematous	erythematous	ADJ
ecj-10468	59	59	/	/	SYM
ecj-10468	59	60	maculopapular	maculopapular	ADJ
ecj-10468	59	61	/	/	SYM
ecj-10468	59	62	morbilliform	morbilliform	NOUN
ecj-10468	59	63	rash	rash	NOUN
ecj-10468	59	64	,	,	PUNCT
ecj-10468	59	65	iii	iii	X
ecj-10468	59	66	)	)	PUNCT
ecj-10468	59	67	papulovesicular	papulovesicular	ADJ
ecj-10468	59	68	exanthem	exanthem	PROPN
ecj-10468	59	69	,	,	PUNCT
ecj-10468	59	70	iv	iv	X
ecj-10468	59	71	)	)	PUNCT
ecj-10468	59	72	a	a	DET
ecj-10468	59	73	chilblain	chilblain	NOUN
ecj-10468	59	74	-	-	PUNCT
ecj-10468	59	75	like	like	ADJ
ecj-10468	59	76	acral	acral	ADJ
ecj-10468	59	77	pattern	pattern	NOUN
ecj-10468	59	78	,	,	PUNCT
ecj-10468	59	79	v	v	NOUN
ecj-10468	59	80	)	)	PUNCT
ecj-10468	59	81	a	a	DET
ecj-10468	59	82	livedo	livedo	NOUN
ecj-10468	59	83	reticularis	reticularis	PROPN
ecj-10468	59	84	/	/	SYM
ecj-10468	59	85	racemosa	racemosa	NOUN
ecj-10468	59	86	-	-	PUNCT
ecj-10468	59	87	like	like	ADJ
ecj-10468	59	88	pattern	pattern	NOUN
ecj-10468	59	89	,	,	PUNCT
ecj-10468	59	90	and	and	CCONJ
ecj-10468	59	91	vi	vi	X
ecj-10468	59	92	)	)	PUNCT
ecj-10468	59	93	a	a	DET
ecj-10468	59	94	purpuric	purpuric	ADJ
ecj-10468	59	95	vasculitic	vasculitic	ADJ
ecj-10468	59	96	pattern.13	pattern.13	NOUN
ecj-10468	59	97	in	in	ADP
ecj-10468	59	98	addition	addition	NOUN
ecj-10468	59	99	,	,	PUNCT
ecj-10468	59	100	case	case	NOUN
ecj-10468	59	101	series	series	NOUN
ecj-10468	59	102	of	of	ADP
ecj-10468	59	103	a	a	DET
ecj-10468	59	104	miscellany	miscellany	NOUN
ecj-10468	59	105	of	of	ADP
ecj-10468	59	106	other	other	ADJ
ecj-10468	59	107	cutaneous	cutaneous	ADJ
ecj-10468	59	108	presentations	presentation	NOUN
ecj-10468	59	109	that	that	PRON
ecj-10468	59	110	can	can	AUX
ecj-10468	59	111	not	not	PART
ecj-10468	59	112	be	be	AUX
ecj-10468	59	113	included	include	VERB
ecj-10468	59	114	in	in	ADP
ecj-10468	59	115	this	this	DET
ecj-10468	59	116	classification	classification	NOUN
ecj-10468	59	117	,	,	PUNCT
ecj-10468	59	118	such	such	ADJ
ecj-10468	59	119	as	as	ADP
ecj-10468	59	120	erythema	erythema	ADJ
ecj-10468	59	121	multiforme	multiforme	NOUN
ecj-10468	59	122	like,14	like,14	ADV
ecj-10468	59	123	pityriasis	pityriasis	ADV
ecj-10468	59	124	rosea	rosea	NOUN
ecj-10468	59	125	like,15	like,15	NOUN
ecj-10468	59	126	and	and	CCONJ
ecj-10468	59	127	grover	grover	NOUN
ecj-10468	59	128	disease	disease	NOUN
ecj-10468	59	129	like	like	ADP
ecj-10468	59	130	manifestations16	manifestations16	PROPN
ecj-10468	59	131	have	have	AUX
ecj-10468	59	132	been	be	AUX
ecj-10468	59	133	published	publish	VERB
ecj-10468	59	134	.	.	PUNCT
ecj-10468	60	1	considering	consider	VERB
ecj-10468	60	2	the	the	DET
ecj-10468	60	3	pathophysiological	pathophysiological	ADJ
ecj-10468	60	4	mechanisms	mechanism	NOUN
ecj-10468	60	5	,	,	PUNCT
ecj-10468	60	6	these	these	DET
ecj-10468	60	7	six	six	NUM
ecj-10468	60	8	patterns	pattern	NOUN
ecj-10468	60	9	can	can	AUX
ecj-10468	60	10	be	be	AUX
ecj-10468	60	11	assigned	assign	VERB
ecj-10468	60	12	to	to	ADP
ecj-10468	60	13	two	two	NUM
ecj-10468	60	14	broader	broad	ADJ
ecj-10468	60	15	categories	category	NOUN
ecj-10468	60	16	:	:	PUNCT
ecj-10468	60	17	i	i	NOUN
ecj-10468	60	18	)	)	PUNCT
ecj-10468	60	19	inflammatory	inflammatory	ADJ
ecj-10468	60	20	/	/	SYM
ecj-10468	60	21	exanthematous	exanthematous	ADJ
ecj-10468	60	22	eruptions	eruption	NOUN
ecj-10468	60	23	,	,	PUNCT
ecj-10468	60	24	including	include	VERB
ecj-10468	60	25	urticarial	urticarial	ADJ
ecj-10468	60	26	rash	rash	NOUN
ecj-10468	60	27	,	,	PUNCT
ecj-10468	60	28	confluent	confluent	ADJ
ecj-10468	60	29	erythematous	erythematous	ADJ
ecj-10468	60	30	/	/	SYM
ecj-10468	60	31	maculopapular	maculopapular	ADJ
ecj-10468	60	32	/	/	SYM
ecj-10468	60	33	morbilliform	morbilliform	NOUN
ecj-10468	60	34	rash	rash	NOUN
ecj-10468	60	35	and	and	CCONJ
ecj-10468	60	36	papulovesicular	papulovesicular	ADJ
ecj-10468	60	37	exanthem	exanthem	NOUN
ecj-10468	60	38	,	,	PUNCT
ecj-10468	60	39	and	and	CCONJ
ecj-10468	60	40	ii	ii	NOUN
ecj-10468	60	41	)	)	PUNCT
ecj-10468	60	42	vasculopathic	vasculopathic	ADJ
ecj-10468	60	43	/	/	SYM
ecj-10468	60	44	vasculitic	vasculitic	ADJ
ecj-10468	60	45	lesions	lesion	NOUN
ecj-10468	60	46	,	,	PUNCT
ecj-10468	60	47	including	include	VERB
ecj-10468	60	48	chilblainlike	chilblainlike	PROPN
ecj-10468	60	49	acral	acral	PROPN
ecj-10468	60	50	pattern	pattern	NOUN
ecj-10468	60	51	,	,	PUNCT
ecj-10468	60	52	livedo	livedo	PROPN
ecj-10468	60	53	reticularis	reticularis	PROPN
ecj-10468	60	54	/	/	SYM
ecj-10468	60	55	racemosa	racemosa	NOUN
ecj-10468	60	56	-	-	PUNCT
ecj-10468	60	57	like	like	ADJ
ecj-10468	60	58	pattern	pattern	NOUN
ecj-10468	60	59	and	and	CCONJ
ecj-10468	60	60	purpuric	purpuric	ADJ
ecj-10468	60	61	“	"	PUNCT
ecj-10468	60	62	vasculitic	vasculitic	ADJ
ecj-10468	60	63	”	"	PUNCT
ecj-10468	60	64	pattern	pattern	NOUN
ecj-10468	60	65	.	.	PUNCT
ecj-10468	61	1	the	the	DET
ecj-10468	61	2	most	most	ADV
ecj-10468	61	3	frequent	frequent	ADJ
ecj-10468	61	4	cutaneous	cutaneous	ADJ
ecj-10468	61	5	phenotypes	phenotype	NOUN
ecj-10468	61	6	are	be	AUX
ecj-10468	61	7	confluent	confluent	ADJ
ecj-10468	61	8	erythematous	erythematous	ADJ
ecj-10468	61	9	/	/	SYM
ecj-10468	61	10	maculopapular	maculopapular	ADJ
ecj-10468	61	11	/	/	SYM
ecj-10468	61	12	morbilliform	morbilliform	NOUN
ecj-10468	61	13	rash	rash	NOUN
ecj-10468	61	14	and	and	CCONJ
ecj-10468	61	15	a	a	DET
ecj-10468	61	16	chilblain	chilblain	NOUN
ecj-10468	61	17	-	-	PUNCT
ecj-10468	61	18	like	like	ADJ
ecj-10468	61	19	acral	acral	ADJ
ecj-10468	61	20	pattern	pattern	NOUN
ecj-10468	61	21	,	,	PUNCT
ecj-10468	61	22	whereas	whereas	SCONJ
ecj-10468	61	23	the	the	DET
ecj-10468	61	24	least	least	ADJ
ecj-10468	61	25	frequent	frequent	ADJ
ecj-10468	61	26	is	be	AUX
ecj-10468	61	27	a	a	DET
ecj-10468	61	28	livedo	livedo	PROPN
ecj-10468	61	29	reticularis	reticularis	NOUN
ecj-10468	61	30	-	-	PUNCT
ecj-10468	61	31	like	like	ADJ
ecj-10468	61	32	/	/	SYM
ecj-10468	61	33	racemosa	racemosa	NOUN
ecj-10468	61	34	-	-	PUNCT
ecj-10468	61	35	like	like	ADJ
ecj-10468	61	36	pattern	pattern	NOUN
ecj-10468	61	37	.	.	PUNCT
ecj-10468	62	1	mucous	mucous	ADJ
ecj-10468	62	2	membrane	membrane	NOUN
ecj-10468	62	3	lesions	lesion	NOUN
ecj-10468	62	4	have	have	AUX
ecj-10468	62	5	very	very	ADV
ecj-10468	62	6	rarely	rarely	ADV
ecj-10468	62	7	been	be	AUX
ecj-10468	62	8	reported	report	VERB
ecj-10468	62	9	in	in	ADP
ecj-10468	62	10	covid-19	covid-19	PROPN
ecj-10468	62	11	patients	patient	NOUN
ecj-10468	62	12	.	.	PUNCT
ecj-10468	63	1	the	the	DET
ecj-10468	63	2	median	median	ADJ
ecj-10468	63	3	latency	latency	NOUN
ecj-10468	63	4	between	between	ADP
ecj-10468	63	5	the	the	DET
ecj-10468	63	6	onset	onset	NOUN
ecj-10468	63	7	of	of	ADP
ecj-10468	63	8	the	the	DET
ecj-10468	63	9	cutaneous	cutaneous	ADJ
ecj-10468	63	10	manifestations	manifestation	NOUN
ecj-10468	63	11	and	and	CCONJ
ecj-10468	63	12	systemic	systemic	ADJ
ecj-10468	63	13	symptoms	symptom	NOUN
ecj-10468	63	14	is	be	AUX
ecj-10468	63	15	14	14	NUM
ecj-10468	63	16	days	day	NOUN
ecj-10468	63	17	,	,	PUNCT
ecj-10468	63	18	varying	vary	VERB
ecj-10468	63	19	from	from	ADP
ecj-10468	63	20	4	4	NUM
ecj-10468	63	21	days	day	NOUN
ecj-10468	63	22	in	in	ADP
ecj-10468	63	23	the	the	DET
ecj-10468	63	24	case	case	NOUN
ecj-10468	63	25	of	of	ADP
ecj-10468	63	26	papulovesicular	papulovesicular	ADJ
ecj-10468	63	27	exanthem	exanthem	PRON
ecj-10468	63	28	to	to	ADP
ecj-10468	63	29	24.5	24.5	NUM
ecj-10468	63	30	days	day	NOUN
ecj-10468	63	31	in	in	ADP
ecj-10468	63	32	the	the	DET
ecj-10468	63	33	case	case	NOUN
ecj-10468	63	34	of	of	ADP
ecj-10468	63	35	a	a	DET
ecj-10468	63	36	livedo	livedo	PROPN
ecj-10468	63	37	reticularis	reticularis	NOUN
ecj-10468	63	38	-	-	PUNCT
ecj-10468	63	39	like	like	ADJ
ecj-10468	63	40	/	/	SYM
ecj-10468	63	41	racemosa	racemosa	NOUN
ecj-10468	63	42	-	-	PUNCT
ecj-10468	63	43	like	like	ADJ
ecj-10468	63	44	pattern	pattern	NOUN
ecj-10468	63	45	,	,	PUNCT
ecj-10468	63	46	and	and	CCONJ
ecj-10468	63	47	the	the	DET
ecj-10468	63	48	median	median	ADJ
ecj-10468	63	49	duration	duration	NOUN
ecj-10468	63	50	of	of	ADP
ecj-10468	63	51	the	the	DET
ecj-10468	63	52	cutaneous	cutaneous	ADJ
ecj-10468	63	53	manifestations	manifestation	NOUN
ecj-10468	63	54	is	be	AUX
ecj-10468	63	55	12	12	NUM
ecj-10468	63	56	days	day	NOUN
ecj-10468	63	57	,	,	PUNCT
ecj-10468	63	58	ranging	range	VERB
ecj-10468	63	59	from	from	ADP
ecj-10468	63	60	8	8	NUM
ecj-10468	63	61	days	day	NOUN
ecj-10468	63	62	in	in	ADP
ecj-10468	63	63	the	the	DET
ecj-10468	63	64	case	case	NOUN
ecj-10468	63	65	of	of	ADP
ecj-10468	63	66	urticarial	urticarial	ADJ
ecj-10468	63	67	rash	rash	NOUN
ecj-10468	63	68	to	to	ADP
ecj-10468	63	69	22	22	NUM
ecj-10468	63	70	days	day	NOUN
ecj-10468	63	71	in	in	ADP
ecj-10468	63	72	the	the	DET
ecj-10468	63	73	case	case	NOUN
ecj-10468	63	74	of	of	ADP
ecj-10468	63	75	a	a	DET
ecj-10468	63	76	chilblain	chilblain	NOUN
ecj-10468	63	77	-	-	PUNCT
ecj-10468	63	78	like	like	ADJ
ecj-10468	63	79	acral	acral	ADJ
ecj-10468	63	80	pattern	pattern	NOUN
ecj-10468	63	81	.	.	PUNCT
ecj-10468	64	1	only	only	ADV
ecj-10468	64	2	chilblain	chilblain	ADJ
ecj-10468	64	3	-	-	PUNCT
ecj-10468	64	4	like	like	ADJ
ecj-10468	64	5	acral	acral	ADJ
ecj-10468	64	6	phenotype	phenotype	NOUN
ecj-10468	64	7	is	be	AUX
ecj-10468	64	8	significantly	significantly	ADV
ecj-10468	64	9	associated	associate	VERB
ecj-10468	64	10	with	with	ADP
ecj-10468	64	11	the	the	DET
ecj-10468	64	12	benign	benign	ADJ
ecj-10468	64	13	/	/	SYM
ecj-10468	64	14	subclinical	subclinical	ADJ
ecj-10468	64	15	course	course	NOUN
ecj-10468	64	16	of	of	ADP
ecj-10468	64	17	covid-19	covid-19	PROPN
ecj-10468	64	18	.	.	PROPN
ecj-10468	65	1	chilblainlike	chilblainlike	PROPN
ecj-10468	65	2	acral	acral	PROPN
ecj-10468	65	3	phenotype	phenotype	NOUN
ecj-10468	65	4	is	be	AUX
ecj-10468	65	5	also	also	ADV
ecj-10468	65	6	associated	associate	VERB
ecj-10468	65	7	with	with	ADP
ecj-10468	65	8	a	a	DET
ecj-10468	65	9	younger	young	ADJ
ecj-10468	65	10	age	age	NOUN
ecj-10468	65	11	,	,	PUNCT
ecj-10468	65	12	whereas	whereas	SCONJ
ecj-10468	65	13	the	the	DET
ecj-10468	65	14	livedo	livedo	NOUN
ecj-10468	65	15	-	-	PUNCT
ecj-10468	65	16	like	like	ADJ
ecj-10468	65	17	/	/	SYM
ecj-10468	65	18	vasculitic	vasculitic	ADJ
ecj-10468	65	19	and	and	CCONJ
ecj-10468	65	20	maculopapular	maculopapular	ADJ
ecj-10468	65	21	phenotypes	phenotype	NOUN
ecj-10468	65	22	are	be	AUX
ecj-10468	65	23	associated	associate	VERB
ecj-10468	65	24	with	with	ADP
ecj-10468	65	25	an	an	DET
ecj-10468	65	26	older	old	ADJ
ecj-10468	65	27	age.13	age.13	NOUN
ecj-10468	65	28	here	here	ADV
ecj-10468	65	29	we	we	PRON
ecj-10468	65	30	report	report	VERB
ecj-10468	65	31	the	the	DET
ecj-10468	65	32	main	main	ADJ
ecj-10468	65	33	characteristics	characteristic	NOUN
ecj-10468	65	34	for	for	ADP
ecj-10468	65	35	each	each	DET
ecj-10468	65	36	phenotype	phenotype	NOUN
ecj-10468	65	37	(	(	PUNCT
ecj-10468	65	38	table	table	NOUN
ecj-10468	65	39	1	1	NUM
ecj-10468	65	40	)	)	PUNCT
ecj-10468	65	41	.	.	PUNCT
ecj-10468	66	1	inflammatory	inflammatory	ADJ
ecj-10468	66	2	/	/	SYM
ecj-10468	66	3	exanthematous	exanthematous	ADJ
ecj-10468	66	4	eruptions	eruption	NOUN
ecj-10468	66	5	urticarial	urticarial	ADJ
ecj-10468	66	6	rash	rash	NOUN
ecj-10468	66	7	and	and	CCONJ
ecj-10468	66	8	angioedema	angioedema	VERB
ecj-10468	66	9	estimated	estimate	VERB
ecj-10468	66	10	incidence	incidence	NOUN
ecj-10468	66	11	of	of	ADP
ecj-10468	66	12	urticarial	urticarial	ADJ
ecj-10468	66	13	eruptions	eruption	NOUN
ecj-10468	66	14	associated	associate	VERB
ecj-10468	66	15	with	with	ADP
ecj-10468	66	16	covid-19	covid-19	PROPN
ecj-10468	66	17	varies	vary	VERB
ecj-10468	66	18	from	from	ADP
ecj-10468	66	19	16.7	16.7	NUM
ecj-10468	66	20	%	%	NOUN
ecj-10468	66	21	to	to	PART
ecj-10468	66	22	19	19	NUM
ecj-10468	66	23	%	%	NOUN
ecj-10468	66	24	of	of	ADP
ecj-10468	66	25	total	total	ADJ
ecj-10468	66	26	skin	skin	NOUN
ecj-10468	66	27	manifestations.5,12	manifestations.5,12	PROPN
ecj-10468	66	28	familial	familial	ADJ
ecj-10468	66	29	clusters	cluster	NOUN
ecj-10468	66	30	have	have	AUX
ecj-10468	66	31	been	be	AUX
ecj-10468	66	32	reported.17	reported.17	ADJ
ecj-10468	66	33	the	the	DET
ecj-10468	66	34	rash	rash	NOUN
ecj-10468	66	35	tends	tend	VERB
ecj-10468	66	36	to	to	PART
ecj-10468	66	37	appear	appear	VERB
ecj-10468	66	38	simultaneously	simultaneously	ADV
ecj-10468	66	39	with	with	ADP
ecj-10468	66	40	systemic	systemic	ADJ
ecj-10468	66	41	symptoms	symptom	NOUN
ecj-10468	66	42	,	,	PUNCT
ecj-10468	66	43	involving	involve	VERB
ecj-10468	66	44	predominantly	predominantly	ADV
ecj-10468	66	45	the	the	DET
ecj-10468	66	46	trunk	trunk	NOUN
ecj-10468	66	47	and	and	CCONJ
ecj-10468	66	48	limbs	limb	NOUN
ecj-10468	66	49	,	,	PUNCT
ecj-10468	66	50	and	and	CCONJ
ecj-10468	66	51	relatively	relatively	ADV
ecj-10468	66	52	sparing	spare	VERB
ecj-10468	66	53	the	the	DET
ecj-10468	66	54	acral	acral	PROPN
ecj-10468	66	55	sites.18	sites.18	PROPN
ecj-10468	66	56	itch	itch	PROPN
ecj-10468	66	57	is	be	AUX
ecj-10468	66	58	generally	generally	ADV
ecj-10468	66	59	,	,	PUNCT
ecj-10468	66	60	as	as	SCONJ
ecj-10468	66	61	reported	report	VERB
ecj-10468	66	62	in	in	ADP
ecj-10468	66	63	the	the	DET
ecj-10468	66	64	case	case	NOUN
ecj-10468	66	65	1	1	NUM
ecj-10468	66	66	.	.	PUNCT
ecj-10468	67	1	the	the	DET
ecj-10468	67	2	rash	rash	NOUN
ecj-10468	67	3	lasts	last	VERB
ecj-10468	67	4	approximately	approximately	ADV
ecj-10468	67	5	1	1	NUM
ecj-10468	67	6	week	week	NOUN
ecj-10468	67	7	,	,	PUNCT
ecj-10468	67	8	and	and	CCONJ
ecj-10468	67	9	it	it	PRON
ecj-10468	67	10	is	be	AUX
ecj-10468	67	11	associated	associate	VERB
ecj-10468	67	12	with	with	ADP
ecj-10468	67	13	medium	medium	ADJ
ecj-10468	67	14	high	high	ADJ
ecj-10468	67	15	severity	severity	NOUN
ecj-10468	67	16	of	of	ADP
ecj-10468	67	17	covid-19.12	covid-19.12	NOUN
ecj-10468	67	18	angioedema	angioedema	NOUN
ecj-10468	67	19	can	can	AUX
ecj-10468	67	20	accompany	accompany	VERB
ecj-10468	67	21	the	the	DET
ecj-10468	67	22	urticarial	urticarial	ADJ
ecj-10468	67	23	rash	rash	NOUN
ecj-10468	67	24	,	,	PUNCT
ecj-10468	67	25	as	as	SCONJ
ecj-10468	67	26	reported	report	VERB
ecj-10468	67	27	in	in	ADP
ecj-10468	67	28	the	the	DET
ecj-10468	67	29	case	case	NOUN
ecj-10468	67	30	2	2	NUM
ecj-10468	67	31	and	and	CCONJ
ecj-10468	67	32	by	by	ADP
ecj-10468	67	33	najafzadeh	najafzadeh	ADJ
ecj-10468	67	34	et	et	NOUN
ecj-10468	67	35	al.19	al.19	PROPN
ecj-10468	67	36	histopathological	histopathological	ADJ
ecj-10468	67	37	studies	study	NOUN
ecj-10468	67	38	are	be	AUX
ecj-10468	67	39	poor.20	poor.20	PROPN
ecj-10468	67	40	amatore	amatore	PROPN
ecj-10468	67	41	et	et	PROPN
ecj-10468	67	42	al	al	PROPN
ecj-10468	67	43	.	.	PROPN
ecj-10468	67	44	documented	document	VERB
ecj-10468	67	45	the	the	DET
ecj-10468	67	46	presence	presence	NOUN
ecj-10468	67	47	of	of	ADP
ecj-10468	67	48	lichenoid	lichenoid	PROPN
ecj-10468	67	49	and	and	CCONJ
ecj-10468	67	50	vacuolar	vacuolar	ADJ
ecj-10468	67	51	interface	interface	NOUN
ecj-10468	67	52	dermatitis	dermatitis	NOUN
ecj-10468	67	53	,	,	PUNCT
ecj-10468	67	54	associated	associate	VERB
ecj-10468	67	55	with	with	ADP
ecj-10468	67	56	mild	mild	ADJ
ecj-10468	67	57	spongiosis	spongiosis	NOUN
ecj-10468	67	58	,	,	PUNCT
ecj-10468	67	59	dyskeratotic	dyskeratotic	ADJ
ecj-10468	67	60	basal	basal	NOUN
ecj-10468	67	61	keratinocytes	keratinocyte	NOUN
ecj-10468	67	62	and	and	CCONJ
ecj-10468	67	63	mini	mini	ADJ
ecj-10468	67	64	review	review	NOUN
ecj-10468	67	65	table	table	NOUN
ecj-10468	67	66	1	1	NUM
ecj-10468	67	67	.	.	PUNCT
ecj-10468	68	1	the	the	DET
ecj-10468	68	2	six	six	NUM
ecj-10468	68	3	main	main	ADJ
ecj-10468	68	4	covid-19	covid-19	PROPN
ecj-10468	68	5	related	relate	VERB
ecj-10468	68	6	cutaneous	cutaneous	ADJ
ecj-10468	68	7	manifestations	manifestation	NOUN
ecj-10468	68	8	.	.	PUNCT
ecj-10468	69	1	type	type	NOUN
ecj-10468	69	2	clinical	clinical	ADJ
ecj-10468	69	3	features	feature	NOUN
ecj-10468	69	4	body	body	NOUN
ecj-10468	69	5	involvement	involvement	NOUN
ecj-10468	69	6	therapy	therapy	NOUN
ecj-10468	69	7	inflammatory/	inflammatory/	NUM
ecj-10468	69	8	urticarial	urticarial	ADJ
ecj-10468	69	9	rash	rash	NOUN
ecj-10468	69	10	itching	itching	NOUN
ecj-10468	69	11	urticarial	urticarial	ADJ
ecj-10468	69	12	rash	rash	ADJ
ecj-10468	69	13	trunk	trunk	NOUN
ecj-10468	69	14	and	and	CCONJ
ecj-10468	69	15	limbs	limb	NOUN
ecj-10468	69	16	low	low	ADV
ecj-10468	69	17	-	-	PUNCT
ecj-10468	69	18	dose	dose	NOUN
ecj-10468	69	19	systemic	systemic	ADJ
ecj-10468	69	20	corticosteroids	corticosteroid	NOUN
ecj-10468	69	21	+	+	CCONJ
ecj-10468	69	22	exanthematous	exanthematous	ADJ
ecj-10468	69	23	lasting	last	VERB
ecj-10468	69	24	1	1	NUM
ecj-10468	69	25	week	week	NOUN
ecj-10468	69	26	+	+	NOUN
ecj-10468	69	27	/angioedema	/angioedema	SYM
ecj-10468	69	28	non	non	ADJ
ecj-10468	69	29	-	-	ADJ
ecj-10468	69	30	sedating	sedating	ADJ
ecj-10468	69	31	antihistamines	antihistamine	NOUN
ecj-10468	69	32	eruptions	eruption	NOUN
ecj-10468	69	33	confluent	confluent	ADJ
ecj-10468	69	34	erythematous	erythematous	ADJ
ecj-10468	69	35	/	/	SYM
ecj-10468	69	36	symmetrical	symmetrical	ADJ
ecj-10468	69	37	itchy	itchy	ADJ
ecj-10468	69	38	maculopapular	maculopapular	ADJ
ecj-10468	69	39	trunk	trunk	NOUN
ecj-10468	69	40	and	and	CCONJ
ecj-10468	69	41	limbs	limb	NOUN
ecj-10468	69	42	with	with	ADP
ecj-10468	69	43	topical	topical	ADJ
ecj-10468	69	44	steroids	steroid	NOUN
ecj-10468	69	45	.	.	PUNCT
ecj-10468	70	1	maculopapular	maculopapular	ADJ
ecj-10468	70	2	/	/	SYM
ecj-10468	70	3	eruption	eruption	NOUN
ecj-10468	70	4	after	after	ADP
ecj-10468	70	5	covid-19	covid-19	PROPN
ecj-10468	70	6	centrifugal	centrifugal	ADJ
ecj-10468	70	7	progression	progression	NOUN
ecj-10468	70	8	parenteral	parenteral	ADJ
ecj-10468	70	9	route	route	NOUN
ecj-10468	70	10	for	for	ADP
ecj-10468	70	11	severe	severe	ADJ
ecj-10468	70	12	morbilliform	morbilliform	NOUN
ecj-10468	70	13	rash	rash	ADJ
ecj-10468	70	14	systemic	systemic	ADJ
ecj-10468	70	15	symptoms	symptom	NOUN
ecj-10468	70	16	’	'	PUNCT
ecj-10468	70	17	onset	onset	NOUN
ecj-10468	70	18	.	.	PUNCT
ecj-10468	71	1	and	and	CCONJ
ecj-10468	71	2	widespread	widespread	ADJ
ecj-10468	71	3	cases	case	NOUN
ecj-10468	71	4	evolution	evolution	NOUN
ecj-10468	71	5	in	in	ADP
ecj-10468	71	6	morbilliform	morbilliform	NOUN
ecj-10468	71	7	rash	rash	NOUN
ecj-10468	71	8	.	.	PUNCT
ecj-10468	72	1	papulovesicular	papulovesicular	PROPN
ecj-10468	72	2	exanthem	exanthem	PRON
ecj-10468	72	3	“	"	PUNCT
ecj-10468	72	4	varicella	varicella	NOUN
ecj-10468	72	5	-	-	PUNCT
ecj-10468	72	6	like	like	ADJ
ecj-10468	72	7	”	"	PUNCT
ecj-10468	72	8	:	:	PUNCT
ecj-10468	72	9	i	i	PROPN
ecj-10468	72	10	)	)	PUNCT
ecj-10468	72	11	widespread	widespread	ADJ
ecj-10468	72	12	pattern	pattern	NOUN
ecj-10468	72	13	:	:	PUNCT
ecj-10468	72	14	small	small	ADJ
ecj-10468	72	15	papules	papule	NOUN
ecj-10468	72	16	,	,	PUNCT
ecj-10468	72	17	i	i	NOUN
ecj-10468	72	18	)	)	PUNCT
ecj-10468	72	19	widespread	widespread	ADJ
ecj-10468	72	20	;	;	PUNCT
ecj-10468	72	21	wait	wait	VERB
ecj-10468	72	22	and	and	CCONJ
ecj-10468	72	23	see	see	VERB
ecj-10468	72	24	vesicles	vesicle	NOUN
ecj-10468	72	25	,	,	PUNCT
ecj-10468	72	26	and	and	CCONJ
ecj-10468	72	27	pustules	pustule	NOUN
ecj-10468	72	28	of	of	ADP
ecj-10468	72	29	different	different	ADJ
ecj-10468	72	30	sizes	size	NOUN
ecj-10468	72	31	;	;	PUNCT
ecj-10468	72	32	ii	ii	X
ecj-10468	72	33	)	)	PUNCT
ecj-10468	72	34	mid	mid	ADJ
ecj-10468	72	35	chest	chest	NOUN
ecj-10468	72	36	,	,	PUNCT
ecj-10468	72	37	upper	upper	PROPN
ecj-10468	72	38	ii	ii	NOUN
ecj-10468	72	39	)	)	PUNCT
ecj-10468	72	40	localized	localized	ADJ
ecj-10468	72	41	pattern	pattern	NOUN
ecj-10468	72	42	:	:	PUNCT
ecj-10468	72	43	monomorphic	monomorphic	ADJ
ecj-10468	72	44	abdominal	abdominal	ADJ
ecj-10468	72	45	region	region	NOUN
ecj-10468	72	46	or	or	CCONJ
ecj-10468	72	47	the	the	DET
ecj-10468	72	48	back	back	ADJ
ecj-10468	72	49	papulovescicular	papulovescicular	ADJ
ecj-10468	72	50	lesions	lesion	NOUN
ecj-10468	72	51	vasculopathic/	vasculopathic/	NUM
ecj-10468	72	52	chilblain	chilblain	ADV
ecj-10468	72	53	-	-	PUNCT
ecj-10468	72	54	like	like	ADJ
ecj-10468	72	55	acral	acral	ADJ
ecj-10468	72	56	pattern	pattern	NOUN
ecj-10468	72	57	erythematous	erythematous	ADJ
ecj-10468	72	58	-	-	PUNCT
ecj-10468	72	59	violaceous	violaceous	NOUN
ecj-10468	72	60	patches	patch	NOUN
ecj-10468	72	61	or	or	CCONJ
ecj-10468	72	62	feet	foot	NOUN
ecj-10468	72	63	and	and	CCONJ
ecj-10468	72	64	hands	hand	NOUN
ecj-10468	72	65	,	,	PUNCT
ecj-10468	72	66	rarely	rarely	ADV
ecj-10468	72	67	wait	wait	VERB
ecj-10468	72	68	and	and	CCONJ
ecj-10468	72	69	see	see	VERB
ecj-10468	72	70	vasculitic	vasculitic	ADJ
ecj-10468	72	71	lesions	lesion	NOUN
ecj-10468	72	72	plaques	plaque	NOUN
ecj-10468	72	73	+	+	CCONJ
ecj-10468	72	74	pain	pain	NOUN
ecj-10468	72	75	/	/	SYM
ecj-10468	72	76	burning	burn	VERB
ecj-10468	72	77	sensation	sensation	NOUN
ecj-10468	72	78	auricular	auricular	ADJ
ecj-10468	72	79	region	region	NOUN
ecj-10468	72	80	+	+	CCONJ
ecj-10468	72	81	pruritus	pruritus	PROPN
ecj-10468	72	82	livedo	livedo	PROPN
ecj-10468	72	83	reticularis	reticularis	PROPN
ecj-10468	72	84	/	/	SYM
ecj-10468	72	85	i	i	PROPN
ecj-10468	72	86	)	)	PUNCT
ecj-10468	72	87	livedo	livedo	PROPN
ecj-10468	72	88	reticularis	reticularis	PROPN
ecj-10468	72	89	:	:	PUNCT
ecj-10468	72	90	tight	tight	ADJ
ecj-10468	72	91	,	,	PUNCT
ecj-10468	72	92	not	not	PART
ecj-10468	72	93	specific	specific	ADJ
ecj-10468	72	94	wait	wait	NOUN
ecj-10468	72	95	and	and	CCONJ
ecj-10468	72	96	see	see	VERB
ecj-10468	72	97	racemosa	racemosa	NOUN
ecj-10468	72	98	-	-	PUNCT
ecj-10468	72	99	like	like	ADJ
ecj-10468	72	100	pattern	pattern	NOUN
ecj-10468	72	101	symmetrical	symmetrical	ADJ
ecj-10468	72	102	,	,	PUNCT
ecj-10468	72	103	lace	lace	NOUN
ecj-10468	72	104	-	-	PUNCT
ecj-10468	72	105	like	like	ADJ
ecj-10468	72	106	,	,	PUNCT
ecj-10468	72	107	dusky	dusky	ADJ
ecj-10468	72	108	patches	patch	NOUN
ecj-10468	72	109	forming	form	VERB
ecj-10468	72	110	complete	complete	ADJ
ecj-10468	72	111	rings	ring	NOUN
ecj-10468	72	112	surrounding	surround	VERB
ecj-10468	72	113	a	a	DET
ecj-10468	72	114	pale	pale	ADJ
ecj-10468	72	115	center	center	NOUN
ecj-10468	72	116	.	.	PUNCT
ecj-10468	73	1	ii	ii	X
ecj-10468	73	2	)	)	PUNCT
ecj-10468	73	3	livedo	livedo	PROPN
ecj-10468	73	4	racemosa	racemosa	NOUN
ecj-10468	73	5	:	:	PUNCT
ecj-10468	73	6	larger	large	ADJ
ecj-10468	73	7	,	,	PUNCT
ecj-10468	73	8	irregular	irregular	ADJ
ecj-10468	73	9	,	,	PUNCT
ecj-10468	73	10	and	and	CCONJ
ecj-10468	73	11	asymmetrical	asymmetrical	ADJ
ecj-10468	73	12	rings	ring	NOUN
ecj-10468	73	13	.	.	PUNCT
ecj-10468	74	1	possible	possible	ADJ
ecj-10468	74	2	microthrombotic	microthrombotic	ADJ
ecj-10468	74	3	vasculopathy	vasculopathy	NOUN
ecj-10468	74	4	and	and	CCONJ
ecj-10468	74	5	severe	severe	ADJ
ecj-10468	74	6	coagulopathy	coagulopathy	ADJ
ecj-10468	74	7	.	.	PUNCT
ecj-10468	75	1	purpuric	purpuric	ADJ
ecj-10468	75	2	vasculitic	vasculitic	ADJ
ecj-10468	75	3	pattern	pattern	NOUN
ecj-10468	75	4	purpuric	purpuric	ADJ
ecj-10468	75	5	lesions	lesion	NOUN
ecj-10468	75	6	with	with	ADP
ecj-10468	75	7	possible	possible	ADJ
ecj-10468	75	8	evolution	evolution	NOUN
ecj-10468	75	9	acral	acral	ADJ
ecj-10468	75	10	distribution	distribution	NOUN
ecj-10468	75	11	or	or	CCONJ
ecj-10468	75	12	topical	topical	ADJ
ecj-10468	75	13	corticosteroids	corticosteroid	NOUN
ecj-10468	75	14	in	in	ADP
ecj-10468	75	15	haemorrhagic	haemorrhagic	ADJ
ecj-10468	75	16	blisters	blister	NOUN
ecj-10468	75	17	and	and	CCONJ
ecj-10468	75	18	intertriginous	intertriginous	ADJ
ecj-10468	75	19	regions	region	NOUN
ecj-10468	75	20	for	for	ADP
ecj-10468	75	21	mild	mild	ADJ
ecj-10468	75	22	cases	case	NOUN
ecj-10468	75	23	.	.	PUNCT
ecj-10468	76	1	necrotic	necrotic	ADJ
ecj-10468	76	2	-	-	PUNCT
ecj-10468	76	3	ulcerative	ulcerative	ADJ
ecj-10468	76	4	lesions	lesion	NOUN
ecj-10468	76	5	systemic	systemic	ADJ
ecj-10468	76	6	corticosteroids	corticosteroid	NOUN
ecj-10468	76	7	for	for	ADP
ecj-10468	76	8	ulcerative	ulcerative	ADJ
ecj-10468	76	9	lesions	lesion	NOUN
ecj-10468	76	10	and	and	CCONJ
ecj-10468	76	11	widespread	widespread	ADJ
ecj-10468	76	12	presentation	presentation	NOUN
ecj-10468	76	13	[	[	X
ecj-10468	76	14	emergency	emergency	NOUN
ecj-10468	76	15	care	care	NOUN
ecj-10468	76	16	journal	journal	NOUN
ecj-10468	76	17	2022	2022	NUM
ecj-10468	76	18	;	;	PUNCT
ecj-10468	76	19	18:10468	18:10468	NUM
ecj-10468	76	20	]	]	X
ecj-10468	77	1	[	[	X
ecj-10468	77	2	page	page	NOUN
ecj-10468	77	3	11	11	NUM
ecj-10468	77	4	]	]	PUNCT
ecj-10468	77	5	non	non	ADJ
ecj-10468	77	6	-co	-co	PROPN
ecj-10468	77	7	mmerc	mmerc	PROPN
ecj-10468	77	8	ial	ial	PROPN
ecj-10468	77	9	us	us	PROPN
ecj-10468	77	10	e	e	NOUN
ecj-10468	77	11	o	o	NOUN
ecj-10468	77	12	nly	nly	ADV
ecj-10468	77	13	superficial	superficial	ADJ
ecj-10468	77	14	perivascular	perivascular	ADJ
ecj-10468	77	15	lymphocytic	lymphocytic	ADJ
ecj-10468	77	16	infiltrate.21	infiltrate.21	PROPN
ecj-10468	77	17	rodriguezjiménez	rodriguezjiménez	PROPN
ecj-10468	77	18	et	et	PROPN
ecj-10468	77	19	al	al	PROPN
ecj-10468	77	20	.	.	PROPN
ecj-10468	77	21	found	find	VERB
ecj-10468	77	22	a	a	DET
ecj-10468	77	23	vacuolar	vacuolar	ADJ
ecj-10468	77	24	interface	interface	NOUN
ecj-10468	77	25	dermatitis	dermatitis	NOUN
ecj-10468	77	26	with	with	ADP
ecj-10468	77	27	occasional	occasional	ADJ
ecj-10468	77	28	necrotic	necrotic	ADJ
ecj-10468	77	29	keratinocytes	keratinocyte	NOUN
ecj-10468	77	30	compatible	compatible	ADJ
ecj-10468	77	31	with	with	ADP
ecj-10468	77	32	an	an	DET
ecj-10468	77	33	erythema	erythema	ADJ
ecj-10468	77	34	multiformelike	multiformelike	NOUN
ecj-10468	77	35	pattern	pattern	NOUN
ecj-10468	77	36	in	in	ADP
ecj-10468	77	37	a	a	DET
ecj-10468	77	38	60	60	NUM
ecj-10468	77	39	-	-	PUNCT
ecj-10468	77	40	year	year	NOUN
ecj-10468	77	41	-	-	PUNCT
ecj-10468	77	42	old	old	ADJ
ecj-10468	77	43	woman	woman	NOUN
ecj-10468	77	44	with	with	ADP
ecj-10468	77	45	persistent	persistent	ADJ
ecj-10468	77	46	urticarial	urticarial	ADJ
ecj-10468	77	47	eruption	eruption	NOUN
ecj-10468	77	48	and	and	CCONJ
ecj-10468	77	49	interstitial	interstitial	ADJ
ecj-10468	77	50	pneumonia	pneumonia	NOUN
ecj-10468	77	51	who	who	PRON
ecj-10468	77	52	was	be	AUX
ecj-10468	77	53	not	not	PART
ecj-10468	77	54	under	under	ADP
ecj-10468	77	55	any	any	DET
ecj-10468	77	56	medication.22	medication.22	PROPN
ecj-10468	77	57	low	low	ADV
ecj-10468	77	58	-	-	PUNCT
ecj-10468	77	59	dose	dose	NOUN
ecj-10468	77	60	systemic	systemic	ADJ
ecj-10468	77	61	corticosteroids	corticosteroid	NOUN
ecj-10468	77	62	combined	combine	VERB
ecj-10468	77	63	with	with	ADP
ecj-10468	77	64	non	non	ADJ
ecj-10468	77	65	-	-	ADJ
ecj-10468	77	66	sedating	sedating	ADJ
ecj-10468	77	67	antihistamines	antihistamine	NOUN
ecj-10468	77	68	have	have	AUX
ecj-10468	77	69	been	be	AUX
ecj-10468	77	70	suggested	suggest	VERB
ecj-10468	77	71	as	as	ADP
ecj-10468	77	72	therapeutic	therapeutic	ADJ
ecj-10468	77	73	option,23	option,23	NOUN
ecj-10468	77	74	based	base	VERB
ecj-10468	77	75	on	on	ADP
ecj-10468	77	76	the	the	DET
ecj-10468	77	77	hypothesis	hypothesis	NOUN
ecj-10468	77	78	of	of	ADP
ecj-10468	77	79	hyperactivity	hyperactivity	NOUN
ecj-10468	77	80	of	of	ADP
ecj-10468	77	81	the	the	DET
ecj-10468	77	82	immune	immune	ADJ
ecj-10468	77	83	system	system	NOUN
ecj-10468	77	84	in	in	ADP
ecj-10468	77	85	covid-19	covid-19	PROPN
ecj-10468	77	86	patients	patient	NOUN
ecj-10468	77	87	.	.	PUNCT
ecj-10468	78	1	confluent	confluent	ADJ
ecj-10468	78	2	erythematous	erythematous	ADJ
ecj-10468	78	3	/	/	SYM
ecj-10468	78	4	maculopapular	maculopapular	ADJ
ecj-10468	78	5	/	/	SYM
ecj-10468	78	6	morbilliform	morbilliform	NOUN
ecj-10468	78	7	rash	rash	VERB
ecj-10468	78	8	the	the	DET
ecj-10468	78	9	clinical	clinical	ADJ
ecj-10468	78	10	picture	picture	NOUN
ecj-10468	78	11	of	of	ADP
ecj-10468	78	12	this	this	DET
ecj-10468	78	13	group	group	NOUN
ecj-10468	78	14	may	may	AUX
ecj-10468	78	15	range	range	VERB
ecj-10468	78	16	from	from	ADP
ecj-10468	78	17	erythematous	erythematous	ADJ
ecj-10468	78	18	confluent	confluent	ADJ
ecj-10468	78	19	rashes	rash	NOUN
ecj-10468	78	20	to	to	ADP
ecj-10468	78	21	maculopapular	maculopapular	ADJ
ecj-10468	78	22	eruptions	eruption	NOUN
ecj-10468	78	23	and	and	CCONJ
ecj-10468	78	24	morbilliform	morbilliform	NOUN
ecj-10468	78	25	exanthems	exanthem	NOUN
ecj-10468	78	26	,	,	PUNCT
ecj-10468	78	27	similar	similar	ADJ
ecj-10468	78	28	to	to	ADP
ecj-10468	78	29	non	non	ADJ
ecj-10468	78	30	-	-	ADJ
ecj-10468	78	31	specific	specific	ADJ
ecj-10468	78	32	rashes	rash	NOUN
ecj-10468	78	33	observed	observe	VERB
ecj-10468	78	34	in	in	ADP
ecj-10468	78	35	common	common	ADJ
ecj-10468	78	36	viral	viral	ADJ
ecj-10468	78	37	infections	infection	NOUN
ecj-10468	78	38	.	.	PUNCT
ecj-10468	79	1	the	the	DET
ecj-10468	79	2	most	most	ADV
ecj-10468	79	3	commonly	commonly	ADV
ecj-10468	79	4	reported	report	VERB
ecj-10468	79	5	skin	skin	NOUN
ecj-10468	79	6	manifestations	manifestation	NOUN
ecj-10468	79	7	are	be	AUX
ecj-10468	79	8	maculopapular	maculopapular	ADJ
ecj-10468	79	9	eruptions,12	eruptions,12	NOUN
ecj-10468	79	10	which	which	PRON
ecj-10468	79	11	appear	appear	VERB
ecj-10468	79	12	generalized	generalized	ADJ
ecj-10468	79	13	,	,	PUNCT
ecj-10468	79	14	symmetrical	symmetrical	ADJ
ecj-10468	79	15	,	,	PUNCT
ecj-10468	79	16	itchy	itchy	ADJ
ecj-10468	79	17	,	,	PUNCT
ecj-10468	79	18	and	and	CCONJ
ecj-10468	79	19	predominantly	predominantly	ADV
ecj-10468	79	20	localized	localize	VERB
ecj-10468	79	21	on	on	ADP
ecj-10468	79	22	the	the	DET
ecj-10468	79	23	trunk	trunk	NOUN
ecj-10468	79	24	and	and	CCONJ
ecj-10468	79	25	limbs	limb	NOUN
ecj-10468	79	26	with	with	ADP
ecj-10468	79	27	centrifugal	centrifugal	ADJ
ecj-10468	79	28	progression,24	progression,24	VERB
ecj-10468	79	29	more	more	ADV
ecj-10468	79	30	frequently	frequently	ADV
ecj-10468	79	31	after	after	SCONJ
ecj-10468	79	32	covid-19	covid-19	PROPN
ecj-10468	79	33	systemic	systemic	ADJ
ecj-10468	79	34	symptoms	symptom	NOUN
ecj-10468	79	35	’	'	PUNCT
ecj-10468	79	36	onset.25	onset.25	VERB
ecj-10468	79	37	erythematous	erythematous	ADJ
ecj-10468	79	38	lesions	lesion	NOUN
ecj-10468	79	39	can	can	AUX
ecj-10468	79	40	progress	progress	VERB
ecj-10468	79	41	to	to	ADP
ecj-10468	79	42	a	a	DET
ecj-10468	79	43	purpuric	purpuric	ADJ
ecj-10468	79	44	evolution25	evolution25	NOUN
ecj-10468	79	45	or	or	CCONJ
ecj-10468	79	46	coexist	coexist	VERB
ecj-10468	79	47	with	with	ADP
ecj-10468	79	48	purpuric	purpuric	ADJ
ecj-10468	79	49	lesions.26	lesions.26	ADJ
ecj-10468	79	50	maculopapular	maculopapular	ADJ
ecj-10468	79	51	eruptions	eruption	NOUN
ecj-10468	79	52	can	can	AUX
ecj-10468	79	53	change	change	VERB
ecj-10468	79	54	in	in	ADP
ecj-10468	79	55	a	a	DET
ecj-10468	79	56	morbilliform	morbilliform	ADJ
ecj-10468	79	57	pattern.27	pattern.27	PROPN
ecj-10468	79	58	histopathological	histopathological	ADJ
ecj-10468	79	59	studies	study	NOUN
ecj-10468	79	60	were	be	AUX
ecj-10468	79	61	possible	possible	ADJ
ecj-10468	79	62	only	only	ADV
ecj-10468	79	63	in	in	ADP
ecj-10468	79	64	a	a	DET
ecj-10468	79	65	few	few	ADJ
ecj-10468	79	66	patients	patient	NOUN
ecj-10468	79	67	.	.	PUNCT
ecj-10468	80	1	gianotti	gianotti	NOUN
ecj-10468	80	2	at	at	ADP
ecj-10468	80	3	al	al	PROPN
ecj-10468	80	4	.	.	PROPN
ecj-10468	80	5	described	describe	VERB
ecj-10468	80	6	a	a	DET
ecj-10468	80	7	vascular	vascular	ADJ
ecj-10468	80	8	damage	damage	NOUN
ecj-10468	80	9	in	in	ADP
ecj-10468	80	10	all	all	DET
ecj-10468	80	11	the	the	DET
ecj-10468	80	12	3	3	NUM
ecj-10468	80	13	cases	case	NOUN
ecj-10468	80	14	investigated,28	investigated,28	NOUN
ecj-10468	80	15	while	while	SCONJ
ecj-10468	80	16	reymundo	reymundo	VERB
ecj-10468	80	17	et	et	PROPN
ecj-10468	80	18	al	al	PROPN
ecj-10468	80	19	.	.	PROPN
ecj-10468	80	20	documented	document	VERB
ecj-10468	80	21	a	a	DET
ecj-10468	80	22	mild	mild	ADJ
ecj-10468	80	23	superficial	superficial	ADJ
ecj-10468	80	24	perivascular	perivascular	ADJ
ecj-10468	80	25	lymphocytic	lymphocytic	ADJ
ecj-10468	80	26	infiltrate.29	infiltrate.29	NOUN
ecj-10468	80	27	the	the	DET
ecj-10468	80	28	main	main	ADJ
ecj-10468	80	29	differential	differential	NOUN
ecj-10468	80	30	diagnoses	diagnosis	NOUN
ecj-10468	80	31	are	be	AUX
ecj-10468	80	32	drug	drug	NOUN
ecj-10468	80	33	-	-	PUNCT
ecj-10468	80	34	induced	induce	VERB
ecj-10468	80	35	cutaneous	cutaneous	ADJ
ecj-10468	80	36	reactions	reaction	NOUN
ecj-10468	80	37	and	and	CCONJ
ecj-10468	80	38	viral	viral	ADJ
ecj-10468	80	39	exanthems	exanthem	NOUN
ecj-10468	80	40	.	.	PUNCT
ecj-10468	81	1	the	the	DET
ecj-10468	81	2	therapeutic	therapeutic	ADJ
ecj-10468	81	3	management	management	NOUN
ecj-10468	81	4	consists	consist	VERB
ecj-10468	81	5	in	in	ADP
ecj-10468	81	6	corticosteroids	corticosteroid	NOUN
ecj-10468	81	7	according	accord	VERB
ecj-10468	81	8	to	to	ADP
ecj-10468	81	9	the	the	DET
ecj-10468	81	10	severity	severity	NOUN
ecj-10468	81	11	of	of	ADP
ecj-10468	81	12	the	the	DET
ecj-10468	81	13	rash	rash	NOUN
ecj-10468	81	14	:	:	PUNCT
ecj-10468	81	15	topical	topical	ADJ
ecj-10468	81	16	steroids	steroid	NOUN
ecj-10468	81	17	can	can	AUX
ecj-10468	81	18	be	be	AUX
ecj-10468	81	19	used	use	VERB
ecj-10468	81	20	successfully	successfully	ADV
ecj-10468	81	21	in	in	ADP
ecj-10468	81	22	most	most	ADJ
ecj-10468	81	23	cases	case	NOUN
ecj-10468	81	24	,	,	PUNCT
ecj-10468	81	25	reserving	reserve	VERB
ecj-10468	81	26	the	the	DET
ecj-10468	81	27	parenteral	parenteral	ADJ
ecj-10468	81	28	route	route	NOUN
ecj-10468	81	29	to	to	ADP
ecj-10468	81	30	severe	severe	ADJ
ecj-10468	81	31	and	and	CCONJ
ecj-10468	81	32	widespread	widespread	ADJ
ecj-10468	81	33	cases.27	cases.27	PROPN
ecj-10468	81	34	papulovesicular	papulovesicular	ADJ
ecj-10468	81	35	exanthem	exanthem	PRON
ecj-10468	81	36	covid-19	covid-19	PROPN
ecj-10468	81	37	-	-	PUNCT
ecj-10468	81	38	associated	associate	VERB
ecj-10468	81	39	papulovesicular	papulovesicular	ADJ
ecj-10468	81	40	exanthem	exanthem	PRON
ecj-10468	81	41	was	be	AUX
ecj-10468	81	42	firstly	firstly	ADV
ecj-10468	81	43	described	describe	VERB
ecj-10468	81	44	as	as	ADP
ecj-10468	81	45	“	"	PUNCT
ecj-10468	81	46	varicella	varicella	NOUN
ecj-10468	81	47	-	-	PUNCT
ecj-10468	81	48	like	like	ADJ
ecj-10468	81	49	”	"	PUNCT
ecj-10468	81	50	in	in	ADP
ecj-10468	81	51	an	an	DET
ecj-10468	81	52	italian	italian	ADJ
ecj-10468	81	53	multicentre	multicentre	NOUN
ecj-10468	81	54	case	case	NOUN
ecj-10468	81	55	series	series	NOUN
ecj-10468	81	56	of	of	ADP
ecj-10468	81	57	22	22	NUM
ecj-10468	81	58	patients.30	patients.30	NOUN
ecj-10468	81	59	as	as	SCONJ
ecj-10468	81	60	reported	report	VERB
ecj-10468	81	61	by	by	ADP
ecj-10468	81	62	marzano	marzano	PROPN
ecj-10468	81	63	et	et	PROPN
ecj-10468	81	64	al.20	al.20	PROPN
ecj-10468	81	65	this	this	DET
ecj-10468	81	66	exanthem	exanthem	NOUN
ecj-10468	81	67	is	be	AUX
ecj-10468	81	68	a	a	DET
ecj-10468	81	69	rare	rare	ADJ
ecj-10468	81	70	,	,	PUNCT
ecj-10468	81	71	but	but	CCONJ
ecj-10468	81	72	specific	specific	ADJ
ecj-10468	81	73	covid-19	covid-19	PROPN
ecj-10468	81	74	skin	skin	NOUN
ecj-10468	81	75	manifestation	manifestation	NOUN
ecj-10468	81	76	,	,	PUNCT
ecj-10468	81	77	that	that	PRON
ecj-10468	81	78	resembles	resemble	VERB
ecj-10468	81	79	that	that	PRON
ecj-10468	81	80	observed	observe	VERB
ecj-10468	81	81	in	in	ADP
ecj-10468	81	82	true	true	ADJ
ecj-10468	81	83	varicella	varicella	NOUN
ecj-10468	81	84	,	,	PUNCT
ecj-10468	81	85	but	but	CCONJ
ecj-10468	81	86	with	with	ADP
ecj-10468	81	87	a	a	DET
ecj-10468	81	88	different	different	ADJ
ecj-10468	81	89	pattern	pattern	NOUN
ecj-10468	81	90	,	,	PUNCT
ecj-10468	81	91	as	as	SCONJ
ecj-10468	81	92	follows	follow	VERB
ecj-10468	81	93	:	:	PUNCT
ecj-10468	81	94	a	a	DET
ecj-10468	81	95	frequent	frequent	ADJ
ecj-10468	81	96	trunk	trunk	NOUN
ecj-10468	81	97	involvement	involvement	NOUN
ecj-10468	81	98	,	,	PUNCT
ecj-10468	81	99	usually	usually	ADV
ecj-10468	81	100	scattered	scatter	VERB
ecj-10468	81	101	distribution	distribution	NOUN
ecj-10468	81	102	,	,	PUNCT
ecj-10468	81	103	and	and	CCONJ
ecj-10468	81	104	mild	mild	ADJ
ecj-10468	81	105	/	/	SYM
ecj-10468	81	106	absent	absent	ADJ
ecj-10468	81	107	pruritus	pruritus	NOUN
ecj-10468	81	108	.	.	PUNCT
ecj-10468	82	1	lesions	lesion	NOUN
ecj-10468	82	2	generally	generally	ADV
ecj-10468	82	3	appear	appear	VERB
ecj-10468	82	4	3	3	NUM
ecj-10468	82	5	days	day	NOUN
ecj-10468	82	6	after	after	ADP
ecj-10468	82	7	systemic	systemic	ADJ
ecj-10468	82	8	symptoms	symptom	NOUN
ecj-10468	82	9	and	and	CCONJ
ecj-10468	82	10	disappear	disappear	VERB
ecj-10468	82	11	after	after	ADP
ecj-10468	82	12	8	8	NUM
ecj-10468	82	13	days	day	NOUN
ecj-10468	82	14	without	without	ADP
ecj-10468	82	15	leaving	leave	VERB
ecj-10468	82	16	scarring	scarring	NOUN
ecj-10468	82	17	,	,	PUNCT
ecj-10468	82	18	and	and	CCONJ
ecj-10468	82	19	they	they	PRON
ecj-10468	82	20	are	be	AUX
ecj-10468	82	21	associated	associate	VERB
ecj-10468	82	22	with	with	ADP
ecj-10468	82	23	intermediate	intermediate	ADJ
ecj-10468	82	24	covid-19	covid-19	PROPN
ecj-10468	82	25	severity.20	severity.20	PROPN
ecj-10468	82	26	this	this	DET
ecj-10468	82	27	rash	rash	NOUN
ecj-10468	82	28	is	be	AUX
ecj-10468	82	29	more	more	ADV
ecj-10468	82	30	common	common	ADJ
ecj-10468	82	31	in	in	ADP
ecj-10468	82	32	adult	adult	NOUN
ecj-10468	82	33	patients,30	patients,30	NOUN
ecj-10468	82	34	but	but	CCONJ
ecj-10468	82	35	also	also	ADV
ecj-10468	82	36	children	child	NOUN
ecj-10468	82	37	can	can	AUX
ecj-10468	82	38	be	be	AUX
ecj-10468	82	39	affected.31	affected.31	NOUN
ecj-10468	82	40	two	two	NUM
ecj-10468	82	41	different	different	ADJ
ecj-10468	82	42	presentation	presentation	NOUN
ecj-10468	82	43	patterns	pattern	NOUN
ecj-10468	82	44	have	have	AUX
ecj-10468	82	45	been	be	AUX
ecj-10468	82	46	reported	report	VERB
ecj-10468	82	47	:	:	PUNCT
ecj-10468	83	1	i	i	X
ecj-10468	83	2	)	)	PUNCT
ecj-10468	83	3	a	a	DET
ecj-10468	83	4	more	more	ADV
ecj-10468	83	5	common	common	ADJ
ecj-10468	83	6	widespread	widespread	ADJ
ecj-10468	83	7	polymorphic	polymorphic	ADJ
ecj-10468	83	8	pattern	pattern	NOUN
ecj-10468	83	9	consisting	consist	VERB
ecj-10468	83	10	of	of	ADP
ecj-10468	83	11	small	small	ADJ
ecj-10468	83	12	papules	papule	NOUN
ecj-10468	83	13	,	,	PUNCT
ecj-10468	83	14	vesicles	vesicle	NOUN
ecj-10468	83	15	,	,	PUNCT
ecj-10468	83	16	and	and	CCONJ
ecj-10468	83	17	pustules	pustule	NOUN
ecj-10468	83	18	of	of	ADP
ecj-10468	83	19	different	different	ADJ
ecj-10468	83	20	sizes	size	NOUN
ecj-10468	83	21	,	,	PUNCT
ecj-10468	83	22	and	and	CCONJ
ecj-10468	83	23	ii	ii	X
ecj-10468	83	24	)	)	PUNCT
ecj-10468	83	25	a	a	DET
ecj-10468	83	26	localized	localized	ADJ
ecj-10468	83	27	pattern	pattern	NOUN
ecj-10468	83	28	,	,	PUNCT
ecj-10468	83	29	less	less	ADV
ecj-10468	83	30	frequent	frequent	ADJ
ecj-10468	83	31	and	and	CCONJ
ecj-10468	83	32	consisting	consisting	NOUN
ecj-10468	83	33	of	of	ADP
ecj-10468	83	34	monomorphic	monomorphic	ADJ
ecj-10468	83	35	lesions	lesion	NOUN
ecj-10468	83	36	,	,	PUNCT
ecj-10468	83	37	usually	usually	ADV
ecj-10468	83	38	involving	involve	VERB
ecj-10468	83	39	the	the	DET
ecj-10468	83	40	mid	mid	ADJ
ecj-10468	83	41	chest	chest	NOUN
ecj-10468	83	42	/	/	SYM
ecj-10468	83	43	upper	upper	ADJ
ecj-10468	83	44	abdominal	abdominal	ADJ
ecj-10468	83	45	region	region	NOUN
ecj-10468	83	46	or	or	CCONJ
ecj-10468	83	47	the	the	DET
ecj-10468	83	48	back.32	back.32	NOUN
ecj-10468	83	49	the	the	DET
ecj-10468	83	50	prevalence	prevalence	NOUN
ecj-10468	83	51	is	be	AUX
ecj-10468	83	52	extremely	extremely	ADV
ecj-10468	83	53	variable	variable	ADJ
ecj-10468	83	54	.	.	PUNCT
ecj-10468	84	1	indeed	indeed	ADV
ecj-10468	84	2	,	,	PUNCT
ecj-10468	84	3	in	in	ADP
ecj-10468	84	4	a	a	DET
ecj-10468	84	5	cohort	cohort	NOUN
ecj-10468	84	6	of	of	ADP
ecj-10468	84	7	375	375	NUM
ecj-10468	84	8	patients	patient	NOUN
ecj-10468	84	9	with	with	ADP
ecj-10468	84	10	covid-19	covid-19	PROPN
ecj-10468	84	11	-	-	PUNCT
ecj-10468	84	12	associated	associate	VERB
ecj-10468	84	13	cutaneous	cutaneous	ADJ
ecj-10468	84	14	manifestations	manifestation	NOUN
ecj-10468	84	15	patients	patient	NOUN
ecj-10468	84	16	with	with	ADP
ecj-10468	84	17	papulovesicular	papulovesicular	ADJ
ecj-10468	84	18	exanthem	exanthem	PRON
ecj-10468	84	19	were	be	AUX
ecj-10468	84	20	34	34	NUM
ecj-10468	84	21	(	(	PUNCT
ecj-10468	84	22	9%),12	9%),12	NUM
ecj-10468	84	23	while	while	SCONJ
ecj-10468	84	24	they	they	PRON
ecj-10468	84	25	were	be	AUX
ecj-10468	84	26	3	3	NUM
ecj-10468	84	27	out	out	ADP
ecj-10468	84	28	of	of	ADP
ecj-10468	84	29	52	52	NUM
ecj-10468	84	30	(	(	PUNCT
ecj-10468	84	31	5.8	5.8	NUM
ecj-10468	84	32	%	%	NOUN
ecj-10468	84	33	)	)	PUNCT
ecj-10468	84	34	,	,	PUNCT
ecj-10468	84	35	1	1	NUM
ecj-10468	84	36	out	out	ADP
ecj-10468	84	37	of	of	ADP
ecj-10468	84	38	18	18	NUM
ecj-10468	84	39	(	(	PUNCT
ecj-10468	84	40	5.5	5.5	NUM
ecj-10468	84	41	%	%	NOUN
ecj-10468	84	42	)	)	PUNCT
ecj-10468	84	43	and	and	CCONJ
ecj-10468	84	44	2	2	NUM
ecj-10468	84	45	out	out	ADP
ecj-10468	84	46	of	of	ADP
ecj-10468	84	47	53	53	NUM
ecj-10468	84	48	(	(	PUNCT
ecj-10468	84	49	4	4	NUM
ecj-10468	84	50	%	%	NOUN
ecj-10468	84	51	)	)	PUNCT
ecj-10468	84	52	in	in	ADP
ecj-10468	84	53	the	the	DET
ecj-10468	84	54	cohorts	cohort	NOUN
ecj-10468	84	55	published	publish	VERB
ecj-10468	84	56	respectively	respectively	ADV
ecj-10468	84	57	by	by	ADP
ecj-10468	84	58	askin	askin	PROPN
ecj-10468	84	59	et	et	PROPN
ecj-10468	84	60	al	al	PROPN
ecj-10468	84	61	.	.	PROPN
ecj-10468	84	62	,33	,33	PROPN
ecj-10468	84	63	recalcati,5	recalcati,5	PROPN
ecj-10468	84	64	and	and	CCONJ
ecj-10468	84	65	de	de	PROPN
ecj-10468	84	66	giorgi	giorgi	PROPN
ecj-10468	84	67	et	et	PROPN
ecj-10468	84	68	al.11	al.11	ADJ
ecj-10468	84	69	histopathological	histopathological	ADJ
ecj-10468	84	70	studies	study	NOUN
ecj-10468	84	71	showed	show	VERB
ecj-10468	84	72	epidermal	epidermal	ADJ
ecj-10468	84	73	necrosis	necrosis	NOUN
ecj-10468	84	74	with	with	ADP
ecj-10468	84	75	acantholysis	acantholysis	NOUN
ecj-10468	84	76	,	,	PUNCT
ecj-10468	84	77	dyskeratosis	dyskeratosis	NOUN
ecj-10468	84	78	and	and	CCONJ
ecj-10468	84	79	signs	sign	NOUN
ecj-10468	84	80	of	of	ADP
ecj-10468	84	81	endotheliitis	endotheliitis	PRON
ecj-10468	84	82	in	in	ADP
ecj-10468	84	83	the	the	DET
ecj-10468	84	84	dermal	dermal	ADJ
ecj-10468	84	85	vessels.20,34,35	vessels.20,34,35	ADJ
ecj-10468	84	86	immunohistochemical	immunohistochemical	ADJ
ecj-10468	84	87	analysis	analysis	NOUN
ecj-10468	84	88	has	have	AUX
ecj-10468	84	89	demonstrated	demonstrate	VERB
ecj-10468	84	90	the	the	DET
ecj-10468	84	91	presence	presence	NOUN
ecj-10468	84	92	of	of	ADP
ecj-10468	84	93	sars	sar	NOUN
ecj-10468	84	94	-	-	PUNCT
ecj-10468	84	95	cov-2	cov-2	NOUN
ecj-10468	84	96	in	in	ADP
ecj-10468	84	97	the	the	DET
ecj-10468	84	98	endothelial	endothelial	ADJ
ecj-10468	84	99	cells	cell	NOUN
ecj-10468	84	100	of	of	ADP
ecj-10468	84	101	damaged	damage	VERB
ecj-10468	84	102	skin.32	skin.32	NOUN
ecj-10468	84	103	in	in	ADP
ecj-10468	84	104	all	all	DET
ecj-10468	84	105	the	the	DET
ecj-10468	84	106	published	publish	VERB
ecj-10468	84	107	studies	study	NOUN
ecj-10468	84	108	pcr	pcr	ADJ
ecj-10468	84	109	assays	assay	NOUN
ecj-10468	84	110	failed	fail	VERB
ecj-10468	84	111	to	to	PART
ecj-10468	84	112	detect	detect	VERB
ecj-10468	84	113	the	the	DET
ecj-10468	84	114	presence	presence	NOUN
ecj-10468	84	115	of	of	ADP
ecj-10468	84	116	sars	sar	NOUN
ecj-10468	84	117	-	-	PUNCT
ecj-10468	84	118	cov-2	cov-2	NOUN
ecj-10468	84	119	inside	inside	ADP
ecj-10468	84	120	the	the	DET
ecj-10468	84	121	vesicles	vesicle	NOUN
ecj-10468	84	122	.	.	PUNCT
ecj-10468	85	1	however	however	ADV
ecj-10468	85	2	,	,	PUNCT
ecj-10468	85	3	as	as	SCONJ
ecj-10468	85	4	reported	report	VERB
ecj-10468	85	5	by	by	ADP
ecj-10468	85	6	magro	magro	PROPN
ecj-10468	85	7	et	et	PROPN
ecj-10468	85	8	al	al	PROPN
ecj-10468	85	9	.	.	PUNCT
ecj-10468	86	1	a	a	DET
ecj-10468	86	2	small	small	ADJ
ecj-10468	86	3	viral	viral	ADJ
ecj-10468	86	4	load	load	NOUN
ecj-10468	86	5	can	can	AUX
ecj-10468	86	6	result	result	VERB
ecj-10468	86	7	in	in	ADP
ecj-10468	86	8	false	false	ADJ
ecj-10468	86	9	negative	negative	ADJ
ecj-10468	86	10	results	result	NOUN
ecj-10468	86	11	,	,	PUNCT
ecj-10468	86	12	and	and	CCONJ
ecj-10468	86	13	pcr	pcr	ADJ
ecj-10468	86	14	assays	assay	NOUN
ecj-10468	86	15	in	in	ADP
ecj-10468	86	16	skin	skin	NOUN
ecj-10468	86	17	samples	sample	NOUN
ecj-10468	86	18	are	be	AUX
ecj-10468	86	19	not	not	PART
ecj-10468	86	20	standardized.32	standardized.32	VERB
ecj-10468	86	21	the	the	DET
ecj-10468	86	22	differential	differential	ADJ
ecj-10468	86	23	diagnosis	diagnosis	NOUN
ecj-10468	86	24	with	with	ADP
ecj-10468	86	25	infections	infection	NOUN
ecj-10468	86	26	caused	cause	VERB
ecj-10468	86	27	by	by	ADP
ecj-10468	86	28	the	the	DET
ecj-10468	86	29	herpes	herpe	NOUN
ecj-10468	86	30	viridae	viridae	NOUN
ecj-10468	86	31	family	family	NOUN
ecj-10468	86	32	can	can	AUX
ecj-10468	86	33	be	be	AUX
ecj-10468	86	34	difficult	difficult	ADJ
ecj-10468	86	35	and	and	CCONJ
ecj-10468	86	36	in	in	ADP
ecj-10468	86	37	some	some	DET
ecj-10468	86	38	cases	case	NOUN
ecj-10468	86	39	herpes	herpe	NOUN
ecj-10468	86	40	zoster	zoster	NOUN
ecj-10468	86	41	can	can	AUX
ecj-10468	86	42	complicate	complicate	VERB
ecj-10468	86	43	the	the	DET
ecj-10468	86	44	course	course	NOUN
ecj-10468	86	45	of	of	ADP
ecj-10468	86	46	covid-19.36	covid-19.36	VERB
ecj-10468	86	47	the	the	DET
ecj-10468	86	48	current	current	ADJ
ecj-10468	86	49	opinion	opinion	NOUN
ecj-10468	86	50	is	be	AUX
ecj-10468	86	51	to	to	PART
ecj-10468	86	52	consider	consider	VERB
ecj-10468	86	53	herpes	herpe	NOUN
ecj-10468	86	54	viruses	virus	NOUN
ecj-10468	86	55	as	as	ADP
ecj-10468	86	56	a	a	DET
ecj-10468	86	57	mere	mere	ADJ
ecj-10468	86	58	superinfection	superinfection	NOUN
ecj-10468	86	59	in	in	ADP
ecj-10468	86	60	patients	patient	NOUN
ecj-10468	86	61	with	with	ADP
ecj-10468	86	62	dysfunctional	dysfunctional	ADJ
ecj-10468	86	63	immune	immune	ADJ
ecj-10468	86	64	response	response	NOUN
ecj-10468	86	65	associated	associate	VERB
ecj-10468	86	66	with	with	ADP
ecj-10468	86	67	covid-19.37	covid-19.37	NOUN
ecj-10468	86	68	given	give	VERB
ecj-10468	86	69	the	the	DET
ecj-10468	86	70	self	self	NOUN
ecj-10468	86	71	-	-	PUNCT
ecj-10468	86	72	limiting	limit	VERB
ecj-10468	86	73	course	course	NOUN
ecj-10468	86	74	,	,	PUNCT
ecj-10468	86	75	a	a	DET
ecj-10468	86	76	“	"	PUNCT
ecj-10468	86	77	wait	wait	VERB
ecj-10468	86	78	-	-	PUNCT
ecj-10468	86	79	and	and	CCONJ
ecj-10468	86	80	-	-	PUNCT
ecj-10468	86	81	see	see	VERB
ecj-10468	86	82	”	"	PUNCT
ecj-10468	86	83	strategy	strategy	NOUN
ecj-10468	86	84	is	be	AUX
ecj-10468	86	85	the	the	DET
ecj-10468	86	86	most	most	ADV
ecj-10468	86	87	recommend	recommend	ADJ
ecj-10468	86	88	therapeutic	therapeutic	ADJ
ecj-10468	86	89	option	option	NOUN
ecj-10468	86	90	.	.	PUNCT
ecj-10468	87	1	vasculopathic	vasculopathic	ADJ
ecj-10468	87	2	/	/	SYM
ecj-10468	87	3	vasculitic	vasculitic	ADJ
ecj-10468	87	4	lesions	lesion	NOUN
ecj-10468	87	5	chilblain	chilblain	NOUN
ecj-10468	87	6	-	-	PUNCT
ecj-10468	87	7	like	like	ADJ
ecj-10468	87	8	acral	acral	ADJ
ecj-10468	87	9	pattern	pattern	NOUN
ecj-10468	87	10	chilblain	chilblain	NOUN
ecj-10468	87	11	-	-	PUNCT
ecj-10468	87	12	like	like	ADJ
ecj-10468	87	13	acral	acral	ADJ
ecj-10468	87	14	lesions	lesion	NOUN
ecj-10468	87	15	associated	associate	VERB
ecj-10468	87	16	with	with	ADP
ecj-10468	87	17	covid-19	covid-19	PROPN
ecj-10468	87	18	are	be	AUX
ecj-10468	87	19	peculiar	peculiar	ADJ
ecj-10468	87	20	cutaneous	cutaneous	ADJ
ecj-10468	87	21	manifestations	manifestation	NOUN
ecj-10468	87	22	,	,	PUNCT
ecj-10468	87	23	more	more	ADV
ecj-10468	87	24	common	common	ADJ
ecj-10468	87	25	in	in	ADP
ecj-10468	87	26	caucasians,38,39	caucasians,38,39	NOUN
ecj-10468	87	27	that	that	PRON
ecj-10468	87	28	appear	appear	VERB
ecj-10468	87	29	as	as	ADP
ecj-10468	87	30	erythematous	erythematous	ADJ
ecj-10468	87	31	-	-	PUNCT
ecj-10468	87	32	violaceous	violaceous	ADJ
ecj-10468	87	33	patches	patch	NOUN
ecj-10468	87	34	or	or	CCONJ
ecj-10468	87	35	plaques	plaque	NOUN
ecj-10468	87	36	predominantly	predominantly	ADV
ecj-10468	87	37	involving	involve	VERB
ecj-10468	87	38	the	the	DET
ecj-10468	87	39	feet	foot	NOUN
ecj-10468	87	40	and	and	CCONJ
ecj-10468	87	41	hands,40,41	hands,40,41	ADV
ecj-10468	87	42	and	and	CCONJ
ecj-10468	87	43	rarely	rarely	ADV
ecj-10468	87	44	other	other	ADJ
ecj-10468	87	45	acral	acral	ADJ
ecj-10468	87	46	sites	site	NOUN
ecj-10468	87	47	,	,	PUNCT
ecj-10468	87	48	such	such	ADJ
ecj-10468	87	49	as	as	ADP
ecj-10468	87	50	the	the	DET
ecj-10468	87	51	auricular	auricular	ADJ
ecj-10468	87	52	region.42	region.42	NOUN
ecj-10468	87	53	the	the	DET
ecj-10468	87	54	lesions	lesion	NOUN
ecj-10468	87	55	frequently	frequently	ADV
ecj-10468	87	56	appear	appear	VERB
ecj-10468	87	57	late	late	ADV
ecj-10468	87	58	over	over	ADP
ecj-10468	87	59	the	the	DET
ecj-10468	87	60	disease	disease	NOUN
ecj-10468	87	61	course	course	NOUN
ecj-10468	87	62	and	and	CCONJ
ecj-10468	87	63	tend	tend	VERB
ecj-10468	87	64	to	to	PART
ecj-10468	87	65	have	have	VERB
ecj-10468	87	66	a	a	DET
ecj-10468	87	67	longer	long	ADJ
ecj-10468	87	68	duration	duration	NOUN
ecj-10468	87	69	.	.	PUNCT
ecj-10468	88	1	in	in	ADP
ecj-10468	88	2	a	a	DET
ecj-10468	88	3	large	large	ADJ
ecj-10468	88	4	italian	italian	ADJ
ecj-10468	88	5	study	study	NOUN
ecj-10468	88	6	by	by	ADP
ecj-10468	88	7	marzano	marzano	PROPN
ecj-10468	88	8	et	et	PROPN
ecj-10468	88	9	al	al	PROPN
ecj-10468	88	10	.	.	PUNCT
ecj-10468	89	1	the	the	DET
ecj-10468	89	2	chilblain	chilblain	NOUN
ecj-10468	89	3	-	-	PUNCT
ecj-10468	89	4	like	like	ADJ
ecj-10468	89	5	acral	acral	ADJ
ecj-10468	89	6	phenotype	phenotype	NOUN
ecj-10468	89	7	was	be	AUX
ecj-10468	89	8	significantly	significantly	ADV
ecj-10468	89	9	associated	associate	VERB
ecj-10468	89	10	with	with	ADP
ecj-10468	89	11	less	less	ADV
ecj-10468	89	12	severe	severe	ADJ
ecj-10468	89	13	covid-19.13	covid-19.13	PROPN
ecj-10468	89	14	the	the	DET
ecj-10468	89	15	acral	acral	ADJ
ecj-10468	89	16	eruption	eruption	NOUN
ecj-10468	89	17	is	be	AUX
ecj-10468	89	18	frequently	frequently	ADV
ecj-10468	89	19	characterized	characterize	VERB
ecj-10468	89	20	by	by	ADP
ecj-10468	89	21	erythematous	erythematous	ADJ
ecj-10468	89	22	-	-	PUNCT
ecj-10468	89	23	violaceous	violaceous	ADJ
ecj-10468	89	24	papules	papule	NOUN
ecj-10468	89	25	and	and	CCONJ
ecj-10468	89	26	macules	macule	NOUN
ecj-10468	89	27	,	,	PUNCT
ecj-10468	89	28	with	with	ADP
ecj-10468	89	29	possible	possible	ADJ
ecj-10468	89	30	bullous	bullous	ADJ
ecj-10468	89	31	evolution	evolution	NOUN
ecj-10468	89	32	,	,	PUNCT
ecj-10468	89	33	or	or	CCONJ
ecj-10468	89	34	digital	digital	ADJ
ecj-10468	89	35	swelling	swelling	NOUN
ecj-10468	89	36	.	.	PUNCT
ecj-10468	90	1	pain	pain	NOUN
ecj-10468	90	2	/	/	SYM
ecj-10468	90	3	burning	burn	VERB
ecj-10468	90	4	sensation	sensation	NOUN
ecj-10468	90	5	,	,	PUNCT
ecj-10468	90	6	as	as	ADV
ecj-10468	90	7	well	well	ADV
ecj-10468	90	8	as	as	ADP
ecj-10468	90	9	pruritus	pruritus	PROPN
ecj-10468	90	10	,	,	PUNCT
ecj-10468	90	11	are	be	AUX
ecj-10468	90	12	commonly	commonly	ADV
ecj-10468	90	13	reported	report	VERB
ecj-10468	90	14	symptoms	symptom	NOUN
ecj-10468	90	15	.	.	PUNCT
ecj-10468	91	1	dermoscopy	dermoscopy	AUX
ecj-10468	91	2	revealed	reveal	VERB
ecj-10468	91	3	the	the	DET
ecj-10468	91	4	presence	presence	NOUN
ecj-10468	91	5	of	of	ADP
ecj-10468	91	6	an	an	DET
ecj-10468	91	7	indicative	indicative	ADJ
ecj-10468	91	8	pattern	pattern	NOUN
ecj-10468	91	9	represented	represent	VERB
ecj-10468	91	10	by	by	ADP
ecj-10468	91	11	a	a	DET
ecj-10468	91	12	red	red	ADJ
ecj-10468	91	13	background	background	NOUN
ecj-10468	91	14	area	area	NOUN
ecj-10468	91	15	with	with	ADP
ecj-10468	91	16	purpuric	purpuric	ADJ
ecj-10468	91	17	globules.43	globules.43	ADJ
ecj-10468	91	18	young	young	ADJ
ecj-10468	91	19	patients	patient	NOUN
ecj-10468	91	20	confined	confine	VERB
ecj-10468	91	21	at	at	ADP
ecj-10468	91	22	home	home	NOUN
ecj-10468	91	23	,	,	PUNCT
ecj-10468	91	24	in	in	ADP
ecj-10468	91	25	the	the	DET
ecj-10468	91	26	absence	absence	NOUN
ecj-10468	91	27	of	of	ADP
ecj-10468	91	28	cold	cold	ADJ
ecj-10468	91	29	exposure	exposure	NOUN
ecj-10468	91	30	,	,	PUNCT
ecj-10468	91	31	comorbidities	comorbiditie	NOUN
ecj-10468	91	32	or	or	CCONJ
ecj-10468	91	33	other	other	ADJ
ecj-10468	91	34	potential	potential	ADJ
ecj-10468	91	35	triggers	trigger	NOUN
ecj-10468	91	36	,	,	PUNCT
ecj-10468	91	37	and	and	CCONJ
ecj-10468	91	38	without	without	ADP
ecj-10468	91	39	systemic	systemic	ADJ
ecj-10468	91	40	symptoms	symptom	NOUN
ecj-10468	91	41	seem	seem	VERB
ecj-10468	91	42	to	to	PART
ecj-10468	91	43	be	be	AUX
ecj-10468	91	44	mostly	mostly	ADV
ecj-10468	91	45	affected.12,44	affected.12,44	VERB
ecj-10468	91	46	the	the	DET
ecj-10468	91	47	pathogenesis	pathogenesis	NOUN
ecj-10468	91	48	is	be	AUX
ecj-10468	91	49	not	not	PART
ecj-10468	91	50	completely	completely	ADV
ecj-10468	91	51	clear	clear	ADJ
ecj-10468	91	52	.	.	PUNCT
ecj-10468	92	1	different	different	ADJ
ecj-10468	92	2	hypotheses	hypothesis	NOUN
ecj-10468	92	3	have	have	AUX
ecj-10468	92	4	been	be	AUX
ecj-10468	92	5	proposed	propose	VERB
ecj-10468	92	6	,	,	PUNCT
ecj-10468	92	7	including	include	VERB
ecj-10468	92	8	increased	increase	VERB
ecj-10468	92	9	interferon	interferon	ADJ
ecj-10468	92	10	release	release	NOUN
ecj-10468	92	11	induced	induce	VERB
ecj-10468	92	12	by	by	ADP
ecj-10468	92	13	covid-19	covid-19	PROPN
ecj-10468	92	14	and	and	CCONJ
ecj-10468	92	15	consequent	consequent	ADJ
ecj-10468	92	16	cytokine	cytokine	NOUN
ecj-10468	92	17	-	-	PUNCT
ecj-10468	92	18	mediated	mediate	VERB
ecj-10468	92	19	inflammatory	inflammatory	ADJ
ecj-10468	92	20	response	response	NOUN
ecj-10468	92	21	,	,	PUNCT
ecj-10468	92	22	and	and	CCONJ
ecj-10468	92	23	virus	virus	NOUN
ecj-10468	92	24	-	-	PUNCT
ecj-10468	92	25	induced	induce	VERB
ecj-10468	92	26	endothelial	endothelial	ADJ
ecj-10468	92	27	damage	damage	NOUN
ecj-10468	92	28	with	with	ADP
ecj-10468	92	29	obliterative	obliterative	ADJ
ecj-10468	92	30	microangiopathy	microangiopathy	ADJ
ecj-10468	92	31	and	and	CCONJ
ecj-10468	92	32	coagulation	coagulation	NOUN
ecj-10468	92	33	abnormalities.45	abnormalities.45	PROPN
ecj-10468	92	34	data	datum	NOUN
ecj-10468	92	35	on	on	ADP
ecj-10468	92	36	the	the	DET
ecj-10468	92	37	relationship	relationship	NOUN
ecj-10468	92	38	between	between	ADP
ecj-10468	92	39	the	the	DET
ecj-10468	92	40	sars	sar	NOUN
ecj-10468	92	41	-	-	PUNCT
ecj-10468	92	42	cov-2	cov-2	PART
ecj-10468	92	43	infection	infection	NOUN
ecj-10468	92	44	and	and	CCONJ
ecj-10468	92	45	these	these	DET
ecj-10468	92	46	clinical	clinical	ADJ
ecj-10468	92	47	manifestations	manifestation	NOUN
ecj-10468	92	48	are	be	AUX
ecj-10468	92	49	controversial	controversial	ADJ
ecj-10468	92	50	.	.	PUNCT
ecj-10468	93	1	in	in	ADP
ecj-10468	93	2	most	most	ADJ
ecj-10468	93	3	cases	case	NOUN
ecj-10468	93	4	laboratory	laboratory	NOUN
ecj-10468	93	5	confirmation	confirmation	NOUN
ecj-10468	93	6	of	of	ADP
ecj-10468	93	7	the	the	DET
ecj-10468	93	8	infection	infection	NOUN
ecj-10468	93	9	was	be	AUX
ecj-10468	93	10	not	not	PART
ecj-10468	93	11	performed	perform	VERB
ecj-10468	93	12	or	or	CCONJ
ecj-10468	93	13	gave	give	VERB
ecj-10468	93	14	negative	negative	ADJ
ecj-10468	93	15	results	result	NOUN
ecj-10468	93	16	.	.	PUNCT
ecj-10468	94	1	colmenero	colmenero	PROPN
ecj-10468	94	2	et	et	PROPN
ecj-10468	94	3	al	al	PROPN
ecj-10468	94	4	.	.	PROPN
ecj-10468	94	5	demonstrated	demonstrate	VERB
ecj-10468	94	6	the	the	DET
ecj-10468	94	7	presence	presence	NOUN
ecj-10468	94	8	of	of	ADP
ecj-10468	94	9	sars	sars	PROPN
ecj-10468	94	10	cov2	cov2	PROPN
ecj-10468	94	11	in	in	ADP
ecj-10468	94	12	endothelial	endothelial	ADJ
ecj-10468	94	13	cells	cell	NOUN
ecj-10468	94	14	of	of	ADP
ecj-10468	94	15	skin	skin	NOUN
ecj-10468	94	16	biopsies	biopsy	NOUN
ecj-10468	94	17	of	of	ADP
ecj-10468	94	18	7	7	NUM
ecj-10468	94	19	children	child	NOUN
ecj-10468	94	20	with	with	ADP
ecj-10468	94	21	chilblainlike	chilblainlike	ADJ
ecj-10468	94	22	acral	acral	ADJ
ecj-10468	94	23	lesions	lesion	NOUN
ecj-10468	94	24	by	by	ADP
ecj-10468	94	25	immunohistochemistry	immunohistochemistry	NOUN
ecj-10468	94	26	and	and	CCONJ
ecj-10468	94	27	electron	electron	NOUN
ecj-10468	94	28	microscopy	microscopy	NOUN
ecj-10468	94	29	,	,	PUNCT
ecj-10468	94	30	suggesting	suggest	VERB
ecj-10468	94	31	that	that	SCONJ
ecj-10468	94	32	virus	virus	NOUN
ecj-10468	94	33	-	-	PUNCT
ecj-10468	94	34	induced	induce	VERB
ecj-10468	94	35	vascular	vascular	ADJ
ecj-10468	94	36	damage	damage	NOUN
ecj-10468	94	37	and	and	CCONJ
ecj-10468	94	38	secondary	secondary	ADJ
ecj-10468	94	39	ischemia	ischemia	NOUN
ecj-10468	94	40	could	could	AUX
ecj-10468	94	41	explain	explain	VERB
ecj-10468	94	42	the	the	DET
ecj-10468	94	43	pathophysiology	pathophysiology	NOUN
ecj-10468	94	44	of	of	ADP
ecj-10468	94	45	these	these	DET
ecj-10468	94	46	lesions.46	lesions.46	NOUN
ecj-10468	94	47	chilblain	chilblain	VERB
ecj-10468	94	48	-	-	PUNCT
ecj-10468	94	49	like	like	ADJ
ecj-10468	94	50	lesions	lesion	NOUN
ecj-10468	94	51	share	share	VERB
ecj-10468	94	52	many	many	ADJ
ecj-10468	94	53	histopathological	histopathological	ADJ
ecj-10468	94	54	features	feature	NOUN
ecj-10468	94	55	with	with	ADP
ecj-10468	94	56	idiopathic	idiopathic	ADJ
ecj-10468	94	57	and	and	CCONJ
ecj-10468	94	58	autoimmunity	autoimmunity	NOUN
ecj-10468	94	59	-	-	PUNCT
ecj-10468	94	60	related	relate	VERB
ecj-10468	94	61	chilblains	chilblain	NOUN
ecj-10468	94	62	,	,	PUNCT
ecj-10468	94	63	including	include	VERB
ecj-10468	94	64	epidermal	epidermal	ADJ
ecj-10468	94	65	necrotic	necrotic	ADJ
ecj-10468	94	66	keratinocytes	keratinocyte	NOUN
ecj-10468	94	67	,	,	PUNCT
ecj-10468	94	68	dermal	dermal	NOUN
ecj-10468	94	69	edema	edema	NOUN
ecj-10468	94	70	,	,	PUNCT
ecj-10468	94	71	perivascular	perivascular	ADJ
ecj-10468	94	72	and	and	CCONJ
ecj-10468	94	73	perieccrine	perieccrine	ADJ
ecj-10468	94	74	sweat	sweat	NOUN
ecj-10468	94	75	gland	gland	VERB
ecj-10468	94	76	lymphocytic	lymphocytic	ADJ
ecj-10468	94	77	inflammation	inflammation	NOUN
ecj-10468	94	78	.	.	PUNCT
ecj-10468	95	1	in	in	ADP
ecj-10468	95	2	the	the	DET
ecj-10468	95	3	absence	absence	NOUN
ecj-10468	95	4	of	of	ADP
ecj-10468	95	5	significant	significant	ADJ
ecj-10468	95	6	therapeutic	therapeutic	ADJ
ecj-10468	95	7	options	option	NOUN
ecj-10468	95	8	and	and	CCONJ
ecj-10468	95	9	given	give	VERB
ecj-10468	95	10	the	the	DET
ecj-10468	95	11	tendency	tendency	NOUN
ecj-10468	95	12	of	of	ADP
ecj-10468	95	13	these	these	DET
ecj-10468	95	14	cutaneous	cutaneous	ADJ
ecj-10468	95	15	lesions	lesion	NOUN
ecj-10468	95	16	to	to	PART
ecj-10468	95	17	spontaneously	spontaneously	ADV
ecj-10468	95	18	heal	heal	VERB
ecj-10468	95	19	,	,	PUNCT
ecj-10468	95	20	a	a	DET
ecj-10468	95	21	“	"	PUNCT
ecj-10468	95	22	wait	wait	VERB
ecj-10468	95	23	and	and	CCONJ
ecj-10468	95	24	see	see	VERB
ecj-10468	95	25	”	"	PUNCT
ecj-10468	95	26	strategy	strategy	NOUN
ecj-10468	95	27	is	be	AUX
ecj-10468	95	28	recommended	recommend	VERB
ecj-10468	95	29	.	.	PUNCT
ecj-10468	96	1	livedo	livedo	PROPN
ecj-10468	96	2	reticularis	reticularis	PROPN
ecj-10468	96	3	/	/	SYM
ecj-10468	96	4	racemosa	racemosa	NOUN
ecj-10468	96	5	-	-	PUNCT
ecj-10468	96	6	like	like	ADJ
ecj-10468	96	7	pattern	pattern	NOUN
ecj-10468	96	8	livedo	livedo	NOUN
ecj-10468	96	9	appears	appear	VERB
ecj-10468	96	10	as	as	ADP
ecj-10468	96	11	a	a	DET
ecj-10468	96	12	reticulate	reticulate	ADJ
ecj-10468	96	13	pattern	pattern	NOUN
ecj-10468	96	14	of	of	ADP
ecj-10468	96	15	slow	slow	ADJ
ecj-10468	96	16	blood	blood	NOUN
ecj-10468	96	17	flow	flow	NOUN
ecj-10468	96	18	,	,	PUNCT
ecj-10468	96	19	with	with	ADP
ecj-10468	96	20	consequent	consequent	ADJ
ecj-10468	96	21	desaturation	desaturation	NOUN
ecj-10468	96	22	of	of	ADP
ecj-10468	96	23	blood	blood	NOUN
ecj-10468	96	24	and	and	CCONJ
ecj-10468	96	25	bluish	bluish	ADJ
ecj-10468	96	26	cutaneous	cutaneous	ADJ
ecj-10468	96	27	discoloration	discoloration	NOUN
ecj-10468	96	28	.	.	PUNCT
ecj-10468	97	1	it	it	PRON
ecj-10468	97	2	can	can	AUX
ecj-10468	97	3	be	be	AUX
ecj-10468	97	4	classified	classify	VERB
ecj-10468	97	5	in	in	ADP
ecj-10468	97	6	2	2	NUM
ecj-10468	97	7	types	type	NOUN
ecj-10468	97	8	,	,	PUNCT
ecj-10468	97	9	as	as	SCONJ
ecj-10468	97	10	follows	follow	VERB
ecj-10468	97	11	:	:	PUNCT
ecj-10468	97	12	i	i	PRON
ecj-10468	97	13	)	)	PUNCT
ecj-10468	97	14	livedo	livedo	PROPN
ecj-10468	97	15	reticularis	reticularis	PROPN
ecj-10468	97	16	,	,	PUNCT
ecj-10468	97	17	which	which	PRON
ecj-10468	97	18	develops	develop	VERB
ecj-10468	97	19	as	as	ADP
ecj-10468	97	20	tight	tight	ADJ
ecj-10468	97	21	,	,	PUNCT
ecj-10468	97	22	symmetrical	symmetrical	ADJ
ecj-10468	97	23	,	,	PUNCT
ecj-10468	97	24	lace	lace	NOUN
ecj-10468	97	25	-	-	PUNCT
ecj-10468	97	26	like	like	ADJ
ecj-10468	97	27	,	,	PUNCT
ecj-10468	97	28	dusky	dusky	ADJ
ecj-10468	97	29	patches	patch	NOUN
ecj-10468	97	30	forming	form	VERB
ecj-10468	97	31	complete	complete	ADJ
ecj-10468	97	32	rings	ring	NOUN
ecj-10468	97	33	surrounding	surround	VERB
ecj-10468	97	34	a	a	DET
ecj-10468	97	35	pale	pale	ADJ
ecj-10468	97	36	center	center	NOUN
ecj-10468	97	37	,	,	PUNCT
ecj-10468	97	38	and	and	CCONJ
ecj-10468	97	39	ii	ii	X
ecj-10468	97	40	)	)	PUNCT
ecj-10468	97	41	livedo	livedo	PROPN
ecj-10468	97	42	racemosa	racemosa	PROPN
ecj-10468	97	43	,	,	PUNCT
ecj-10468	97	44	characterized	characterize	VERB
ecj-10468	97	45	by	by	ADP
ecj-10468	97	46	larger	large	ADJ
ecj-10468	97	47	,	,	PUNCT
ecj-10468	97	48	irregular	irregular	ADJ
ecj-10468	97	49	,	,	PUNCT
ecj-10468	97	50	and	and	CCONJ
ecj-10468	97	51	asymmetrical	asymmetrical	ADJ
ecj-10468	97	52	rings.47	rings.47	NOUN
ecj-10468	97	53	in	in	ADP
ecj-10468	97	54	a	a	DET
ecj-10468	97	55	large	large	ADJ
ecj-10468	97	56	cases	case	NOUN
ecj-10468	97	57	series	series	NOUN
ecj-10468	97	58	of	of	ADP
ecj-10468	97	59	716	716	NUM
ecj-10468	97	60	patients	patient	NOUN
ecj-10468	97	61	by	by	ADP
ecj-10468	97	62	freeman	freeman	PROPN
ecj-10468	97	63	et	et	PROPN
ecj-10468	97	64	al	al	PROPN
ecj-10468	97	65	.	.	PROPN
ecj-10468	97	66	livedo	livedo	PROPN
ecj-10468	97	67	reticularis	reticularis	PROPN
ecj-10468	97	68	-	-	PUNCT
ecj-10468	97	69	like	like	ADJ
ecj-10468	97	70	lesions	lesion	NOUN
ecj-10468	97	71	and	and	CCONJ
ecj-10468	97	72	livedo	livedo	PROPN
ecj-10468	97	73	racemosa	racemosa	PROPN
ecj-10468	97	74	-	-	PUNCT
ecj-10468	97	75	like	like	ADJ
ecj-10468	97	76	lesions	lesion	NOUN
ecj-10468	97	77	accounted	account	VERB
ecj-10468	97	78	for	for	ADP
ecj-10468	97	79	3.5	3.5	NUM
ecj-10468	97	80	%	%	NOUN
ecj-10468	97	81	and	and	CCONJ
ecj-10468	97	82	0.6	0.6	NUM
ecj-10468	97	83	%	%	NOUN
ecj-10468	97	84	of	of	ADP
ecj-10468	97	85	all	all	DET
ecj-10468	97	86	cutaneous	cutaneous	ADJ
ecj-10468	97	87	manifestations	manifestation	NOUN
ecj-10468	97	88	,	,	PUNCT
ecj-10468	97	89	respectively.18	respectively.18	VERB
ecj-10468	97	90	therefore	therefore	ADV
ecj-10468	97	91	,	,	PUNCT
ecj-10468	97	92	livedo	livedo	PROPN
ecj-10468	97	93	reticularis	reticularis	PROPN
ecj-10468	97	94	and	and	CCONJ
ecj-10468	97	95	racemosa	racemosa	NOUN
ecj-10468	97	96	-	-	PUNCT
ecj-10468	97	97	like	like	ADJ
ecj-10468	97	98	lesions	lesion	NOUN
ecj-10468	97	99	have	have	AUX
ecj-10468	97	100	been	be	AUX
ecj-10468	97	101	suggested	suggest	VERB
ecj-10468	97	102	to	to	PART
ecj-10468	97	103	occur	occur	VERB
ecj-10468	97	104	in	in	ADP
ecj-10468	97	105	elderly	elderly	ADJ
ecj-10468	97	106	patients	patient	NOUN
ecj-10468	97	107	with	with	ADP
ecj-10468	97	108	severe	severe	ADJ
ecj-10468	97	109	systemic	systemic	ADJ
ecj-10468	97	110	symptoms	symptom	NOUN
ecj-10468	97	111	and	and	CCONJ
ecj-10468	97	112	were	be	AUX
ecj-10468	97	113	pronounced	pronounce	VERB
ecj-10468	97	114	and/or	and/or	CCONJ
ecj-10468	97	115	persistent.12	persistent.12	VERB
ecj-10468	97	116	the	the	DET
ecj-10468	97	117	basis	basis	NOUN
ecj-10468	97	118	of	of	ADP
ecj-10468	97	119	mini	mini	ADJ
ecj-10468	97	120	review	review	NOUN
ecj-10468	97	121	[	[	X
ecj-10468	97	122	page	page	NOUN
ecj-10468	97	123	12	12	NUM
ecj-10468	97	124	]	]	PUNCT
ecj-10468	98	1	[	[	X
ecj-10468	98	2	emergency	emergency	NOUN
ecj-10468	98	3	care	care	NOUN
ecj-10468	98	4	journal	journal	NOUN
ecj-10468	98	5	2022	2022	NUM
ecj-10468	98	6	;	;	PUNCT
ecj-10468	98	7	18:10468	18:10468	NUM
ecj-10468	98	8	]	]	X
ecj-10468	98	9	non	non	ADJ
ecj-10468	98	10	-co	-co	PROPN
ecj-10468	98	11	mmerc	mmerc	PROPN
ecj-10468	98	12	ial	ial	PROPN
ecj-10468	98	13	us	us	PROPN
ecj-10468	98	14	e	e	NOUN
ecj-10468	98	15	o	o	NOUN
ecj-10468	98	16	nly	nly	ADV
ecj-10468	98	17	the	the	DET
ecj-10468	98	18	pathogenetic	pathogenetic	ADJ
ecj-10468	98	19	mechanisms	mechanism	NOUN
ecj-10468	98	20	is	be	AUX
ecj-10468	98	21	an	an	DET
ecj-10468	98	22	occlusive	occlusive	ADJ
ecj-10468	98	23	/	/	SYM
ecj-10468	98	24	microthrombotic	microthrombotic	ADJ
ecj-10468	98	25	vasculopathic	vasculopathic	ADJ
ecj-10468	98	26	aetiology13	aetiology13	NOUN
ecj-10468	98	27	with	with	ADP
ecj-10468	98	28	a	a	DET
ecj-10468	98	29	mechanism	mechanism	NOUN
ecj-10468	98	30	not	not	PART
ecj-10468	98	31	completely	completely	ADV
ecj-10468	98	32	understood	understand	VERB
ecj-10468	98	33	,	,	PUNCT
ecj-10468	98	34	but	but	CCONJ
ecj-10468	98	35	probably	probably	ADV
ecj-10468	98	36	due	due	ADP
ecj-10468	98	37	to	to	ADP
ecj-10468	98	38	several	several	ADJ
ecj-10468	98	39	mechanisms	mechanism	NOUN
ecj-10468	98	40	including	include	VERB
ecj-10468	98	41	neurogenic	neurogenic	ADJ
ecj-10468	98	42	,	,	PUNCT
ecj-10468	98	43	microthrombotic	microthrombotic	ADJ
ecj-10468	98	44	and	and	CCONJ
ecj-10468	98	45	immune	immune	ADJ
ecj-10468	98	46	-	-	PUNCT
ecj-10468	98	47	complex	complex	NOUN
ecj-10468	98	48	mediated	mediate	VERB
ecj-10468	98	49	processes.48	processes.48	NOUN
ecj-10468	98	50	the	the	DET
ecj-10468	98	51	histopathology	histopathology	NOUN
ecj-10468	98	52	of	of	ADP
ecj-10468	98	53	these	these	DET
ecj-10468	98	54	lesions	lesion	NOUN
ecj-10468	98	55	has	have	AUX
ecj-10468	98	56	been	be	AUX
ecj-10468	98	57	described	describe	VERB
ecj-10468	98	58	by	by	ADP
ecj-10468	98	59	magro	magro	PROPN
ecj-10468	98	60	et	et	PROPN
ecj-10468	98	61	al	al	PROPN
ecj-10468	98	62	.	.	PROPN
ecj-10468	98	63	who	who	PRON
ecj-10468	98	64	documented	document	VERB
ecj-10468	98	65	the	the	DET
ecj-10468	98	66	presence	presence	NOUN
ecj-10468	98	67	of	of	ADP
ecj-10468	98	68	thrombotic	thrombotic	ADJ
ecj-10468	98	69	microvascular	microvascular	ADJ
ecj-10468	98	70	damage	damage	NOUN
ecj-10468	98	71	in	in	ADP
ecj-10468	98	72	the	the	DET
ecj-10468	98	73	lung	lung	NOUN
ecj-10468	98	74	and/or	and/or	CCONJ
ecj-10468	98	75	skin	skin	NOUN
ecj-10468	98	76	of	of	ADP
ecj-10468	98	77	five	five	NUM
ecj-10468	98	78	critical	critical	ADJ
ecj-10468	98	79	covid-19	covid-19	PROPN
ecj-10468	98	80	patients.49	patients.49	NOUN
ecj-10468	98	81	the	the	DET
ecj-10468	98	82	authors	author	NOUN
ecj-10468	98	83	demonstrated	demonstrate	VERB
ecj-10468	98	84	that	that	SCONJ
ecj-10468	98	85	in	in	ADP
ecj-10468	98	86	3	3	NUM
ecj-10468	98	87	patients	patient	NOUN
ecj-10468	98	88	with	with	ADP
ecj-10468	98	89	severe	severe	ADJ
ecj-10468	98	90	covid-19	covid-19	PROPN
ecj-10468	98	91	,	,	PUNCT
ecj-10468	98	92	purpuric	purpuric	ADJ
ecj-10468	98	93	/	/	SYM
ecj-10468	98	94	livenoid	livenoid	NOUN
ecj-10468	98	95	skin	skin	NOUN
ecj-10468	98	96	lesions	lesion	NOUN
ecj-10468	98	97	were	be	AUX
ecj-10468	98	98	characterized	characterize	VERB
ecj-10468	98	99	by	by	ADP
ecj-10468	98	100	a	a	DET
ecj-10468	98	101	pauci	pauci	NOUN
ecj-10468	98	102	-	-	PUNCT
ecj-10468	98	103	inflammatory	inflammatory	ADJ
ecj-10468	98	104	microthrombotic	microthrombotic	ADJ
ecj-10468	98	105	vasculopathy	vasculopathy	NOUN
ecj-10468	98	106	,	,	PUNCT
ecj-10468	98	107	associated	associate	VERB
ecj-10468	98	108	with	with	ADP
ecj-10468	98	109	a	a	DET
ecj-10468	98	110	minimal	minimal	ADJ
ecj-10468	98	111	interferon	interferon	ADJ
ecj-10468	98	112	response	response	NOUN
ecj-10468	98	113	,	,	PUNCT
ecj-10468	98	114	that	that	PRON
ecj-10468	98	115	cause	cause	VERB
ecj-10468	98	116	an	an	DET
ecj-10468	98	117	increased	increase	VERB
ecj-10468	98	118	viral	viral	ADJ
ecj-10468	98	119	replication	replication	NOUN
ecj-10468	98	120	with	with	ADP
ecj-10468	98	121	the	the	DET
ecj-10468	98	122	release	release	NOUN
ecj-10468	98	123	of	of	ADP
ecj-10468	98	124	viral	viral	ADJ
ecj-10468	98	125	proteins	protein	NOUN
ecj-10468	98	126	,	,	PUNCT
ecj-10468	98	127	that	that	PRON
ecj-10468	98	128	localize	localize	VERB
ecj-10468	98	129	into	into	ADP
ecj-10468	98	130	the	the	DET
ecj-10468	98	131	endothelium	endothelium	NOUN
ecj-10468	98	132	inducing	induce	VERB
ecj-10468	98	133	widespread	widespread	ADJ
ecj-10468	98	134	complement	complement	NOUN
ecj-10468	98	135	activation	activation	NOUN
ecj-10468	98	136	.	.	PUNCT
ecj-10468	99	1	the	the	DET
ecj-10468	99	2	same	same	ADJ
ecj-10468	99	3	authors	author	NOUN
ecj-10468	99	4	suggested	suggest	VERB
ecj-10468	99	5	that	that	SCONJ
ecj-10468	99	6	severe	severe	ADJ
ecj-10468	99	7	covid-19	covid-19	PROPN
ecj-10468	99	8	may	may	AUX
ecj-10468	99	9	induce	induce	VERB
ecj-10468	99	10	a	a	DET
ecj-10468	99	11	catastrophic	catastrophic	ADJ
ecj-10468	99	12	generalized	generalized	ADJ
ecj-10468	99	13	microvascular	microvascular	NOUN
ecj-10468	99	14	injury	injury	NOUN
ecj-10468	99	15	syndrome	syndrome	NOUN
ecj-10468	99	16	mediated	mediate	VERB
ecj-10468	99	17	by	by	ADP
ecj-10468	99	18	intense	intense	ADJ
ecj-10468	99	19	activation	activation	NOUN
ecj-10468	99	20	of	of	ADP
ecj-10468	99	21	the	the	DET
ecj-10468	99	22	alternative	alternative	NOUN
ecj-10468	99	23	and	and	CCONJ
ecj-10468	99	24	lectin	lectin	NOUN
ecj-10468	99	25	complement	complement	NOUN
ecj-10468	99	26	pathways	pathway	NOUN
ecj-10468	99	27	and	and	CCONJ
ecj-10468	99	28	an	an	DET
ecj-10468	99	29	associated	associated	ADJ
ecj-10468	99	30	procoagulant	procoagulant	NOUN
ecj-10468	99	31	state	state	NOUN
ecj-10468	99	32	.	.	PUNCT
ecj-10468	100	1	therefore	therefore	ADV
ecj-10468	100	2	,	,	PUNCT
ecj-10468	100	3	chinese	chinese	ADJ
ecj-10468	100	4	authors	author	NOUN
ecj-10468	100	5	reported	report	VERB
ecj-10468	100	6	the	the	DET
ecj-10468	100	7	development	development	NOUN
ecj-10468	100	8	of	of	ADP
ecj-10468	100	9	severe	severe	ADJ
ecj-10468	100	10	acro	acro	NOUN
ecj-10468	100	11	-	-	NOUN
ecj-10468	100	12	ischemia	ischemia	NOUN
ecj-10468	100	13	in	in	ADP
ecj-10468	100	14	a	a	DET
ecj-10468	100	15	few	few	ADJ
ecj-10468	100	16	intensive	intensive	ADJ
ecj-10468	100	17	care	care	NOUN
ecj-10468	100	18	unit	unit	NOUN
ecj-10468	100	19	patients	patient	NOUN
ecj-10468	100	20	in	in	ADP
ecj-10468	100	21	wuhan	wuhan	PROPN
ecj-10468	100	22	,	,	PUNCT
ecj-10468	100	23	manifesting	manifest	VERB
ecj-10468	100	24	as	as	ADP
ecj-10468	100	25	finger	finger	NOUN
ecj-10468	100	26	/	/	SYM
ecj-10468	100	27	toe	toe	NOUN
ecj-10468	100	28	cyanosis	cyanosis	NOUN
ecj-10468	100	29	,	,	PUNCT
ecj-10468	100	30	skin	skin	NOUN
ecj-10468	100	31	blisters	blister	NOUN
ecj-10468	100	32	and	and	CCONJ
ecj-10468	100	33	dry	dry	ADJ
ecj-10468	100	34	gangrene	gangrene	NOUN
ecj-10468	100	35	,	,	PUNCT
ecj-10468	100	36	resulting	result	VERB
ecj-10468	100	37	from	from	ADP
ecj-10468	100	38	a	a	DET
ecj-10468	100	39	hypercoagulable	hypercoagulable	ADJ
ecj-10468	100	40	status	status	NOUN
ecj-10468	100	41	or	or	CCONJ
ecj-10468	100	42	confirmed	confirm	VERB
ecj-10468	100	43	disseminated	disseminate	VERB
ecj-10468	100	44	intravascular	intravascular	ADJ
ecj-10468	100	45	coagulation.50	coagulation.50	PROPN
ecj-10468	100	46	in	in	ADP
ecj-10468	100	47	general	general	ADJ
ecj-10468	100	48	,	,	PUNCT
ecj-10468	100	49	livedo	livedo	PROPN
ecj-10468	100	50	reticularis	reticularis	PROPN
ecj-10468	100	51	-	-	PUNCT
ecj-10468	100	52	like	like	ADJ
ecj-10468	100	53	lesions	lesion	NOUN
ecj-10468	100	54	are	be	AUX
ecj-10468	100	55	frequently	frequently	ADV
ecj-10468	100	56	mild	mild	ADJ
ecj-10468	100	57	,	,	PUNCT
ecj-10468	100	58	transient	transient	NOUN
ecj-10468	100	59	,	,	PUNCT
ecj-10468	100	60	and	and	CCONJ
ecj-10468	100	61	not	not	PART
ecj-10468	100	62	associated	associate	VERB
ecj-10468	100	63	with	with	ADP
ecj-10468	100	64	thromboembolic	thromboembolic	ADJ
ecj-10468	100	65	complications.51,52	complications.51,52	NOUN
ecj-10468	100	66	on	on	ADP
ecj-10468	100	67	the	the	DET
ecj-10468	100	68	contrary	contrary	NOUN
ecj-10468	100	69	,	,	PUNCT
ecj-10468	100	70	livedo	livedo	PROPN
ecj-10468	100	71	racemosa	racemosa	NOUN
ecj-10468	100	72	-	-	PUNCT
ecj-10468	100	73	like	like	ADJ
ecj-10468	100	74	lesions	lesion	NOUN
ecj-10468	100	75	and	and	CCONJ
ecj-10468	100	76	retiform	retiform	NOUN
ecj-10468	100	77	purpura	purpura	NOUN
ecj-10468	100	78	have	have	AUX
ecj-10468	100	79	often	often	ADV
ecj-10468	100	80	been	be	AUX
ecj-10468	100	81	described	describe	VERB
ecj-10468	100	82	in	in	ADP
ecj-10468	100	83	patients	patient	NOUN
ecj-10468	100	84	with	with	ADP
ecj-10468	100	85	severe	severe	ADJ
ecj-10468	100	86	coagulopathy.53,54	coagulopathy.53,54	NOUN
ecj-10468	100	87	in	in	ADP
ecj-10468	100	88	absence	absence	NOUN
ecj-10468	100	89	of	of	ADP
ecj-10468	100	90	a	a	DET
ecj-10468	100	91	targeted	target	VERB
ecj-10468	100	92	therapy	therapy	NOUN
ecj-10468	100	93	,	,	PUNCT
ecj-10468	100	94	a	a	DET
ecj-10468	100	95	“	"	PUNCT
ecj-10468	100	96	wait	wait	VERB
ecj-10468	100	97	-	-	PUNCT
ecj-10468	100	98	and	and	CCONJ
ecj-10468	100	99	-	-	PUNCT
ecj-10468	100	100	see	see	VERB
ecj-10468	100	101	”	"	PUNCT
ecj-10468	100	102	approach	approach	NOUN
ecj-10468	100	103	is	be	AUX
ecj-10468	100	104	suggested	suggest	VERB
ecj-10468	100	105	with	with	ADP
ecj-10468	100	106	the	the	DET
ecj-10468	100	107	recommendation	recommendation	NOUN
ecj-10468	100	108	to	to	PART
ecj-10468	100	109	always	always	ADV
ecj-10468	100	110	assess	assess	VERB
ecj-10468	100	111	and	and	CCONJ
ecj-10468	100	112	monitor	monitor	VERB
ecj-10468	100	113	platelet	platelet	NOUN
ecj-10468	100	114	count	count	NOUN
ecj-10468	100	115	,	,	PUNCT
ecj-10468	100	116	coagulation	coagulation	NOUN
ecj-10468	100	117	times	time	NOUN
ecj-10468	100	118	,	,	PUNCT
ecj-10468	100	119	and	and	CCONJ
ecj-10468	100	120	fibrin	fibrin	NOUN
ecj-10468	100	121	degradation	degradation	NOUN
ecj-10468	100	122	products	product	NOUN
ecj-10468	100	123	.	.	PUNCT
ecj-10468	101	1	purpuric	purpuric	ADJ
ecj-10468	101	2	“	"	PUNCT
ecj-10468	101	3	vasculitic	vasculitic	ADJ
ecj-10468	101	4	”	"	PUNCT
ecj-10468	101	5	pattern	pattern	NOUN
ecj-10468	101	6	the	the	DET
ecj-10468	101	7	purpuric	purpuric	ADJ
ecj-10468	101	8	“	"	PUNCT
ecj-10468	101	9	vasculitic	vasculitic	ADJ
ecj-10468	101	10	”	"	PUNCT
ecj-10468	101	11	pattern	pattern	NOUN
ecj-10468	101	12	is	be	AUX
ecj-10468	101	13	the	the	DET
ecj-10468	101	14	expression	expression	NOUN
ecj-10468	101	15	of	of	ADP
ecj-10468	101	16	a	a	DET
ecj-10468	101	17	“	"	PUNCT
ecj-10468	101	18	true	true	ADJ
ecj-10468	101	19	”	"	PUNCT
ecj-10468	101	20	vasculitic	vasculitic	ADJ
ecj-10468	101	21	process	process	NOUN
ecj-10468	101	22	due	due	ADP
ecj-10468	101	23	to	to	ADP
ecj-10468	101	24	the	the	DET
ecj-10468	101	25	direct	direct	ADJ
ecj-10468	101	26	damage	damage	NOUN
ecj-10468	101	27	of	of	ADP
ecj-10468	101	28	the	the	DET
ecj-10468	101	29	endothelial	endothelial	ADJ
ecj-10468	101	30	cells	cell	NOUN
ecj-10468	101	31	by	by	ADP
ecj-10468	101	32	the	the	DET
ecj-10468	101	33	virus	virus	NOUN
ecj-10468	101	34	,	,	PUNCT
ecj-10468	101	35	or	or	CCONJ
ecj-10468	101	36	dysregulated	dysregulated	ADJ
ecj-10468	101	37	host	host	NOUN
ecj-10468	101	38	inflammatory	inflammatory	ADJ
ecj-10468	101	39	responses	response	NOUN
ecj-10468	101	40	induced	induce	VERB
ecj-10468	101	41	by	by	ADP
ecj-10468	101	42	covid-19	covid-19	PROPN
ecj-10468	101	43	.	.	PUNCT
ecj-10468	102	1	it	it	PRON
ecj-10468	102	2	is	be	AUX
ecj-10468	102	3	very	very	ADV
ecj-10468	102	4	rare	rare	ADJ
ecj-10468	102	5	,	,	PUNCT
ecj-10468	102	6	more	more	ADV
ecj-10468	102	7	frequent	frequent	ADJ
ecj-10468	102	8	in	in	ADP
ecj-10468	102	9	elderly	elderly	ADJ
ecj-10468	102	10	patients	patient	NOUN
ecj-10468	102	11	with	with	ADP
ecj-10468	102	12	severe	severe	ADJ
ecj-10468	102	13	covid-19	covid-19	PROPN
ecj-10468	102	14	and	and	CCONJ
ecj-10468	102	15	always	always	ADV
ecj-10468	102	16	associated	associate	VERB
ecj-10468	102	17	with	with	ADP
ecj-10468	102	18	highmortality.12	highmortality.12	PROPN
ecj-10468	102	19	the	the	DET
ecj-10468	102	20	first	first	ADJ
ecj-10468	102	21	case	case	NOUN
ecj-10468	102	22	has	have	AUX
ecj-10468	102	23	been	be	AUX
ecj-10468	102	24	reported	report	VERB
ecj-10468	102	25	in	in	ADP
ecj-10468	102	26	march	march	PROPN
ecj-10468	102	27	2020	2020	NUM
ecj-10468	102	28	by	by	ADP
ecj-10468	102	29	joob	joob	NOUN
ecj-10468	102	30	and	and	CCONJ
ecj-10468	102	31	wiwanitkit	wiwanitkit	PROPN
ecj-10468	102	32	,	,	PUNCT
ecj-10468	102	33	who	who	PRON
ecj-10468	102	34	described	describe	VERB
ecj-10468	102	35	a	a	DET
ecj-10468	102	36	petechial	petechial	ADJ
ecj-10468	102	37	rash	rash	NOUN
ecj-10468	102	38	misdiagnosed	misdiagnose	VERB
ecj-10468	102	39	as	as	ADP
ecj-10468	102	40	dengue	dengue	NOUN
ecj-10468	102	41	in	in	ADP
ecj-10468	102	42	a	a	DET
ecj-10468	102	43	covid-19	covid-19	PROPN
ecj-10468	102	44	patient.8	patient.8	NOUN
ecj-10468	102	45	in	in	ADP
ecj-10468	102	46	a	a	DET
ecj-10468	102	47	case	case	NOUN
ecj-10468	102	48	series	series	NOUN
ecj-10468	102	49	freeman	freeman	PROPN
ecj-10468	102	50	et	et	PROPN
ecj-10468	102	51	al	al	PROPN
ecj-10468	102	52	.	.	PROPN
ecj-10468	102	53	reported	report	VERB
ecj-10468	102	54	1.8	1.8	NUM
ecj-10468	102	55	%	%	NOUN
ecj-10468	102	56	and	and	CCONJ
ecj-10468	102	57	1.6	1.6	NUM
ecj-10468	102	58	%	%	NOUN
ecj-10468	102	59	of	of	ADP
ecj-10468	102	60	patients	patient	NOUN
ecj-10468	102	61	with	with	ADP
ecj-10468	102	62	purpura	purpura	NOUN
ecj-10468	102	63	and	and	CCONJ
ecj-10468	102	64	dengue	dengue	NOUN
ecj-10468	102	65	-	-	PUNCT
ecj-10468	102	66	like	like	ADJ
ecj-10468	102	67	eruption	eruption	NOUN
ecj-10468	102	68	,	,	PUNCT
ecj-10468	102	69	respectively.18	respectively.18	VERB
ecj-10468	102	70	purpuric	purpuric	ADJ
ecj-10468	102	71	lesions	lesion	NOUN
ecj-10468	102	72	can	can	AUX
ecj-10468	102	73	be	be	AUX
ecj-10468	102	74	generalized	generalize	VERB
ecj-10468	102	75	or	or	CCONJ
ecj-10468	102	76	localized	localize	VERB
ecj-10468	102	77	in	in	ADP
ecj-10468	102	78	the	the	DET
ecj-10468	102	79	intertriginous	intertriginous	ADJ
ecj-10468	102	80	regions	region	NOUN
ecj-10468	102	81	or	or	CCONJ
ecj-10468	102	82	arranged	arrange	VERB
ecj-10468	102	83	in	in	ADP
ecj-10468	102	84	an	an	DET
ecj-10468	102	85	acral	acral	ADJ
ecj-10468	102	86	distribution.55	distribution.55	NOUN
ecj-10468	102	87	-	-	SYM
ecj-10468	102	88	57	57	NUM
ecj-10468	102	89	del	del	PROPN
ecj-10468	102	90	giudice	giudice	PROPN
ecj-10468	102	91	et	et	PROPN
ecj-10468	102	92	al	al	PROPN
ecj-10468	102	93	.	.	PROPN
ecj-10468	102	94	described	describe	VERB
ecj-10468	102	95	a	a	DET
ecj-10468	102	96	case	case	NOUN
ecj-10468	102	97	of	of	ADP
ecj-10468	102	98	an	an	DET
ecj-10468	102	99	83	83	NUM
ecj-10468	102	100	-	-	PUNCT
ecj-10468	102	101	year	year	NOUN
ecj-10468	102	102	-	-	PUNCT
ecj-10468	102	103	old	old	ADJ
ecj-10468	102	104	man	man	NOUN
ecj-10468	102	105	affected	affect	VERB
ecj-10468	102	106	by	by	ADP
ecj-10468	102	107	obesity	obesity	NOUN
ecj-10468	102	108	and	and	CCONJ
ecj-10468	102	109	distal	distal	ADJ
ecj-10468	102	110	arteriopathy	arteriopathy	PROPN
ecj-10468	102	111	,	,	PUNCT
ecj-10468	102	112	who	who	PRON
ecj-10468	102	113	developed	develop	VERB
ecj-10468	102	114	a	a	DET
ecj-10468	102	115	catastrophic	catastrophic	ADJ
ecj-10468	102	116	acute	acute	ADJ
ecj-10468	102	117	bilateral	bilateral	ADJ
ecj-10468	102	118	lower	low	ADJ
ecj-10468	102	119	limbs	limb	NOUN
ecj-10468	102	120	and	and	CCONJ
ecj-10468	102	121	foot	foot	NOUN
ecj-10468	102	122	necrosis	necrosis	NOUN
ecj-10468	102	123	associated	associate	VERB
ecj-10468	102	124	with	with	ADP
ecj-10468	102	125	covid	covid	PROPN
ecj-10468	102	126	-19	-19	PROPN
ecj-10468	102	127	as	as	ADP
ecj-10468	102	128	a	a	DET
ecj-10468	102	129	likely	likely	ADJ
ecj-10468	102	130	consequence	consequence	NOUN
ecj-10468	102	131	of	of	ADP
ecj-10468	102	132	a	a	DET
ecj-10468	102	133	malignant	malignant	ADJ
ecj-10468	102	134	synergy	synergy	NOUN
ecj-10468	102	135	of	of	ADP
ecj-10468	102	136	the	the	DET
ecj-10468	102	137	vasculitis	vasculitis	PROPN
ecj-10468	102	138	and	and	CCONJ
ecj-10468	102	139	severe	severe	ADJ
ecj-10468	102	140	coagulopathy.58	coagulopathy.58	NOUN
ecj-10468	102	141	when	when	SCONJ
ecj-10468	102	142	performed	perform	VERB
ecj-10468	102	143	,	,	PUNCT
ecj-10468	102	144	histopathology	histopathology	NOUN
ecj-10468	102	145	showed	show	VERB
ecj-10468	102	146	leukocytoclastic	leukocytoclastic	ADJ
ecj-10468	102	147	vasculitis,55	vasculitis,55	NOUN
ecj-10468	102	148	severe	severe	ADJ
ecj-10468	102	149	neutrophilic	neutrophilic	ADJ
ecj-10468	102	150	infiltrate	infiltrate	NOUN
ecj-10468	102	151	within	within	ADP
ecj-10468	102	152	the	the	DET
ecj-10468	102	153	small	small	ADJ
ecj-10468	102	154	vessel	vessel	NOUN
ecj-10468	102	155	walls	wall	NOUN
ecj-10468	102	156	,	,	PUNCT
ecj-10468	102	157	intense	intense	ADJ
ecj-10468	102	158	lymphocytic	lymphocytic	ADJ
ecj-10468	102	159	perivascular	perivascular	ADJ
ecj-10468	102	160	infiltrates	infiltrate	NOUN
ecj-10468	102	161	,	,	PUNCT
ecj-10468	102	162	presence	presence	NOUN
ecj-10468	102	163	of	of	ADP
ecj-10468	102	164	fibrin	fibrin	NOUN
ecj-10468	102	165	and	and	CCONJ
ecj-10468	102	166	endothelial	endothelial	ADJ
ecj-10468	102	167	swelling.57,59	swelling.57,59	ADJ
ecj-10468	102	168	topical	topical	ADJ
ecj-10468	102	169	corticosteroids	corticosteroid	NOUN
ecj-10468	102	170	have	have	AUX
ecj-10468	102	171	been	be	AUX
ecj-10468	102	172	successfully	successfully	ADV
ecj-10468	102	173	used	use	VERB
ecj-10468	102	174	for	for	ADP
ecj-10468	102	175	treating	treat	VERB
ecj-10468	102	176	mild	mild	ADJ
ecj-10468	102	177	cases	case	NOUN
ecj-10468	102	178	of	of	ADP
ecj-10468	102	179	purpuric	purpuric	ADJ
ecj-10468	102	180	lesions.56	lesions.56	NOUN
ecj-10468	102	181	patients	patient	NOUN
ecj-10468	102	182	with	with	ADP
ecj-10468	102	183	necrotic	necrotic	ADJ
ecj-10468	102	184	-	-	PUNCT
ecj-10468	102	185	ulcerative	ulcerative	ADJ
ecj-10468	102	186	lesions	lesion	NOUN
ecj-10468	102	187	and	and	CCONJ
ecj-10468	102	188	widespread	widespread	ADJ
ecj-10468	102	189	presentation	presentation	NOUN
ecj-10468	102	190	can	can	AUX
ecj-10468	102	191	be	be	AUX
ecj-10468	102	192	treated	treat	VERB
ecj-10468	102	193	with	with	ADP
ecj-10468	102	194	systemic	systemic	ADJ
ecj-10468	102	195	corticosteroids	corticosteroid	NOUN
ecj-10468	102	196	.	.	PUNCT
ecj-10468	103	1	other	other	ADJ
ecj-10468	103	2	unclassifiable	unclassifiable	ADJ
ecj-10468	103	3	covid-19	covid-19	PROPN
ecj-10468	103	4	skin	skin	NOUN
ecj-10468	103	5	lesions	lesion	NOUN
ecj-10468	103	6	rare	rare	ADJ
ecj-10468	103	7	covid-19	covid-19	PROPN
ecj-10468	103	8	-	-	PUNCT
ecj-10468	103	9	related	relate	VERB
ecj-10468	103	10	cutaneous	cutaneous	ADJ
ecj-10468	103	11	manifestations	manifestation	NOUN
ecj-10468	103	12	,	,	PUNCT
ecj-10468	103	13	that	that	PRON
ecj-10468	103	14	can	can	AUX
ecj-10468	103	15	not	not	PART
ecj-10468	103	16	be	be	AUX
ecj-10468	103	17	pigeonholed	pigeonhole	VERB
ecj-10468	103	18	in	in	ADP
ecj-10468	103	19	the	the	DET
ecj-10468	103	20	classification	classification	NOUN
ecj-10468	103	21	proposed	propose	VERB
ecj-10468	103	22	by	by	ADP
ecj-10468	103	23	marzano	marzano	PROPN
ecj-10468	103	24	et	et	PROPN
ecj-10468	103	25	al	al	PROPN
ecj-10468	103	26	.	.	PROPN
ecj-10468	103	27	,13	,13	PUNCT
ecj-10468	103	28	include	include	VERB
ecj-10468	103	29	the	the	DET
ecj-10468	103	30	erythema	erythema	ADJ
ecj-10468	103	31	multiforme	multiforme	NOUN
ecj-10468	103	32	-	-	PUNCT
ecj-10468	103	33	like	like	ADJ
ecj-10468	103	34	eruption,60	eruption,60	NOUN
ecj-10468	103	35	pityriasis	pityriasis	NOUN
ecj-10468	103	36	rosealike	rosealike	VERB
ecj-10468	103	37	rash,15	rash,15	ADJ
ecj-10468	103	38	multi	multi	ADJ
ecj-10468	103	39	-	-	ADJ
ecj-10468	103	40	system	system	ADJ
ecj-10468	103	41	inflammatory	inflammatory	ADJ
ecj-10468	103	42	syndrome	syndrome	NOUN
ecj-10468	103	43	in	in	ADP
ecj-10468	103	44	children,61	children,61	NOUN
ecj-10468	103	45	anagen	anagen	NOUN
ecj-10468	103	46	effluvium,62	effluvium,62	NOUN
ecj-10468	103	47	and	and	CCONJ
ecj-10468	103	48	a	a	DET
ecj-10468	103	49	pseudo	pseudo	NOUN
ecj-10468	103	50	herpetic	herpetic	ADJ
ecj-10468	103	51	variant	variant	NOUN
ecj-10468	103	52	of	of	ADP
ecj-10468	103	53	grover	grover	NOUN
ecj-10468	103	54	disease.16	disease.16	PROPN
ecj-10468	103	55	pityriasis	pityriasis	NOUN
ecj-10468	103	56	rosea	rosea	ADJ
ecj-10468	103	57	like	like	ADP
ecj-10468	103	58	and	and	CCONJ
ecj-10468	103	59	erythema	erythema	ADJ
ecj-10468	103	60	multiforme	multiforme	NOUN
ecj-10468	103	61	like	like	SCONJ
ecj-10468	103	62	patterns	pattern	NOUN
ecj-10468	103	63	are	be	AUX
ecj-10468	103	64	the	the	DET
ecj-10468	103	65	most	most	ADV
ecj-10468	103	66	frequently	frequently	ADV
ecj-10468	103	67	reported	report	VERB
ecj-10468	103	68	skin	skin	NOUN
ecj-10468	103	69	manifestations	manifestation	NOUN
ecj-10468	103	70	falling	fall	VERB
ecj-10468	103	71	outside	outside	ADP
ecj-10468	103	72	the	the	DET
ecj-10468	103	73	classification	classification	NOUN
ecj-10468	103	74	,	,	PUNCT
ecj-10468	103	75	but	but	CCONJ
ecj-10468	103	76	it	it	PRON
ecj-10468	103	77	is	be	AUX
ecj-10468	103	78	still	still	ADV
ecj-10468	103	79	debated	debate	VERB
ecj-10468	103	80	whether	whether	SCONJ
ecj-10468	103	81	the	the	DET
ecj-10468	103	82	former	former	NOUN
ecj-10468	103	83	is	be	AUX
ecj-10468	103	84	directly	directly	ADV
ecj-10468	103	85	mediated	mediate	VERB
ecj-10468	103	86	by	by	ADP
ecj-10468	103	87	sars	sar	NOUN
ecj-10468	103	88	-	-	PUNCT
ecj-10468	103	89	cov-2	cov-2	PUNCT
ecj-10468	103	90	or	or	CCONJ
ecj-10468	103	91	caused	cause	VERB
ecj-10468	103	92	by	by	ADP
ecj-10468	103	93	covid-19	covid-19	PROPN
ecj-10468	103	94	-	-	PUNCT
ecj-10468	103	95	related	relate	VERB
ecj-10468	103	96	immune	immune	ADJ
ecj-10468	103	97	system	system	NOUN
ecj-10468	103	98	dysfunction	dysfunction	NOUN
ecj-10468	103	99	leading	lead	VERB
ecj-10468	103	100	to	to	ADP
ecj-10468	103	101	human	human	ADJ
ecj-10468	103	102	herpes	herpe	NOUN
ecj-10468	103	103	virus	virus	NOUN
ecj-10468	103	104	6/7	6/7	NUM
ecj-10468	103	105	reactivation5	reactivation5	VERB
ecj-10468	103	106	,	,	PUNCT
ecj-10468	103	107	and	and	CCONJ
ecj-10468	103	108	whether	whether	SCONJ
ecj-10468	103	109	the	the	DET
ecj-10468	103	110	latter	latter	ADJ
ecj-10468	103	111	is	be	AUX
ecj-10468	103	112	triggered	trigger	VERB
ecj-10468	103	113	by	by	ADP
ecj-10468	103	114	sars	sar	NOUN
ecj-10468	103	115	-	-	PUNCT
ecj-10468	103	116	cov-2	cov-2	NOUN
ecj-10468	103	117	or	or	CCONJ
ecj-10468	103	118	other	other	ADJ
ecj-10468	103	119	viruses	virus	NOUN
ecj-10468	103	120	.	.	PUNCT
ecj-10468	104	1	conclusions	conclusion	NOUN
ecj-10468	104	2	cutaneous	cutaneous	ADJ
ecj-10468	104	3	manifestations	manifestation	NOUN
ecj-10468	104	4	in	in	ADP
ecj-10468	104	5	covid-19	covid-19	PROPN
ecj-10468	104	6	patients	patient	NOUN
ecj-10468	104	7	are	be	AUX
ecj-10468	104	8	still	still	ADV
ecj-10468	104	9	an	an	DET
ecj-10468	104	10	emerging	emerge	VERB
ecj-10468	104	11	issue	issue	NOUN
ecj-10468	104	12	as	as	SCONJ
ecj-10468	104	13	documented	document	VERB
ecj-10468	104	14	by	by	ADP
ecj-10468	104	15	the	the	DET
ecj-10468	104	16	current	current	ADJ
ecj-10468	104	17	literature	literature	NOUN
ecj-10468	104	18	.	.	PUNCT
ecj-10468	105	1	it	it	PRON
ecj-10468	105	2	is	be	AUX
ecj-10468	105	3	evident	evident	ADJ
ecj-10468	105	4	that	that	SCONJ
ecj-10468	105	5	the	the	DET
ecj-10468	105	6	spectrum	spectrum	NOUN
ecj-10468	105	7	of	of	ADP
ecj-10468	105	8	covid-19	covid-19	PROPN
ecj-10468	105	9	-	-	PUNCT
ecj-10468	105	10	associated	associate	VERB
ecj-10468	105	11	skin	skin	NOUN
ecj-10468	105	12	manifestations	manifestation	NOUN
ecj-10468	105	13	is	be	AUX
ecj-10468	105	14	still	still	ADV
ecj-10468	105	15	incomplete	incomplete	ADJ
ecj-10468	105	16	,	,	PUNCT
ecj-10468	105	17	and	and	CCONJ
ecj-10468	105	18	it	it	PRON
ecj-10468	105	19	is	be	AUX
ecj-10468	105	20	expected	expect	VERB
ecj-10468	105	21	that	that	SCONJ
ecj-10468	105	22	new	new	ADJ
ecj-10468	105	23	skin	skin	NOUN
ecj-10468	105	24	lesions	lesion	NOUN
ecj-10468	105	25	will	will	AUX
ecj-10468	105	26	be	be	AUX
ecj-10468	105	27	described	describe	VERB
ecj-10468	105	28	.	.	PUNCT
ecj-10468	106	1	dermatologists	dermatologist	NOUN
ecj-10468	106	2	play	play	VERB
ecj-10468	106	3	a	a	DET
ecj-10468	106	4	central	central	ADJ
ecj-10468	106	5	role	role	NOUN
ecj-10468	106	6	in	in	ADP
ecj-10468	106	7	the	the	DET
ecj-10468	106	8	diagnosis	diagnosis	NOUN
ecj-10468	106	9	and	and	CCONJ
ecj-10468	106	10	the	the	DET
ecj-10468	106	11	treatment	treatment	NOUN
ecj-10468	106	12	strategy	strategy	NOUN
ecj-10468	106	13	.	.	PUNCT
ecj-10468	107	1	the	the	DET
ecj-10468	107	2	presence	presence	NOUN
ecj-10468	107	3	of	of	ADP
ecj-10468	107	4	cutaneous	cutaneous	ADJ
ecj-10468	107	5	findings	finding	NOUN
ecj-10468	107	6	can	can	AUX
ecj-10468	107	7	lead	lead	VERB
ecj-10468	107	8	to	to	PART
ecj-10468	107	9	suspect	suspect	VERB
ecj-10468	107	10	covid-19	covid-19	PROPN
ecj-10468	107	11	and	and	CCONJ
ecj-10468	107	12	identify	identify	VERB
ecj-10468	107	13	potentially	potentially	ADV
ecj-10468	107	14	contagious	contagious	ADJ
ecj-10468	107	15	cases	case	NOUN
ecj-10468	107	16	with	with	ADP
ecj-10468	107	17	indolent	indolent	ADJ
ecj-10468	107	18	course	course	NOUN
ecj-10468	107	19	.	.	PUNCT
ecj-10468	108	1	the	the	DET
ecj-10468	108	2	role	role	NOUN
ecj-10468	108	3	of	of	ADP
ecj-10468	108	4	covid-19	covid-19	PROPN
ecj-10468	108	5	-	-	PUNCT
ecj-10468	108	6	associated	associate	VERB
ecj-10468	108	7	skin	skin	NOUN
ecj-10468	108	8	manifestations	manifestation	NOUN
ecj-10468	108	9	as	as	SCONJ
ecj-10468	108	10	prognostic	prognostic	ADJ
ecj-10468	108	11	markers	marker	NOUN
ecj-10468	108	12	needs	need	VERB
ecj-10468	108	13	to	to	PART
ecj-10468	108	14	be	be	AUX
ecj-10468	108	15	further	far	ADV
ecj-10468	108	16	investigated	investigate	VERB
ecj-10468	108	17	.	.	PUNCT
ecj-10468	109	1	when	when	SCONJ
ecj-10468	109	2	possible	possible	ADJ
ecj-10468	109	3	,	,	PUNCT
ecj-10468	109	4	histological	histological	ADJ
ecj-10468	109	5	analysis	analysis	NOUN
ecj-10468	109	6	and	and	CCONJ
ecj-10468	109	7	detection	detection	NOUN
ecj-10468	109	8	of	of	ADP
ecj-10468	109	9	sars	sar	NOUN
ecj-10468	109	10	-	-	PUNCT
ecj-10468	109	11	cov-2	cov-2	NOUN
ecj-10468	109	12	in	in	ADP
ecj-10468	109	13	the	the	DET
ecj-10468	109	14	content	content	NOUN
ecj-10468	109	15	of	of	ADP
ecj-10468	109	16	the	the	DET
ecj-10468	109	17	skin	skin	NOUN
ecj-10468	109	18	lesions	lesion	NOUN
ecj-10468	109	19	should	should	AUX
ecj-10468	109	20	be	be	AUX
ecj-10468	109	21	performed	perform	VERB
ecj-10468	109	22	both	both	PRON
ecj-10468	109	23	to	to	PART
ecj-10468	109	24	clarify	clarify	VERB
ecj-10468	109	25	the	the	DET
ecj-10468	109	26	pathophysiological	pathophysiological	ADJ
ecj-10468	109	27	process	process	NOUN
ecj-10468	109	28	at	at	ADP
ecj-10468	109	29	the	the	DET
ecj-10468	109	30	basis	basis	NOUN
ecj-10468	109	31	of	of	ADP
ecj-10468	109	32	covid-19	covid-19	PROPN
ecj-10468	109	33	associated	associate	VERB
ecj-10468	109	34	cutaneous	cutaneous	ADJ
ecj-10468	109	35	manifestations	manifestation	NOUN
ecj-10468	109	36	,	,	PUNCT
ecj-10468	109	37	and	and	CCONJ
ecj-10468	109	38	to	to	PART
ecj-10468	109	39	design	design	VERB
ecj-10468	109	40	a	a	DET
ecj-10468	109	41	tailored	tailor	VERB
ecj-10468	109	42	therapy	therapy	NOUN
ecj-10468	109	43	for	for	ADP
ecj-10468	109	44	each	each	DET
ecj-10468	109	45	patient	patient	NOUN
ecj-10468	109	46	.	.	PUNCT
ecj-10468	110	1	references	reference	NOUN
ecj-10468	110	2	1	1	NUM
ecj-10468	110	3	.	.	PUNCT
ecj-10468	110	4	molina	molina	PROPN
ecj-10468	110	5	-	-	PUNCT
ecj-10468	110	6	ruiz	ruiz	PROPN
ecj-10468	110	7	am	am	NOUN
ecj-10468	110	8	,	,	PUNCT
ecj-10468	110	9	santonja	santonja	VERB
ecj-10468	110	10	c	c	NOUN
ecj-10468	110	11	,	,	PUNCT
ecj-10468	110	12	rütten	rütten	VERB
ecj-10468	110	13	a	a	PRON
ecj-10468	110	14	,	,	PUNCT
ecj-10468	110	15	et	et	PROPN
ecj-10468	110	16	al	al	PROPN
ecj-10468	110	17	.	.	PROPN
ecj-10468	110	18	immunohistochemistry	immunohistochemistry	PROPN
ecj-10468	110	19	in	in	ADP
ecj-10468	110	20	the	the	DET
ecj-10468	110	21	diagnosis	diagnosis	NOUN
ecj-10468	110	22	of	of	ADP
ecj-10468	110	23	cutaneous	cutaneous	ADJ
ecj-10468	110	24	viral	viral	ADJ
ecj-10468	110	25	infections	infection	NOUN
ecj-10468	110	26	--	--	PUNCT
ecj-10468	110	27	part	part	NOUN
ecj-10468	110	28	i.	i.	NOUN
ecj-10468	110	29	cutaneous	cutaneous	ADJ
ecj-10468	110	30	viral	viral	ADJ
ecj-10468	110	31	infections	infection	NOUN
ecj-10468	110	32	by	by	ADP
ecj-10468	110	33	herpesviruses	herpesviruse	NOUN
ecj-10468	110	34	and	and	CCONJ
ecj-10468	110	35	papillomaviruses	papillomaviruse	NOUN
ecj-10468	110	36	.	.	PUNCT
ecj-10468	111	1	am	be	AUX
ecj-10468	111	2	j	j	PROPN
ecj-10468	111	3	dermatopathol	dermatopathol	NOUN
ecj-10468	111	4	2015;37:1	2015;37:1	NUM
ecj-10468	111	5	-	-	PUNCT
ecj-10468	111	6	14	14	NUM
ecj-10468	111	7	.	.	PUNCT
ecj-10468	112	1	2	2	X
ecj-10468	112	2	.	.	NOUN
ecj-10468	112	3	muehlenbachs	muehlenbach	NOUN
ecj-10468	112	4	a	a	PRON
ecj-10468	112	5	,	,	PUNCT
ecj-10468	112	6	bhatnagar	bhatnagar	PROPN
ecj-10468	112	7	j	j	PROPN
ecj-10468	112	8	,	,	PUNCT
ecj-10468	112	9	zaki	zaki	PROPN
ecj-10468	112	10	sr	sr	PROPN
ecj-10468	112	11	.	.	PUNCT
ecj-10468	113	1	tissue	tissue	PROPN
ecj-10468	113	2	tropism	tropism	PROPN
ecj-10468	113	3	,	,	PUNCT
ecj-10468	113	4	pathology	pathology	NOUN
ecj-10468	113	5	and	and	CCONJ
ecj-10468	113	6	pathogenesis	pathogenesis	NOUN
ecj-10468	113	7	of	of	ADP
ecj-10468	113	8	enterovirus	enterovirus	NOUN
ecj-10468	113	9	infection	infection	NOUN
ecj-10468	113	10	.	.	PUNCT
ecj-10468	114	1	j	j	PROPN
ecj-10468	114	2	pathol	pathol	NOUN
ecj-10468	114	3	2015;235:217	2015;235:217	NUM
ecj-10468	114	4	-	-	SYM
ecj-10468	114	5	28	28	NUM
ecj-10468	114	6	.	.	PUNCT
ecj-10468	115	1	3	3	X
ecj-10468	115	2	.	.	X
ecj-10468	115	3	keighley	keighley	PROPN
ecj-10468	115	4	cl	cl	PROPN
ecj-10468	115	5	,	,	PUNCT
ecj-10468	115	6	saunderson	saunderson	NOUN
ecj-10468	115	7	rb	rb	PROPN
ecj-10468	115	8	,	,	PUNCT
ecj-10468	115	9	kok	kok	PROPN
ecj-10468	115	10	j	j	PROPN
ecj-10468	115	11	,	,	PUNCT
ecj-10468	115	12	dwyer	dwyer	PROPN
ecj-10468	115	13	de	de	PROPN
ecj-10468	115	14	.	.	PROPN
ecj-10468	115	15	viral	viral	ADJ
ecj-10468	115	16	exanthems	exanthem	NOUN
ecj-10468	115	17	.	.	PUNCT
ecj-10468	116	1	curr	curr	PROPN
ecj-10468	116	2	opin	opin	PROPN
ecj-10468	116	3	infect	infect	NOUN
ecj-10468	116	4	dis	dis	PROPN
ecj-10468	116	5	2015;28:139	2015;28:139	NUM
ecj-10468	116	6	-	-	SYM
ecj-10468	116	7	50	50	NUM
ecj-10468	116	8	.	.	PUNCT
ecj-10468	117	1	4	4	NUM
ecj-10468	117	2	.	.	X
ecj-10468	117	3	su	su	PROPN
ecj-10468	117	4	cj	cj	PROPN
ecj-10468	117	5	,	,	PUNCT
ecj-10468	117	6	lee	lee	PROPN
ecj-10468	117	7	ch	ch	PROPN
ecj-10468	117	8	.	.	PROPN
ecj-10468	117	9	viral	viral	ADJ
ecj-10468	117	10	exanthem	exanthem	NOUN
ecj-10468	117	11	in	in	ADP
ecj-10468	117	12	covid-19	covid-19	PROPN
ecj-10468	117	13	,	,	PUNCT
ecj-10468	117	14	a	a	DET
ecj-10468	117	15	clinical	clinical	ADJ
ecj-10468	117	16	enigma	enigma	NOUN
ecj-10468	117	17	with	with	ADP
ecj-10468	117	18	biological	biological	ADJ
ecj-10468	117	19	significance	significance	NOUN
ecj-10468	117	20	.	.	PUNCT
ecj-10468	118	1	j	j	PROPN
ecj-10468	118	2	eur	eur	PROPN
ecj-10468	118	3	acad	acad	PROPN
ecj-10468	118	4	dermatol	dermatol	NOUN
ecj-10468	118	5	venereol	venereol	PROPN
ecj-10468	118	6	2020;34	2020;34	NUM
ecj-10468	118	7	:	:	PUNCT
ecj-10468	118	8	e251	e251	PROPN
ecj-10468	118	9	-	-	SYM
ecj-10468	118	10	2	2	NUM
ecj-10468	118	11	.	.	NOUN
ecj-10468	118	12	5	5	NUM
ecj-10468	118	13	.	.	PUNCT
ecj-10468	118	14	recalcati	recalcati	PROPN
ecj-10468	118	15	s.	s.	PROPN
ecj-10468	118	16	cutaneous	cutaneous	ADJ
ecj-10468	118	17	manifestations	manifestation	NOUN
ecj-10468	118	18	in	in	ADP
ecj-10468	118	19	covid-19	covid-19	PROPN
ecj-10468	118	20	:	:	PUNCT
ecj-10468	118	21	a	a	DET
ecj-10468	118	22	first	first	ADJ
ecj-10468	118	23	perspective	perspective	NOUN
ecj-10468	118	24	.	.	PUNCT
ecj-10468	119	1	j	j	PROPN
ecj-10468	119	2	eur	eur	PROPN
ecj-10468	119	3	acad	acad	PROPN
ecj-10468	119	4	dermatol	dermatol	NOUN
ecj-10468	119	5	venereol	venereol	PROPN
ecj-10468	119	6	2020;34	2020;34	NUM
ecj-10468	119	7	:	:	PUNCT
ecj-10468	119	8	e212–3	e212–3	ADJ
ecj-10468	119	9	.	.	PUNCT
ecj-10468	120	1	6	6	X
ecj-10468	120	2	.	.	X
ecj-10468	120	3	guan	guan	PROPN
ecj-10468	120	4	wj	wj	PROPN
ecj-10468	120	5	,	,	PUNCT
ecj-10468	120	6	ni	ni	PROPN
ecj-10468	120	7	zy	zy	PROPN
ecj-10468	120	8	,	,	PUNCT
ecj-10468	120	9	hu	hu	PROPN
ecj-10468	120	10	y	y	PROPN
ecj-10468	120	11	,	,	PUNCT
ecj-10468	120	12	et	et	PROPN
ecj-10468	120	13	al	al	PROPN
ecj-10468	120	14	.	.	PUNCT
ecj-10468	121	1	china	china	PROPN
ecj-10468	121	2	medical	medical	PROPN
ecj-10468	121	3	treatment	treatment	PROPN
ecj-10468	121	4	expert	expert	NOUN
ecj-10468	121	5	group	group	NOUN
ecj-10468	121	6	for	for	ADP
ecj-10468	121	7	covid-19	covid-19	PROPN
ecj-10468	121	8	.	.	PUNCT
ecj-10468	122	1	clinical	clinical	ADJ
ecj-10468	122	2	characteristics	characteristic	NOUN
ecj-10468	122	3	of	of	ADP
ecj-10468	122	4	coronavirus	coronavirus	NOUN
ecj-10468	122	5	disease	disease	NOUN
ecj-10468	122	6	2019	2019	NUM
ecj-10468	122	7	in	in	ADP
ecj-10468	122	8	china	china	PROPN
ecj-10468	122	9	.	.	PUNCT
ecj-10468	123	1	n	n	PROPN
ecj-10468	123	2	engl	engl	PROPN
ecj-10468	123	3	j	j	PROPN
ecj-10468	123	4	med	med	PROPN
ecj-10468	123	5	2020;382:1708	2020;382:1708	NUM
ecj-10468	123	6	-	-	SYM
ecj-10468	123	7	20	20	NUM
ecj-10468	123	8	.	.	PUNCT
ecj-10468	123	9	7	7	X
ecj-10468	123	10	.	.	X
ecj-10468	123	11	hoehl	hoehl	PROPN
ecj-10468	123	12	s	s	PROPN
ecj-10468	123	13	,	,	PUNCT
ecj-10468	123	14	rabenau	rabenau	VERB
ecj-10468	123	15	h	h	NOUN
ecj-10468	123	16	,	,	PUNCT
ecj-10468	123	17	berger	berger	PROPN
ecj-10468	123	18	a	a	PROPN
ecj-10468	123	19	,	,	PUNCT
ecj-10468	123	20	et	et	PROPN
ecj-10468	123	21	al	al	PROPN
ecj-10468	123	22	.	.	PROPN
ecj-10468	124	1	evidence	evidence	NOUN
ecj-10468	124	2	of	of	ADP
ecj-10468	124	3	sars	sars	PROPN
ecj-10468	124	4	-	-	PUNCT
ecj-10468	124	5	cov2	cov2	PROPN
ecj-10468	124	6	infection	infection	NOUN
ecj-10468	124	7	in	in	ADP
ecj-10468	124	8	returning	return	VERB
ecj-10468	124	9	travelers	traveler	NOUN
ecj-10468	124	10	from	from	ADP
ecj-10468	124	11	wuhan	wuhan	PROPN
ecj-10468	124	12	,	,	PUNCT
ecj-10468	124	13	china	china	PROPN
ecj-10468	124	14	.	.	PUNCT
ecj-10468	125	1	n	n	PROPN
ecj-10468	125	2	engl	engl	PROPN
ecj-10468	125	3	j	j	PROPN
ecj-10468	125	4	med	me	VERB
ecj-10468	125	5	2020;382:1278	2020;382:1278	NUM
ecj-10468	125	6	-	-	SYM
ecj-10468	125	7	80	80	NUM
ecj-10468	125	8	.	.	NOUN
ecj-10468	126	1	8	8	NUM
ecj-10468	126	2	.	.	PUNCT
ecj-10468	126	3	joob	joob	PROPN
ecj-10468	126	4	b	b	PROPN
ecj-10468	126	5	,	,	PUNCT
ecj-10468	126	6	wiwanitkit	wiwanitkit	PROPN
ecj-10468	126	7	v.	v.	PROPN
ecj-10468	126	8	covid-19	covid-19	PROPN
ecj-10468	126	9	can	can	AUX
ecj-10468	126	10	present	present	VERB
ecj-10468	126	11	with	with	ADP
ecj-10468	126	12	a	a	DET
ecj-10468	126	13	rash	rash	NOUN
ecj-10468	126	14	and	and	CCONJ
ecj-10468	126	15	be	be	AUX
ecj-10468	126	16	mistaken	mistaken	ADJ
ecj-10468	126	17	for	for	ADP
ecj-10468	126	18	dengue	dengue	NOUN
ecj-10468	126	19	.	.	PUNCT
ecj-10468	127	1	j	j	PROPN
ecj-10468	127	2	am	be	AUX
ecj-10468	127	3	acad	acad	ADJ
ecj-10468	127	4	dermatol	dermatol	NOUN
ecj-10468	127	5	2020;82	2020;82	NUM
ecj-10468	127	6	:	:	PUNCT
ecj-10468	127	7	e177	e177	PROPN
ecj-10468	127	8	.	.	NOUN
ecj-10468	128	1	9	9	NUM
ecj-10468	128	2	.	.	X
ecj-10468	128	3	kamali	kamali	PROPN
ecj-10468	128	4	aghdam	aghdam	PROPN
ecj-10468	128	5	m	m	PROPN
ecj-10468	128	6	,	,	PUNCT
ecj-10468	128	7	jafari	jafari	PROPN
ecj-10468	128	8	n	n	CCONJ
ecj-10468	128	9	,	,	PUNCT
ecj-10468	128	10	eftekhari	eftekhari	PROPN
ecj-10468	128	11	k.	k.	PROPN
ecj-10468	128	12	novel	novel	PROPN
ecj-10468	128	13	coronavirus	coronavirus	NOUN
ecj-10468	128	14	in	in	ADP
ecj-10468	128	15	a	a	DET
ecj-10468	128	16	15	15	NUM
ecj-10468	128	17	-	-	PUNCT
ecj-10468	128	18	day	day	NOUN
ecj-10468	128	19	-	-	PUNCT
ecj-10468	128	20	old	old	ADJ
ecj-10468	128	21	neonate	neonate	NOUN
ecj-10468	128	22	with	with	ADP
ecj-10468	128	23	clinical	clinical	ADJ
ecj-10468	128	24	signs	sign	NOUN
ecj-10468	128	25	of	of	ADP
ecj-10468	128	26	sepsis	sepsis	NOUN
ecj-10468	128	27	,	,	PUNCT
ecj-10468	128	28	a	a	DET
ecj-10468	128	29	case	case	NOUN
ecj-10468	128	30	report	report	NOUN
ecj-10468	128	31	.	.	PUNCT
ecj-10468	129	1	infect	infect	VERB
ecj-10468	129	2	dis	dis	PROPN
ecj-10468	129	3	(	(	PUNCT
ecj-10468	129	4	lond	lond	ADJ
ecj-10468	129	5	)	)	PUNCT
ecj-10468	129	6	2020;52:427	2020;52:427	NOUN
ecj-10468	129	7	-	-	SYM
ecj-10468	129	8	9	9	NUM
ecj-10468	129	9	.	.	NOUN
ecj-10468	129	10	10	10	NUM
ecj-10468	129	11	.	.	X
ecj-10468	130	1	uchonwanit	uchonwanit	PROPN
ecj-10468	130	2	p	p	X
ecj-10468	130	3	,	,	PUNCT
ecj-10468	130	4	leerunyakul	leerunyakul	PROPN
ecj-10468	130	5	k	k	PROPN
ecj-10468	130	6	,	,	PUNCT
ecj-10468	130	7	kositkuljorn	kositkuljorn	PROPN
ecj-10468	130	8	c.	c.	PROPN
ecj-10468	130	9	cutaneous	cutaneous	ADJ
ecj-10468	130	10	manifestations	manifestation	NOUN
ecj-10468	130	11	in	in	ADP
ecj-10468	130	12	covid-19	covid-19	PROPN
ecj-10468	130	13	:	:	PUNCT
ecj-10468	130	14	lessons	lesson	NOUN
ecj-10468	130	15	learned	learn	VERB
ecj-10468	130	16	from	from	ADP
ecj-10468	130	17	current	current	ADJ
ecj-10468	130	18	evidence	evidence	NOUN
ecj-10468	130	19	.	.	PUNCT
ecj-10468	131	1	j	j	PROPN
ecj-10468	131	2	am	be	AUX
ecj-10468	131	3	acad	acad	ADJ
ecj-10468	131	4	dermatol	dermatol	NOUN
ecj-10468	131	5	2020;83	2020;83	NUM
ecj-10468	131	6	:	:	PUNCT
ecj-10468	131	7	e57	e57	NOUN
ecj-10468	131	8	-	-	PUNCT
ecj-10468	131	9	e60	e60	NOUN
ecj-10468	131	10	.	.	PUNCT
ecj-10468	132	1	11	11	NUM
ecj-10468	132	2	.	.	X
ecj-10468	132	3	de	de	PROPN
ecj-10468	132	4	giorgi	giorgi	PROPN
ecj-10468	132	5	v	v	PROPN
ecj-10468	132	6	,	,	PUNCT
ecj-10468	132	7	recalcati	recalcati	PROPN
ecj-10468	132	8	s	s	PROPN
ecj-10468	132	9	,	,	PUNCT
ecj-10468	132	10	jia	jia	PROPN
ecj-10468	132	11	z	z	PROPN
ecj-10468	132	12	,	,	PUNCT
ecj-10468	132	13	et	et	PROPN
ecj-10468	132	14	al	al	PROPN
ecj-10468	132	15	.	.	PUNCT
ecj-10468	133	1	cutaneous	cutaneous	ADJ
ecj-10468	133	2	manifestations	manifestation	NOUN
ecj-10468	133	3	related	relate	VERB
ecj-10468	133	4	to	to	ADP
ecj-10468	133	5	coronavirus	coronavirus	NOUN
ecj-10468	133	6	disease	disease	NOUN
ecj-10468	133	7	2019	2019	NUM
ecj-10468	133	8	(	(	PUNCT
ecj-10468	133	9	covid-19	covid-19	PROPN
ecj-10468	133	10	):	):	PUNCT
ecj-10468	133	11	a	a	DET
ecj-10468	133	12	prospective	prospective	ADJ
ecj-10468	133	13	study	study	NOUN
ecj-10468	133	14	from	from	ADP
ecj-10468	133	15	china	china	PROPN
ecj-10468	133	16	and	and	CCONJ
ecj-10468	133	17	italy	italy	PROPN
ecj-10468	133	18	.	.	PUNCT
ecj-10468	134	1	j	j	PROPN
ecj-10468	134	2	am	be	AUX
ecj-10468	134	3	acad	acad	ADJ
ecj-10468	134	4	dermatol	dermatol	NOUN
ecj-10468	134	5	2020;83:674–5	2020;83:674–5	NUM
ecj-10468	134	6	.	.	PUNCT
ecj-10468	135	1	12	12	NUM
ecj-10468	135	2	.	.	PUNCT
ecj-10468	136	1	galvan	galvan	PROPN
ecj-10468	136	2	casas	casas	PROPN
ecj-10468	136	3	c	c	PROPN
ecj-10468	136	4	,	,	PUNCT
ecj-10468	136	5	catala	catala	PROPN
ecj-10468	136	6	a	a	NOUN
ecj-10468	136	7	,	,	PUNCT
ecj-10468	136	8	carretero	carretero	PROPN
ecj-10468	136	9	hernandez	hernandez	PROPN
ecj-10468	136	10	g	g	PROPN
ecj-10468	136	11	,	,	PUNCT
ecj-10468	136	12	et	et	PROPN
ecj-10468	136	13	al	al	PROPN
ecj-10468	136	14	.	.	PUNCT
ecj-10468	136	15	mini	mini	PROPN
ecj-10468	136	16	review	review	NOUN
ecj-10468	136	17	[	[	X
ecj-10468	136	18	emergency	emergency	NOUN
ecj-10468	136	19	care	care	NOUN
ecj-10468	136	20	journal	journal	NOUN
ecj-10468	136	21	2022	2022	NUM
ecj-10468	136	22	;	;	PUNCT
ecj-10468	136	23	18:10468	18:10468	NUM
ecj-10468	136	24	]	]	X
ecj-10468	137	1	[	[	X
ecj-10468	137	2	page	page	NOUN
ecj-10468	137	3	13	13	NUM
ecj-10468	137	4	]	]	PUNCT
ecj-10468	137	5	non	non	ADJ
ecj-10468	137	6	-co	-co	PROPN
ecj-10468	137	7	mmerc	mmerc	PROPN
ecj-10468	137	8	ial	ial	PROPN
ecj-10468	137	9	us	us	PROPN
ecj-10468	137	10	e	e	NOUN
ecj-10468	137	11	o	o	NOUN
ecj-10468	137	12	nly	nly	ADV
ecj-10468	137	13	classification	classification	NOUN
ecj-10468	137	14	of	of	ADP
ecj-10468	137	15	the	the	DET
ecj-10468	137	16	cutaneous	cutaneous	ADJ
ecj-10468	137	17	manifestations	manifestation	NOUN
ecj-10468	137	18	of	of	ADP
ecj-10468	137	19	covid-19	covid-19	PROPN
ecj-10468	137	20	:	:	PUNCT
ecj-10468	137	21	a	a	DET
ecj-10468	137	22	rapid	rapid	ADJ
ecj-10468	137	23	prospective	prospective	ADJ
ecj-10468	137	24	nationwide	nationwide	ADJ
ecj-10468	137	25	consensus	consensus	NOUN
ecj-10468	137	26	study	study	NOUN
ecj-10468	137	27	in	in	ADP
ecj-10468	137	28	spain	spain	PROPN
ecj-10468	137	29	with	with	ADP
ecj-10468	137	30	375	375	NUM
ecj-10468	137	31	cases	case	NOUN
ecj-10468	137	32	.	.	PUNCT
ecj-10468	138	1	br	br	X
ecj-10468	138	2	j	j	PROPN
ecj-10468	138	3	dermatol	dermatol	NOUN
ecj-10468	138	4	2020;183:71	2020;183:71	NUM
ecj-10468	138	5	-	-	SYM
ecj-10468	138	6	7	7	NUM
ecj-10468	138	7	.	.	NOUN
ecj-10468	138	8	13	13	NUM
ecj-10468	138	9	.	.	PUNCT
ecj-10468	139	1	marzano	marzano	PROPN
ecj-10468	139	2	av	av	PROPN
ecj-10468	139	3	,	,	PUNCT
ecj-10468	139	4	cassano	cassano	PROPN
ecj-10468	139	5	n	n	CCONJ
ecj-10468	139	6	,	,	PUNCT
ecj-10468	139	7	genovese	genovese	NOUN
ecj-10468	139	8	g	g	NOUN
ecj-10468	139	9	,	,	PUNCT
ecj-10468	139	10	et	et	PROPN
ecj-10468	139	11	al	al	PROPN
ecj-10468	139	12	.	.	PUNCT
ecj-10468	140	1	cutaneous	cutaneous	ADJ
ecj-10468	140	2	manifestations	manifestation	NOUN
ecj-10468	140	3	in	in	ADP
ecj-10468	140	4	patients	patient	NOUN
ecj-10468	140	5	with	with	ADP
ecj-10468	140	6	covid-19	covid-19	PROPN
ecj-10468	140	7	:	:	PUNCT
ecj-10468	140	8	a	a	DET
ecj-10468	140	9	preliminary	preliminary	ADJ
ecj-10468	140	10	review	review	NOUN
ecj-10468	140	11	of	of	ADP
ecj-10468	140	12	an	an	DET
ecj-10468	140	13	emerging	emerge	VERB
ecj-10468	140	14	issue	issue	NOUN
ecj-10468	140	15	.	.	PUNCT
ecj-10468	141	1	br	br	PROPN
ecj-10468	141	2	j	j	PROPN
ecj-10468	141	3	dermatol	dermatol	NOUN
ecj-10468	141	4	2020;183:431	2020;183:431	NUM
ecj-10468	141	5	-	-	SYM
ecj-10468	141	6	42	42	NUM
ecj-10468	141	7	.	.	PUNCT
ecj-10468	142	1	14	14	NUM
ecj-10468	142	2	.	.	PUNCT
ecj-10468	142	3	torrelo	torrelo	VERB
ecj-10468	142	4	a	a	PRON
ecj-10468	142	5	,	,	PUNCT
ecj-10468	142	6	andina	andina	PROPN
ecj-10468	142	7	d	d	PROPN
ecj-10468	142	8	,	,	PUNCT
ecj-10468	142	9	santonja	santonja	VERB
ecj-10468	142	10	c	c	NOUN
ecj-10468	142	11	,	,	PUNCT
ecj-10468	142	12	et	et	PROPN
ecj-10468	142	13	al	al	PROPN
ecj-10468	143	1	.	.	PROPN
ecj-10468	143	2	erythema	erythema	ADJ
ecj-10468	143	3	multiformelike	multiformelike	ADJ
ecj-10468	143	4	lesions	lesion	NOUN
ecj-10468	143	5	in	in	ADP
ecj-10468	143	6	children	child	NOUN
ecj-10468	143	7	and	and	CCONJ
ecj-10468	143	8	covid-19	covid-19	PROPN
ecj-10468	143	9	.	.	PUNCT
ecj-10468	144	1	pediatr	pediatr	ADJ
ecj-10468	144	2	dermatol	dermatol	NOUN
ecj-10468	144	3	2020;37:442	2020;37:442	NUM
ecj-10468	144	4	-	-	SYM
ecj-10468	144	5	6	6	NUM
ecj-10468	144	6	.	.	NOUN
ecj-10468	144	7	15	15	NUM
ecj-10468	144	8	.	.	PUNCT
ecj-10468	145	1	ehsani	ehsani	PROPN
ecj-10468	145	2	ah	ah	INTJ
ecj-10468	145	3	,	,	PUNCT
ecj-10468	145	4	nasimi	nasimi	PROPN
ecj-10468	145	5	m	m	PROPN
ecj-10468	145	6	,	,	PUNCT
ecj-10468	145	7	bigdelo	bigdelo	PROPN
ecj-10468	145	8	z.	z.	PROPN
ecj-10468	145	9	pityriasis	pityriasis	PROPN
ecj-10468	145	10	rosea	rosea	ADJ
ecj-10468	145	11	as	as	ADP
ecj-10468	145	12	a	a	DET
ecj-10468	145	13	cutaneous	cutaneous	ADJ
ecj-10468	145	14	manifestation	manifestation	NOUN
ecj-10468	145	15	of	of	ADP
ecj-10468	145	16	covid-19	covid-19	PROPN
ecj-10468	145	17	infection	infection	NOUN
ecj-10468	145	18	.	.	PUNCT
ecj-10468	146	1	j	j	PROPN
ecj-10468	146	2	eur	eur	PROPN
ecj-10468	146	3	acad	acad	PROPN
ecj-10468	146	4	dermatol	dermatol	NOUN
ecj-10468	146	5	venereol	venereol	PROPN
ecj-10468	146	6	2020;34	2020;34	NUM
ecj-10468	146	7	:	:	PUNCT
ecj-10468	146	8	e436	e436	NUM
ecj-10468	146	9	-	-	SYM
ecj-10468	146	10	7	7	NUM
ecj-10468	146	11	.	.	NOUN
ecj-10468	146	12	16	16	NUM
ecj-10468	146	13	.	.	PUNCT
ecj-10468	147	1	llamas	llamas	PROPN
ecj-10468	147	2	-	-	PUNCT
ecj-10468	147	3	velasco	velasco	PROPN
ecj-10468	147	4	m	m	PROPN
ecj-10468	147	5	,	,	PUNCT
ecj-10468	148	1	chicharro	chicharro	PROPN
ecj-10468	148	2	p	p	X
ecj-10468	148	3	,	,	PUNCT
ecj-10468	148	4	rodríguez	rodríguez	VERB
ecj-10468	148	5	jiménez	jiménez	PROPN
ecj-10468	148	6	p	p	PROPN
ecj-10468	148	7	,	,	PUNCT
ecj-10468	148	8	et	et	PROPN
ecj-10468	148	9	al	al	PROPN
ecj-10468	148	10	.	.	PROPN
ecj-10468	148	11	comment	comment	NOUN
ecj-10468	148	12	on	on	ADP
ecj-10468	148	13	‘	'	PUNCT
ecj-10468	148	14	clinical	clinical	ADJ
ecj-10468	148	15	and	and	CCONJ
ecj-10468	148	16	histological	histological	ADJ
ecj-10468	148	17	characterization	characterization	NOUN
ecj-10468	148	18	of	of	ADP
ecj-10468	148	19	vesicular	vesicular	ADJ
ecj-10468	148	20	covid-19	covid-19	PROPN
ecj-10468	148	21	rashes	rash	NOUN
ecj-10468	148	22	:	:	PUNCT
ecj-10468	148	23	a	a	DET
ecj-10468	148	24	prospective	prospective	ADJ
ecj-10468	148	25	study	study	NOUN
ecj-10468	148	26	in	in	ADP
ecj-10468	148	27	a	a	DET
ecj-10468	148	28	tertiary	tertiary	ADJ
ecj-10468	148	29	care	care	NOUN
ecj-10468	148	30	hospital	hospital	NOUN
ecj-10468	148	31	’	'	PUNCT
ecj-10468	148	32	.	.	PUNCT
ecj-10468	149	1	pseudoherpetic	pseudoherpetic	ADJ
ecj-10468	149	2	grover	grover	NOUN
ecj-10468	149	3	disease	disease	NOUN
ecj-10468	149	4	seems	seem	VERB
ecj-10468	149	5	to	to	PART
ecj-10468	149	6	occur	occur	VERB
ecj-10468	149	7	in	in	ADP
ecj-10468	149	8	patients	patient	NOUN
ecj-10468	149	9	with	with	ADP
ecj-10468	149	10	covid-19	covid-19	PROPN
ecj-10468	149	11	infection	infection	NOUN
ecj-10468	149	12	.	.	PUNCT
ecj-10468	150	1	clin	clin	PROPN
ecj-10468	150	2	exp	exp	PROPN
ecj-10468	150	3	dermatol	dermatol	NOUN
ecj-10468	150	4	2020;45:896–8	2020;45:896–8	NUM
ecj-10468	150	5	.	.	PROPN
ecj-10468	150	6	17	17	NUM
ecj-10468	150	7	.	.	PUNCT
ecj-10468	151	1	cepeda	cepeda	PROPN
ecj-10468	151	2	-	-	PUNCT
ecj-10468	151	3	valdes	valdes	PROPN
ecj-10468	151	4	r	r	NOUN
ecj-10468	151	5	,	,	PUNCT
ecj-10468	151	6	carrion	carrion	NOUN
ecj-10468	151	7	-	-	PUNCT
ecj-10468	151	8	alvarez	alvarez	PROPN
ecj-10468	151	9	d	d	PROPN
ecj-10468	151	10	,	,	PUNCT
ecj-10468	151	11	trejo	trejo	PROPN
ecj-10468	151	12	castro	castro	PROPN
ecj-10468	151	13	a	a	PRON
ecj-10468	151	14	,	,	PUNCT
ecj-10468	151	15	et	et	PROPN
ecj-10468	151	16	al	al	PROPN
ecj-10468	151	17	.	.	PUNCT
ecj-10468	152	1	cutaneous	cutaneous	ADJ
ecj-10468	152	2	manifestations	manifestation	NOUN
ecj-10468	152	3	in	in	ADP
ecj-10468	152	4	covid-19	covid-19	PROPN
ecj-10468	152	5	:	:	PUNCT
ecj-10468	152	6	familial	familial	ADJ
ecj-10468	152	7	cluster	cluster	NOUN
ecj-10468	152	8	of	of	ADP
ecj-10468	152	9	urticarial	urticarial	ADJ
ecj-10468	152	10	rash	rash	NOUN
ecj-10468	152	11	.	.	PUNCT
ecj-10468	153	1	clin	clin	PROPN
ecj-10468	153	2	exp	exp	NOUN
ecj-10468	153	3	dermatol	dermatol	NOUN
ecj-10468	153	4	2020;45:895–6	2020;45:895–6	NUM
ecj-10468	153	5	.	.	PUNCT
ecj-10468	154	1	18	18	NUM
ecj-10468	154	2	.	.	X
ecj-10468	154	3	freeman	freeman	PROPN
ecj-10468	154	4	ee	ee	PROPN
ecj-10468	154	5	,	,	PUNCT
ecj-10468	154	6	mcmahon	mcmahon	PROPN
ecj-10468	154	7	de	de	PROPN
ecj-10468	154	8	,	,	PUNCT
ecj-10468	154	9	lipoff	lipoff	PROPN
ecj-10468	154	10	jb	jb	PROPN
ecj-10468	154	11	,	,	PUNCT
ecj-10468	154	12	et	et	PROPN
ecj-10468	154	13	al	al	PROPN
ecj-10468	154	14	.	.	PUNCT
ecj-10468	155	1	the	the	DET
ecj-10468	155	2	spectrum	spectrum	NOUN
ecj-10468	155	3	of	of	ADP
ecj-10468	155	4	covid-19	covid-19	PROPN
ecj-10468	155	5	-	-	PUNCT
ecj-10468	155	6	associated	associate	VERB
ecj-10468	155	7	dermatologic	dermatologic	ADJ
ecj-10468	155	8	manifestations	manifestation	NOUN
ecj-10468	155	9	:	:	PUNCT
ecj-10468	155	10	an	an	DET
ecj-10468	155	11	international	international	ADJ
ecj-10468	155	12	registry	registry	NOUN
ecj-10468	155	13	of	of	ADP
ecj-10468	155	14	716	716	NUM
ecj-10468	155	15	patients	patient	NOUN
ecj-10468	155	16	from	from	ADP
ecj-10468	155	17	31	31	NUM
ecj-10468	155	18	countries	country	NOUN
ecj-10468	155	19	.	.	PUNCT
ecj-10468	156	1	j	j	PROPN
ecj-10468	156	2	am	be	AUX
ecj-10468	156	3	acad	acad	ADJ
ecj-10468	156	4	dermatol	dermatol	NOUN
ecj-10468	156	5	2020;83:1118–29	2020;83:1118–29	NUM
ecj-10468	156	6	.	.	PUNCT
ecj-10468	157	1	19	19	NUM
ecj-10468	157	2	.	.	PUNCT
ecj-10468	157	3	najafzadeh	najafzadeh	PROPN
ecj-10468	157	4	m	m	PROPN
ecj-10468	157	5	,	,	PUNCT
ecj-10468	157	6	shahzad	shahzad	PROPN
ecj-10468	157	7	f	f	PROPN
ecj-10468	157	8	,	,	PUNCT
ecj-10468	157	9	ghaderi	ghaderi	NOUN
ecj-10468	157	10	n	n	CCONJ
ecj-10468	157	11	,	,	PUNCT
ecj-10468	157	12	et	et	PROPN
ecj-10468	157	13	al	al	PROPN
ecj-10468	157	14	.	.	PUNCT
ecj-10468	157	15	urticaria	urticaria	PROPN
ecj-10468	157	16	(	(	PUNCT
ecj-10468	157	17	angioedema	angioedema	PROPN
ecj-10468	157	18	)	)	PUNCT
ecj-10468	157	19	and	and	CCONJ
ecj-10468	157	20	covid-19	covid-19	PROPN
ecj-10468	157	21	infection	infection	NOUN
ecj-10468	157	22	.	.	PUNCT
ecj-10468	158	1	j	j	PROPN
ecj-10468	158	2	eur	eur	PROPN
ecj-10468	158	3	acad	acad	PROPN
ecj-10468	158	4	dermatol	dermatol	NOUN
ecj-10468	158	5	venereol	venereol	PROPN
ecj-10468	158	6	2020;34	2020;34	NUM
ecj-10468	158	7	:	:	PUNCT
ecj-10468	158	8	e568–70	e568–70	PROPN
ecj-10468	158	9	.	.	PROPN
ecj-10468	159	1	20	20	NUM
ecj-10468	159	2	.	.	PUNCT
ecj-10468	159	3	fernandez	fernandez	PROPN
ecj-10468	159	4	-	-	PUNCT
ecj-10468	159	5	nieto	nieto	PROPN
ecj-10468	159	6	d	d	PROPN
ecj-10468	159	7	,	,	PUNCT
ecj-10468	159	8	ortega	ortega	PROPN
ecj-10468	159	9	-	-	PUNCT
ecj-10468	159	10	quijano	quijano	PROPN
ecj-10468	159	11	d	d	PROPN
ecj-10468	159	12	,	,	PUNCT
ecj-10468	159	13	jimenez	jimenez	PROPN
ecj-10468	159	14	-	-	PUNCT
ecj-10468	159	15	cauhe	cauhe	PROPN
ecj-10468	159	16	j	j	PROPN
ecj-10468	159	17	,	,	PUNCT
ecj-10468	159	18	et	et	PROPN
ecj-10468	159	19	al	al	PROPN
ecj-10468	159	20	.	.	PROPN
ecj-10468	160	1	clinical	clinical	ADJ
ecj-10468	160	2	and	and	CCONJ
ecj-10468	160	3	histological	histological	ADJ
ecj-10468	160	4	characterization	characterization	NOUN
ecj-10468	160	5	of	of	ADP
ecj-10468	160	6	vesicular	vesicular	ADJ
ecj-10468	160	7	covid19	covid19	NOUN
ecj-10468	160	8	rashes	rash	NOUN
ecj-10468	160	9	:	:	PUNCT
ecj-10468	160	10	a	a	DET
ecj-10468	160	11	prospective	prospective	ADJ
ecj-10468	160	12	study	study	NOUN
ecj-10468	160	13	in	in	ADP
ecj-10468	160	14	a	a	DET
ecj-10468	160	15	tertiary	tertiary	ADJ
ecj-10468	160	16	care	care	NOUN
ecj-10468	160	17	hospital	hospital	NOUN
ecj-10468	160	18	.	.	PUNCT
ecj-10468	161	1	clin	clin	PROPN
ecj-10468	161	2	exp	exp	NOUN
ecj-10468	161	3	dermatol	dermatol	NOUN
ecj-10468	161	4	2020;45:872–5	2020;45:872–5	NUM
ecj-10468	161	5	.	.	PUNCT
ecj-10468	162	1	21	21	NUM
ecj-10468	162	2	.	.	PUNCT
ecj-10468	163	1	amatore	amatore	PROPN
ecj-10468	163	2	f	f	PROPN
ecj-10468	163	3	,	,	PUNCT
ecj-10468	163	4	macagno	macagno	NOUN
ecj-10468	163	5	n	n	CCONJ
ecj-10468	163	6	,	,	PUNCT
ecj-10468	163	7	mailhe	mailhe	PROPN
ecj-10468	163	8	m	m	PROPN
ecj-10468	163	9	,	,	PUNCT
ecj-10468	163	10	demarez	demarez	NOUN
ecj-10468	163	11	b	b	PROPN
ecj-10468	163	12	,	,	PUNCT
ecj-10468	163	13	gaudymarqueste	gaudymarqueste	ADP
ecj-10468	163	14	c	c	PROPN
ecj-10468	163	15	,	,	PUNCT
ecj-10468	163	16	grob	grob	PROPN
ecj-10468	163	17	jj	jj	PROPN
ecj-10468	163	18	,	,	PUNCT
ecj-10468	163	19	raoult	raoult	VERB
ecj-10468	163	20	d	d	NOUN
ecj-10468	163	21	,	,	PUNCT
ecj-10468	163	22	brouqui	brouqui	NOUN
ecj-10468	163	23	p	p	NOUN
ecj-10468	163	24	,	,	PUNCT
ecj-10468	163	25	richard	richard	PROPN
ecj-10468	163	26	ma	ma	PROPN
ecj-10468	163	27	.	.	PROPN
ecj-10468	164	1	sars	sars	PROPN
ecj-10468	164	2	-	-	PUNCT
ecj-10468	164	3	cov-2	cov-2	PART
ecj-10468	164	4	infection	infection	NOUN
ecj-10468	164	5	presenting	present	VERB
ecj-10468	164	6	as	as	ADP
ecj-10468	164	7	a	a	DET
ecj-10468	164	8	febrile	febrile	NOUN
ecj-10468	164	9	rash	rash	NOUN
ecj-10468	164	10	.	.	PUNCT
ecj-10468	165	1	j	j	PROPN
ecj-10468	165	2	eur	eur	PROPN
ecj-10468	165	3	acad	acad	PROPN
ecj-10468	165	4	dermatol	dermatol	NOUN
ecj-10468	165	5	venereol	venereol	PROPN
ecj-10468	165	6	2020;34	2020;34	NUM
ecj-10468	165	7	:	:	PUNCT
ecj-10468	165	8	e304	e304	PROPN
ecj-10468	165	9	-	-	PUNCT
ecj-10468	165	10	e306	e306	PROPN
ecj-10468	165	11	.	.	PROPN
ecj-10468	166	1	22	22	NUM
ecj-10468	166	2	.	.	PUNCT
ecj-10468	167	1	rodríguez	rodríguez	NOUN
ecj-10468	167	2	-	-	PUNCT
ecj-10468	167	3	jiménez	jiménez	PROPN
ecj-10468	167	4	p	p	PROPN
ecj-10468	167	5	,	,	PUNCT
ecj-10468	167	6	chicharro	chicharro	PROPN
ecj-10468	168	1	p	p	X
ecj-10468	168	2	,	,	PUNCT
ecj-10468	168	3	de	de	X
ecj-10468	168	4	argila	argila	NOUN
ecj-10468	168	5	d	d	PROPN
ecj-10468	168	6	,	,	PUNCT
ecj-10468	168	7	et	et	PROPN
ecj-10468	168	8	al	al	PROPN
ecj-10468	168	9	.	.	PUNCT
ecj-10468	169	1	urticaria	urticaria	ADJ
ecj-10468	169	2	-	-	PUNCT
ecj-10468	169	3	like	like	ADJ
ecj-10468	169	4	lesions	lesion	NOUN
ecj-10468	169	5	in	in	ADP
ecj-10468	169	6	covid-19	covid-19	PROPN
ecj-10468	169	7	patients	patient	NOUN
ecj-10468	169	8	are	be	AUX
ecj-10468	169	9	not	not	PART
ecj-10468	169	10	really	really	ADV
ecj-10468	169	11	urticaria	urticaria	ADJ
ecj-10468	169	12	a	a	DET
ecj-10468	169	13	case	case	NOUN
ecj-10468	169	14	with	with	ADP
ecj-10468	169	15	clinicopathological	clinicopathological	ADJ
ecj-10468	169	16	correlation	correlation	NOUN
ecj-10468	169	17	.	.	PUNCT
ecj-10468	170	1	j	j	PROPN
ecj-10468	170	2	eur	eur	PROPN
ecj-10468	170	3	acad	acad	PROPN
ecj-10468	170	4	dermatol	dermatol	NOUN
ecj-10468	170	5	venereol	venereol	PROPN
ecj-10468	170	6	2020;34	2020;34	NUM
ecj-10468	170	7	:	:	PUNCT
ecj-10468	170	8	e459	e459	PROPN
ecj-10468	170	9	-	-	PUNCT
ecj-10468	170	10	60	60	PROPN
ecj-10468	170	11	.	.	PUNCT
ecj-10468	171	1	23	23	NUM
ecj-10468	171	2	.	.	PUNCT
ecj-10468	172	1	shanshal	shanshal	VERB
ecj-10468	172	2	m.	m.	NOUN
ecj-10468	172	3	low	low	ADJ
ecj-10468	172	4	-	-	PUNCT
ecj-10468	172	5	dose	dose	VERB
ecj-10468	172	6	systemic	systemic	ADJ
ecj-10468	172	7	steroids	steroid	NOUN
ecj-10468	172	8	,	,	PUNCT
ecj-10468	172	9	an	an	DET
ecj-10468	172	10	emerging	emerge	VERB
ecj-10468	172	11	therapeutic	therapeutic	ADJ
ecj-10468	172	12	option	option	NOUN
ecj-10468	172	13	for	for	ADP
ecj-10468	172	14	covid-19	covid-19	PROPN
ecj-10468	172	15	-	-	PUNCT
ecj-10468	172	16	related	relate	VERB
ecj-10468	172	17	urticaria	urticaria	NOUN
ecj-10468	172	18	.	.	PUNCT
ecj-10468	173	1	j	j	PROPN
ecj-10468	173	2	dermatolog	dermatolog	PROPN
ecj-10468	173	3	treat	treat	VERB
ecj-10468	173	4	2020;16:1	2020;16:1	NUM
ecj-10468	173	5	-	-	SYM
ecj-10468	173	6	2	2	NUM
ecj-10468	173	7	.	.	NUM
ecj-10468	173	8	24	24	NUM
ecj-10468	173	9	.	.	PUNCT
ecj-10468	174	1	català	català	PROPN
ecj-10468	174	2	a	a	DET
ecj-10468	174	3	,	,	PUNCT
ecj-10468	174	4	galván	galván	NOUN
ecj-10468	174	5	-	-	PUNCT
ecj-10468	174	6	casas	casas	NOUN
ecj-10468	174	7	c	c	NOUN
ecj-10468	174	8	,	,	PUNCT
ecj-10468	174	9	carretero	carretero	NOUN
ecj-10468	174	10	-	-	PUNCT
ecj-10468	174	11	hernández	hernández	NOUN
ecj-10468	174	12	g	g	PROPN
ecj-10468	174	13	,	,	PUNCT
ecj-10468	174	14	et	et	PROPN
ecj-10468	174	15	al	al	PROPN
ecj-10468	174	16	.	.	PROPN
ecj-10468	174	17	maculopapular	maculopapular	ADJ
ecj-10468	174	18	eruptions	eruption	NOUN
ecj-10468	174	19	associated	associate	VERB
ecj-10468	174	20	to	to	ADP
ecj-10468	174	21	covid-19	covid-19	PROPN
ecj-10468	174	22	:	:	PUNCT
ecj-10468	174	23	a	a	DET
ecj-10468	174	24	subanalysis	subanalysis	NOUN
ecj-10468	174	25	of	of	ADP
ecj-10468	174	26	the	the	DET
ecj-10468	174	27	covid	covid	NOUN
ecj-10468	174	28	-	-	PUNCT
ecj-10468	174	29	piel	piel	PROPN
ecj-10468	174	30	study	study	NOUN
ecj-10468	174	31	.	.	PUNCT
ecj-10468	175	1	dermatol	dermatol	NOUN
ecj-10468	175	2	ther	ther	ADV
ecj-10468	175	3	2020;33	2020;33	NUM
ecj-10468	175	4	:	:	PUNCT
ecj-10468	175	5	e14170	e14170	ADJ
ecj-10468	175	6	.	.	PROPN
ecj-10468	175	7	25	25	NUM
ecj-10468	175	8	.	.	PUNCT
ecj-10468	176	1	rivera	rivera	PROPN
ecj-10468	176	2	-	-	PUNCT
ecj-10468	176	3	oyola	oyola	PROPN
ecj-10468	176	4	r	r	PROPN
ecj-10468	176	5	,	,	PUNCT
ecj-10468	176	6	koschitzky	koschitzky	PROPN
ecj-10468	176	7	m	m	PROPN
ecj-10468	176	8	,	,	PUNCT
ecj-10468	176	9	printy	printy	ADJ
ecj-10468	176	10	r	r	NOUN
ecj-10468	176	11	,	,	PUNCT
ecj-10468	176	12	et	et	PROPN
ecj-10468	176	13	al	al	PROPN
ecj-10468	176	14	.	.	PUNCT
ecj-10468	177	1	dermatologic	dermatologic	ADJ
ecj-10468	177	2	findings	finding	NOUN
ecj-10468	177	3	in	in	ADP
ecj-10468	177	4	2	2	NUM
ecj-10468	177	5	patients	patient	NOUN
ecj-10468	177	6	with	with	ADP
ecj-10468	177	7	covid-19	covid-19	PROPN
ecj-10468	177	8	.	.	PUNCT
ecj-10468	177	9	jaad	jaad	PROPN
ecj-10468	177	10	case	case	NOUN
ecj-10468	177	11	rep	rep	PROPN
ecj-10468	177	12	2020;6:537–9	2020;6:537–9	ADJ
ecj-10468	177	13	.	.	PUNCT
ecj-10468	178	1	26	26	NUM
ecj-10468	178	2	.	.	PUNCT
ecj-10468	178	3	jimenez	jimenez	PROPN
ecj-10468	178	4	-	-	PUNCT
ecj-10468	178	5	cauhe	cauhe	PROPN
ecj-10468	178	6	j	j	PROPN
ecj-10468	178	7	,	,	PUNCT
ecj-10468	178	8	ortega	ortega	PROPN
ecj-10468	178	9	-	-	PUNCT
ecj-10468	178	10	quijano	quijano	PROPN
ecj-10468	178	11	d	d	PROPN
ecj-10468	178	12	,	,	PUNCT
ecj-10468	178	13	prieto	prieto	NOUN
ecj-10468	178	14	-	-	PUNCT
ecj-10468	178	15	barrios	barrio	NOUN
ecj-10468	178	16	m	m	NOUN
ecj-10468	178	17	,	,	PUNCT
ecj-10468	178	18	et	et	PROPN
ecj-10468	178	19	al	al	PROPN
ecj-10468	178	20	.	.	PROPN
ecj-10468	178	21	reply	reply	PROPN
ecj-10468	178	22	to	to	ADP
ecj-10468	178	23	"	"	PUNCT
ecj-10468	178	24	covid-19	covid-19	PROPN
ecj-10468	178	25	can	can	AUX
ecj-10468	178	26	present	present	VERB
ecj-10468	178	27	with	with	ADP
ecj-10468	178	28	a	a	DET
ecj-10468	178	29	rash	rash	NOUN
ecj-10468	178	30	and	and	CCONJ
ecj-10468	178	31	be	be	AUX
ecj-10468	178	32	mistaken	mistaken	ADJ
ecj-10468	178	33	for	for	ADP
ecj-10468	178	34	dengue	dengue	NOUN
ecj-10468	178	35	"	"	PUNCT
ecj-10468	178	36	:	:	PUNCT
ecj-10468	178	37	petechial	petechial	ADJ
ecj-10468	178	38	rash	rash	NOUN
ecj-10468	178	39	in	in	ADP
ecj-10468	178	40	a	a	DET
ecj-10468	178	41	patient	patient	NOUN
ecj-10468	178	42	with	with	ADP
ecj-10468	178	43	covid-19	covid-19	PROPN
ecj-10468	178	44	infection	infection	NOUN
ecj-10468	178	45	.	.	PUNCT
ecj-10468	179	1	j	j	PROPN
ecj-10468	179	2	am	be	AUX
ecj-10468	179	3	acad	acad	ADJ
ecj-10468	179	4	dermatol	dermatol	NOUN
ecj-10468	179	5	2020;83	2020;83	NUM
ecj-10468	179	6	:	:	PUNCT
ecj-10468	179	7	e141	e141	NUM
ecj-10468	179	8	-	-	SYM
ecj-10468	179	9	2	2	NUM
ecj-10468	179	10	.	.	NUM
ecj-10468	179	11	27	27	NUM
ecj-10468	179	12	.	.	PUNCT
ecj-10468	180	1	najarian	najarian	PROPN
ecj-10468	180	2	dj	dj	PROPN
ecj-10468	180	3	.	.	PROPN
ecj-10468	181	1	morbilliform	morbilliform	PROPN
ecj-10468	181	2	exanthem	exanthem	PRON
ecj-10468	181	3	associated	associate	VERB
ecj-10468	181	4	with	with	ADP
ecj-10468	181	5	covid19	covid19	NOUN
ecj-10468	181	6	.	.	PUNCT
ecj-10468	182	1	jaad	jaad	NOUN
ecj-10468	182	2	case	case	NOUN
ecj-10468	182	3	rep	rep	PROPN
ecj-10468	182	4	2020;6:493	2020;6:493	PROPN
ecj-10468	182	5	-	-	PUNCT
ecj-10468	182	6	4	4	NUM
ecj-10468	182	7	.	.	NOUN
ecj-10468	182	8	28	28	NUM
ecj-10468	182	9	.	.	PUNCT
ecj-10468	183	1	gianotti	gianotti	NOUN
ecj-10468	183	2	r	r	NOUN
ecj-10468	183	3	,	,	PUNCT
ecj-10468	183	4	veraldi	veraldi	NOUN
ecj-10468	183	5	s	s	PROPN
ecj-10468	183	6	,	,	PUNCT
ecj-10468	183	7	recalcati	recalcati	PROPN
ecj-10468	183	8	s	s	PROPN
ecj-10468	183	9	,	,	PUNCT
ecj-10468	183	10	et	et	PROPN
ecj-10468	183	11	al	al	PROPN
ecj-10468	183	12	.	.	PUNCT
ecj-10468	184	1	cutaneous	cutaneous	ADJ
ecj-10468	184	2	clinicopathological	clinicopathological	ADJ
ecj-10468	184	3	findings	finding	NOUN
ecj-10468	184	4	in	in	ADP
ecj-10468	184	5	three	three	NUM
ecj-10468	184	6	covid-19	covid-19	PROPN
ecj-10468	184	7	-	-	PUNCT
ecj-10468	184	8	positive	positive	ADJ
ecj-10468	184	9	patients	patient	NOUN
ecj-10468	184	10	observed	observe	VERB
ecj-10468	184	11	in	in	ADP
ecj-10468	184	12	the	the	DET
ecj-10468	184	13	metropolitan	metropolitan	ADJ
ecj-10468	184	14	area	area	NOUN
ecj-10468	184	15	of	of	ADP
ecj-10468	184	16	milan	milan	PROPN
ecj-10468	184	17	,	,	PUNCT
ecj-10468	184	18	italy	italy	PROPN
ecj-10468	184	19	.	.	PUNCT
ecj-10468	185	1	acta	acta	PROPN
ecj-10468	185	2	derm	derm	PROPN
ecj-10468	185	3	venereol	venereol	PROPN
ecj-10468	185	4	2020;100	2020;100	NUM
ecj-10468	185	5	:	:	PUNCT
ecj-10468	186	1	adv00124.2	adv00124.2	PROPN
ecj-10468	186	2	.	.	PROPN
ecj-10468	186	3	29	29	NUM
ecj-10468	186	4	.	.	PUNCT
ecj-10468	187	1	reymundo	reymundo	PROPN
ecj-10468	187	2	a	a	DET
ecj-10468	187	3	,	,	PUNCT
ecj-10468	187	4	fernaldez	fernaldez	PROPN
ecj-10468	187	5	-	-	PUNCT
ecj-10468	187	6	bernaldez	bernaldez	PROPN
ecj-10468	187	7	a	a	PRON
ecj-10468	187	8	,	,	PUNCT
ecj-10468	187	9	reolid	reolid	PROPN
ecj-10468	187	10	a	a	PRON
ecj-10468	187	11	,	,	PUNCT
ecj-10468	187	12	et	et	PROPN
ecj-10468	187	13	al	al	PROPN
ecj-10468	187	14	.	.	PROPN
ecj-10468	188	1	clinical	clinical	ADJ
ecj-10468	188	2	and	and	CCONJ
ecj-10468	188	3	histological	histological	ADJ
ecj-10468	188	4	characterization	characterization	NOUN
ecj-10468	188	5	of	of	ADP
ecj-10468	188	6	late	late	ADJ
ecj-10468	188	7	appearance	appearance	NOUN
ecj-10468	188	8	maculopapular	maculopapular	ADJ
ecj-10468	188	9	eruptions	eruption	NOUN
ecj-10468	188	10	in	in	ADP
ecj-10468	188	11	association	association	NOUN
ecj-10468	188	12	with	with	ADP
ecj-10468	188	13	the	the	DET
ecj-10468	188	14	coronavirus	coronavirus	NOUN
ecj-10468	188	15	disease	disease	NOUN
ecj-10468	188	16	2019	2019	NUM
ecj-10468	188	17	.	.	PUNCT
ecj-10468	189	1	a	a	DET
ecj-10468	189	2	case	case	NOUN
ecj-10468	189	3	series	series	NOUN
ecj-10468	189	4	of	of	ADP
ecj-10468	189	5	seven	seven	NUM
ecj-10468	189	6	patients	patient	NOUN
ecj-10468	189	7	.	.	PUNCT
ecj-10468	190	1	j	j	PROPN
ecj-10468	190	2	eur	eur	PROPN
ecj-10468	190	3	acad	acad	PROPN
ecj-10468	190	4	dermatol	dermatol	NOUN
ecj-10468	190	5	venereol	venereol	PROPN
ecj-10468	190	6	2020;34	2020;34	NUM
ecj-10468	190	7	:	:	PUNCT
ecj-10468	190	8	e755	e755	VERB
ecj-10468	190	9	-	-	SYM
ecj-10468	190	10	7	7	NUM
ecj-10468	190	11	.	.	NOUN
ecj-10468	190	12	30	30	NUM
ecj-10468	190	13	.	.	PUNCT
ecj-10468	191	1	marzano	marzano	PROPN
ecj-10468	191	2	av	av	PROPN
ecj-10468	191	3	,	,	PUNCT
ecj-10468	191	4	genovese	genovese	NOUN
ecj-10468	191	5	g	g	NOUN
ecj-10468	191	6	,	,	PUNCT
ecj-10468	191	7	fabbrocini	fabbrocini	NOUN
ecj-10468	191	8	g	g	NOUN
ecj-10468	191	9	,	,	PUNCT
ecj-10468	191	10	et	et	PROPN
ecj-10468	191	11	al	al	PROPN
ecj-10468	191	12	.	.	PUNCT
ecj-10468	192	1	varicella	varicella	NOUN
ecj-10468	192	2	-	-	PUNCT
ecj-10468	192	3	like	like	VERB
ecj-10468	192	4	exanthem	exanthem	PRON
ecj-10468	192	5	as	as	ADP
ecj-10468	192	6	a	a	DET
ecj-10468	192	7	specific	specific	ADJ
ecj-10468	192	8	covid-19	covid-19	PROPN
ecj-10468	192	9	-	-	PUNCT
ecj-10468	192	10	associated	associate	VERB
ecj-10468	192	11	skin	skin	NOUN
ecj-10468	192	12	manifestation	manifestation	NOUN
ecj-10468	192	13	:	:	PUNCT
ecj-10468	193	1	multicenter	multicenter	NOUN
ecj-10468	193	2	case	case	NOUN
ecj-10468	193	3	series	series	NOUN
ecj-10468	193	4	of	of	ADP
ecj-10468	193	5	22	22	NUM
ecj-10468	193	6	patients	patient	NOUN
ecj-10468	193	7	.	.	PUNCT
ecj-10468	194	1	j	j	PROPN
ecj-10468	194	2	am	be	AUX
ecj-10468	194	3	acad	acad	ADJ
ecj-10468	194	4	dermatol	dermatol	NOUN
ecj-10468	194	5	2020;83:280	2020;83:280	NUM
ecj-10468	194	6	-	-	SYM
ecj-10468	194	7	5	5	NUM
ecj-10468	194	8	.	.	NOUN
ecj-10468	194	9	31	31	NUM
ecj-10468	194	10	.	.	PUNCT
ecj-10468	195	1	genovese	genovese	NOUN
ecj-10468	195	2	g	g	PROPN
ecj-10468	195	3	,	,	PUNCT
ecj-10468	195	4	colonna	colonna	NOUN
ecj-10468	195	5	c	c	NOUN
ecj-10468	195	6	,	,	PUNCT
ecj-10468	195	7	marzano	marzano	PROPN
ecj-10468	195	8	av	av	PROPN
ecj-10468	195	9	.	.	PUNCT
ecj-10468	196	1	varicella	varicella	NOUN
ecj-10468	196	2	-	-	PUNCT
ecj-10468	196	3	like	like	ADJ
ecj-10468	196	4	exanthem	exanthem	NOUN
ecj-10468	196	5	associated	associate	VERB
ecj-10468	196	6	with	with	ADP
ecj-10468	196	7	covid-19	covid-19	PROPN
ecj-10468	196	8	in	in	ADP
ecj-10468	196	9	an	an	DET
ecj-10468	196	10	8	8	NUM
ecj-10468	196	11	-	-	PUNCT
ecj-10468	196	12	year	year	NOUN
ecj-10468	196	13	-	-	PUNCT
ecj-10468	196	14	old	old	ADJ
ecj-10468	196	15	girl	girl	NOUN
ecj-10468	196	16	:	:	PUNCT
ecj-10468	196	17	a	a	DET
ecj-10468	196	18	diagnostic	diagnostic	ADJ
ecj-10468	196	19	clue	clue	NOUN
ecj-10468	196	20	?	?	PUNCT
ecj-10468	197	1	pediatr	pediatr	ADJ
ecj-10468	197	2	dermatol	dermatol	NOUN
ecj-10468	197	3	2020;37:435	2020;37:435	NOUN
ecj-10468	197	4	-	-	SYM
ecj-10468	197	5	6	6	NUM
ecj-10468	197	6	.	.	NOUN
ecj-10468	197	7	32	32	NUM
ecj-10468	197	8	.	.	PUNCT
ecj-10468	198	1	magro	magro	PROPN
ecj-10468	198	2	c	c	PROPN
ecj-10468	198	3	,	,	PUNCT
ecj-10468	198	4	mulvey	mulvey	PROPN
ecj-10468	198	5	jj	jj	PROPN
ecj-10468	198	6	,	,	PUNCT
ecj-10468	198	7	berlin	berlin	PROPN
ecj-10468	198	8	d	d	PROPN
ecj-10468	198	9	,	,	PUNCT
ecj-10468	198	10	et	et	PROPN
ecj-10468	198	11	al	al	PROPN
ecj-10468	198	12	.	.	PROPN
ecj-10468	199	1	complement	complement	PROPN
ecj-10468	199	2	associated	associate	VERB
ecj-10468	199	3	microvascular	microvascular	NOUN
ecj-10468	199	4	injury	injury	NOUN
ecj-10468	199	5	and	and	CCONJ
ecj-10468	199	6	thrombosis	thrombosis	NOUN
ecj-10468	199	7	in	in	ADP
ecj-10468	199	8	the	the	DET
ecj-10468	199	9	pathogenesis	pathogenesis	NOUN
ecj-10468	199	10	of	of	ADP
ecj-10468	199	11	severe	severe	ADJ
ecj-10468	199	12	covid-19	covid-19	PROPN
ecj-10468	199	13	infection	infection	NOUN
ecj-10468	199	14	:	:	PUNCT
ecj-10468	199	15	a	a	DET
ecj-10468	199	16	report	report	NOUN
ecj-10468	199	17	of	of	ADP
ecj-10468	199	18	five	five	NUM
ecj-10468	199	19	cases	case	NOUN
ecj-10468	199	20	.	.	PUNCT
ecj-10468	200	1	transl	transl	PROPN
ecj-10468	200	2	res	re	NOUN
ecj-10468	200	3	2020;220:1	2020;220:1	PROPN
ecj-10468	200	4	-	-	SYM
ecj-10468	200	5	13	13	NUM
ecj-10468	200	6	.	.	PUNCT
ecj-10468	201	1	33	33	NUM
ecj-10468	201	2	.	.	PUNCT
ecj-10468	202	1	askin	askin	PROPN
ecj-10468	203	1	o	o	PROPN
ecj-10468	203	2	,	,	PUNCT
ecj-10468	203	3	altunkalem	altunkalem	PROPN
ecj-10468	203	4	rn	rn	PROPN
ecj-10468	203	5	,	,	PUNCT
ecj-10468	203	6	altinisik	altinisik	PROPN
ecj-10468	203	7	dd	dd	PROPN
ecj-10468	203	8	,	,	PUNCT
ecj-10468	203	9	et	et	PROPN
ecj-10468	203	10	al	al	PROPN
ecj-10468	203	11	.	.	PUNCT
ecj-10468	204	1	cutaneous	cutaneous	ADJ
ecj-10468	204	2	manifestations	manifestation	NOUN
ecj-10468	204	3	in	in	ADP
ecj-10468	204	4	hospitalized	hospitalize	VERB
ecj-10468	204	5	patients	patient	NOUN
ecj-10468	204	6	diagnosed	diagnose	VERB
ecj-10468	204	7	as	as	ADP
ecj-10468	204	8	covid-19	covid-19	PROPN
ecj-10468	204	9	.	.	PUNCT
ecj-10468	204	10	dermatol	dermatol	NOUN
ecj-10468	204	11	ther	ther	VERB
ecj-10468	204	12	2020;24	2020;24	NUM
ecj-10468	204	13	:	:	PUNCT
ecj-10468	204	14	e13896	e13896	PROPN
ecj-10468	204	15	.	.	PUNCT
ecj-10468	205	1	34	34	NUM
ecj-10468	205	2	.	.	PUNCT
ecj-10468	206	1	trellu	trellu	NOUN
ecj-10468	206	2	lt	lt	PROPN
ecj-10468	206	3	,	,	PUNCT
ecj-10468	206	4	kaya	kaya	PROPN
ecj-10468	206	5	g	g	PROPN
ecj-10468	206	6	,	,	PUNCT
ecj-10468	206	7	alberto	alberto	PROPN
ecj-10468	206	8	c	c	PROPN
ecj-10468	206	9	,	,	PUNCT
ecj-10468	206	10	et	et	PROPN
ecj-10468	206	11	al	al	PROPN
ecj-10468	206	12	.	.	PUNCT
ecj-10468	206	13	clinicopathologic	clinicopathologic	ADJ
ecj-10468	206	14	aspects	aspect	NOUN
ecj-10468	206	15	of	of	ADP
ecj-10468	206	16	a	a	DET
ecj-10468	206	17	papulovesicular	papulovesicular	ADJ
ecj-10468	206	18	eruption	eruption	NOUN
ecj-10468	206	19	in	in	ADP
ecj-10468	206	20	a	a	DET
ecj-10468	206	21	patient	patient	NOUN
ecj-10468	206	22	with	with	ADP
ecj-10468	206	23	covid-19	covid-19	PROPN
ecj-10468	206	24	.	.	PROPN
ecj-10468	206	25	jama	jama	PROPN
ecj-10468	206	26	dermatol	dermatol	NOUN
ecj-10468	206	27	2020;156:922	2020;156:922	NUM
ecj-10468	206	28	-	-	SYM
ecj-10468	206	29	4	4	NUM
ecj-10468	206	30	.	.	NOUN
ecj-10468	206	31	35	35	NUM
ecj-10468	206	32	.	.	PUNCT
ecj-10468	206	33	mahé	mahé	NOUN
ecj-10468	206	34	a	a	DET
ecj-10468	206	35	,	,	PUNCT
ecj-10468	206	36	birckel	birckel	NOUN
ecj-10468	206	37	e	e	NOUN
ecj-10468	206	38	,	,	PUNCT
ecj-10468	206	39	merklen	merklen	ADJ
ecj-10468	206	40	c	c	NOUN
ecj-10468	206	41	,	,	PUNCT
ecj-10468	206	42	et	et	PROPN
ecj-10468	206	43	al	al	PROPN
ecj-10468	206	44	.	.	PUNCT
ecj-10468	207	1	histology	histology	PROPN
ecj-10468	207	2	of	of	ADP
ecj-10468	207	3	skin	skin	NOUN
ecj-10468	207	4	lesions	lesion	NOUN
ecj-10468	207	5	establishes	establish	VERB
ecj-10468	207	6	that	that	SCONJ
ecj-10468	207	7	the	the	DET
ecj-10468	207	8	vesicular	vesicular	ADJ
ecj-10468	207	9	rash	rash	NOUN
ecj-10468	207	10	associated	associate	VERB
ecj-10468	207	11	with	with	ADP
ecj-10468	207	12	covid-19	covid-19	PROPN
ecj-10468	207	13	is	be	AUX
ecj-10468	207	14	not	not	PART
ecj-10468	207	15	‘	'	PUNCT
ecj-10468	207	16	varicella	varicella	NOUN
ecj-10468	207	17	-	-	PUNCT
ecj-10468	207	18	like	like	ADJ
ecj-10468	207	19	’	'	PUNCT
ecj-10468	207	20	.	.	PUNCT
ecj-10468	208	1	j	j	PROPN
ecj-10468	208	2	eur	eur	PROPN
ecj-10468	208	3	acad	acad	PROPN
ecj-10468	208	4	dermatol	dermatol	NOUN
ecj-10468	208	5	venereol	venereol	PROPN
ecj-10468	208	6	2020;34	2020;34	NUM
ecj-10468	208	7	:	:	PUNCT
ecj-10468	208	8	e559–61	e559–61	VERB
ecj-10468	208	9	.	.	PROPN
ecj-10468	208	10	36	36	NUM
ecj-10468	208	11	.	.	X
ecj-10468	209	1	elsaie	elsaie	PROPN
ecj-10468	209	2	ml	ml	PROPN
ecj-10468	209	3	,	,	PUNCT
ecj-10468	209	4	nada	nada	PROPN
ecj-10468	209	5	ha	ha	PROPN
ecj-10468	209	6	.	.	PROPN
ecj-10468	209	7	herpes	herpe	NOUN
ecj-10468	209	8	zoster	zoster	NOUN
ecj-10468	209	9	(	(	PUNCT
ecj-10468	209	10	shingles	shingle	NOUN
ecj-10468	209	11	)	)	PUNCT
ecj-10468	209	12	complicating	complicate	VERB
ecj-10468	209	13	the	the	DET
ecj-10468	209	14	course	course	NOUN
ecj-10468	209	15	of	of	ADP
ecj-10468	209	16	covid19	covid19	NOUN
ecj-10468	209	17	infection	infection	NOUN
ecj-10468	209	18	.	.	PUNCT
ecj-10468	210	1	j	j	PROPN
ecj-10468	210	2	dermatolog	dermatolog	PROPN
ecj-10468	210	3	treat	treat	VERB
ecj-10468	210	4	2020;12:1	2020;12:1	NUM
ecj-10468	210	5	-	-	SYM
ecj-10468	210	6	3	3	NUM
ecj-10468	210	7	.	.	NOUN
ecj-10468	210	8	37	37	NUM
ecj-10468	210	9	.	.	PUNCT
ecj-10468	211	1	marzano	marzano	PROPN
ecj-10468	211	2	av	av	PROPN
ecj-10468	211	3	,	,	PUNCT
ecj-10468	211	4	genovese	genovese	ADJ
ecj-10468	211	5	g.	g.	PROPN
ecj-10468	211	6	response	response	NOUN
ecj-10468	211	7	to	to	ADP
ecj-10468	211	8	:	:	PUNCT
ecj-10468	211	9	"	"	PUNCT
ecj-10468	211	10	reply	reply	NOUN
ecj-10468	211	11	to	to	AUX
ecj-10468	211	12	'	'	PUNCT
ecj-10468	211	13	varicellalike	varicellalike	VERB
ecj-10468	211	14	exanthem	exanthem	PRON
ecj-10468	211	15	as	as	ADP
ecj-10468	211	16	a	a	DET
ecj-10468	211	17	specific	specific	ADJ
ecj-10468	211	18	covid-19	covid-19	PROPN
ecj-10468	211	19	-	-	PUNCT
ecj-10468	211	20	associated	associate	VERB
ecj-10468	211	21	skin	skin	NOUN
ecj-10468	211	22	manifestation	manifestation	NOUN
ecj-10468	211	23	:	:	PUNCT
ecj-10468	211	24	multicenter	multicenter	NOUN
ecj-10468	211	25	case	case	NOUN
ecj-10468	211	26	series	series	NOUN
ecj-10468	211	27	of	of	ADP
ecj-10468	211	28	22	22	NUM
ecj-10468	211	29	patients	patient	NOUN
ecj-10468	211	30	'	'	PUNCT
ecj-10468	211	31	:	:	PUNCT
ecj-10468	211	32	to	to	PART
ecj-10468	211	33	consider	consider	VERB
ecj-10468	211	34	varicella	varicella	NOUN
ecj-10468	211	35	-	-	PUNCT
ecj-10468	211	36	like	like	ADJ
ecj-10468	211	37	exanthem	exanthem	NOUN
ecj-10468	211	38	associated	associate	VERB
ecj-10468	211	39	with	with	ADP
ecj-10468	211	40	covid-19	covid-19	PROPN
ecj-10468	211	41	,	,	PUNCT
ecj-10468	211	42	virus	virus	NOUN
ecj-10468	211	43	varicella	varicella	NOUN
ecj-10468	211	44	zoster	zoster	NOUN
ecj-10468	211	45	and	and	CCONJ
ecj-10468	211	46	virus	virus	NOUN
ecj-10468	211	47	herpes	herpe	NOUN
ecj-10468	211	48	simplex	simplex	NOUN
ecj-10468	211	49	must	must	AUX
ecj-10468	211	50	be	be	AUX
ecj-10468	211	51	ruled	rule	VERB
ecj-10468	211	52	out	out	ADP
ecj-10468	211	53	"	"	PUNCT
ecj-10468	211	54	.	.	PUNCT
ecj-10468	212	1	j	j	PROPN
ecj-10468	212	2	am	be	AUX
ecj-10468	212	3	acad	acad	ADJ
ecj-10468	212	4	dermatol	dermatol	NOUN
ecj-10468	212	5	2020;83	2020;83	NUM
ecj-10468	212	6	:	:	PUNCT
ecj-10468	212	7	e255	e255	PROPN
ecj-10468	212	8	-	-	SYM
ecj-10468	212	9	6	6	NUM
ecj-10468	212	10	.	.	NOUN
ecj-10468	213	1	38	38	NUM
ecj-10468	213	2	.	.	PUNCT
ecj-10468	214	1	freeman	freeman	PROPN
ecj-10468	214	2	ee	ee	PROPN
ecj-10468	214	3	,	,	PUNCT
ecj-10468	214	4	mcmahon	mcmahon	PROPN
ecj-10468	214	5	de	de	PROPN
ecj-10468	214	6	,	,	PUNCT
ecj-10468	214	7	lipoff	lipoff	PROPN
ecj-10468	214	8	jb	jb	PROPN
ecj-10468	214	9	,	,	PUNCT
ecj-10468	214	10	et	et	PROPN
ecj-10468	214	11	al	al	PROPN
ecj-10468	214	12	.	.	PROPN
ecj-10468	215	1	american	american	PROPN
ecj-10468	215	2	academy	academy	PROPN
ecj-10468	215	3	of	of	ADP
ecj-10468	215	4	dermatology	dermatology	NOUN
ecj-10468	215	5	ad	ad	X
ecj-10468	215	6	hoc	hoc	X
ecj-10468	215	7	task	task	NOUN
ecj-10468	215	8	force	force	NOUN
ecj-10468	215	9	on	on	ADP
ecj-10468	215	10	covid-19	covid-19	PROPN
ecj-10468	215	11	.	.	PUNCT
ecj-10468	216	1	pernio	pernio	ADJ
ecj-10468	216	2	-	-	PUNCT
ecj-10468	216	3	like	like	ADJ
ecj-10468	216	4	skin	skin	NOUN
ecj-10468	216	5	lesions	lesion	NOUN
ecj-10468	216	6	associated	associate	VERB
ecj-10468	216	7	with	with	ADP
ecj-10468	216	8	covid-19	covid-19	PROPN
ecj-10468	216	9	:	:	PUNCT
ecj-10468	216	10	a	a	DET
ecj-10468	216	11	case	case	NOUN
ecj-10468	216	12	series	series	NOUN
ecj-10468	216	13	of	of	ADP
ecj-10468	216	14	318	318	NUM
ecj-10468	216	15	patients	patient	NOUN
ecj-10468	216	16	from	from	ADP
ecj-10468	216	17	8	8	NUM
ecj-10468	216	18	countries	country	NOUN
ecj-10468	216	19	.	.	PUNCT
ecj-10468	217	1	j	j	PROPN
ecj-10468	217	2	am	be	AUX
ecj-10468	217	3	acad	acad	ADJ
ecj-10468	217	4	dermatol	dermatol	NOUN
ecj-10468	217	5	2020;83:486	2020;83:486	PROPN
ecj-10468	217	6	-	-	SYM
ecj-10468	217	7	92	92	NUM
ecj-10468	217	8	.	.	PUNCT
ecj-10468	218	1	39	39	NUM
ecj-10468	218	2	.	.	PUNCT
ecj-10468	219	1	deutsch	deutsch	VERB
ecj-10468	219	2	a	a	PRON
ecj-10468	219	3	,	,	PUNCT
ecj-10468	219	4	blasiak	blasiak	NOUN
ecj-10468	219	5	r	r	NOUN
ecj-10468	219	6	,	,	PUNCT
ecj-10468	219	7	keyes	keyes	PROPN
ecj-10468	219	8	a	a	PROPN
ecj-10468	219	9	,	,	PUNCT
ecj-10468	219	10	et	et	PROPN
ecj-10468	219	11	al	al	PROPN
ecj-10468	219	12	.	.	PUNCT
ecj-10468	220	1	covid	covid	PROPN
ecj-10468	220	2	toes	toe	NOUN
ecj-10468	220	3	:	:	PUNCT
ecj-10468	220	4	phenomenon	phenomenon	NOUN
ecj-10468	220	5	or	or	CCONJ
ecj-10468	220	6	epiphenomenon	epiphenomenon	NOUN
ecj-10468	220	7	?	?	PUNCT
ecj-10468	221	1	j	j	PROPN
ecj-10468	221	2	am	be	AUX
ecj-10468	221	3	acad	acad	ADJ
ecj-10468	221	4	dermatol	dermatol	NOUN
ecj-10468	221	5	2020;83	2020;83	NUM
ecj-10468	221	6	:	:	PUNCT
ecj-10468	221	7	e347	e347	NUM
ecj-10468	221	8	-	-	SYM
ecj-10468	221	9	8	8	NUM
ecj-10468	221	10	.	.	NUM
ecj-10468	221	11	40	40	NUM
ecj-10468	221	12	.	.	PUNCT
ecj-10468	222	1	colonna	colonna	PROPN
ecj-10468	222	2	c	c	NOUN
ecj-10468	222	3	,	,	PUNCT
ecj-10468	222	4	genovese	genovese	NOUN
ecj-10468	222	5	g	g	NOUN
ecj-10468	222	6	,	,	PUNCT
ecj-10468	222	7	monzani	monzani	NOUN
ecj-10468	222	8	na	na	NOUN
ecj-10468	222	9	,	,	PUNCT
ecj-10468	222	10	et	et	PROPN
ecj-10468	222	11	al	al	PROPN
ecj-10468	222	12	.	.	PROPN
ecj-10468	222	13	outbreak	outbreak	PROPN
ecj-10468	222	14	of	of	ADP
ecj-10468	222	15	chilblain	chilblain	NOUN
ecj-10468	222	16	-	-	PUNCT
ecj-10468	222	17	like	like	ADJ
ecj-10468	222	18	acral	acral	ADJ
ecj-10468	222	19	lesions	lesion	NOUN
ecj-10468	222	20	in	in	ADP
ecj-10468	222	21	children	child	NOUN
ecj-10468	222	22	in	in	ADP
ecj-10468	222	23	the	the	DET
ecj-10468	222	24	metropolitan	metropolitan	ADJ
ecj-10468	222	25	area	area	NOUN
ecj-10468	222	26	of	of	ADP
ecj-10468	222	27	milan	milan	PROPN
ecj-10468	222	28	,	,	PUNCT
ecj-10468	222	29	italy	italy	PROPN
ecj-10468	222	30	,	,	PUNCT
ecj-10468	222	31	during	during	ADP
ecj-10468	222	32	the	the	DET
ecj-10468	222	33	covid-19	covid-19	PROPN
ecj-10468	222	34	pandemic	pandemic	NOUN
ecj-10468	222	35	.	.	PUNCT
ecj-10468	223	1	j	j	PROPN
ecj-10468	223	2	am	be	AUX
ecj-10468	223	3	acad	acad	ADJ
ecj-10468	223	4	dermatol	dermatol	NOUN
ecj-10468	223	5	2020;83:965	2020;83:965	NOUN
ecj-10468	223	6	-	-	SYM
ecj-10468	223	7	9	9	NUM
ecj-10468	223	8	.	.	NOUN
ecj-10468	223	9	41	41	NUM
ecj-10468	223	10	.	.	PUNCT
ecj-10468	223	11	piccolo	piccolo	PROPN
ecj-10468	223	12	v	v	PROPN
ecj-10468	223	13	,	,	PUNCT
ecj-10468	223	14	neri	neri	PROPN
ecj-10468	223	15	i	i	PRON
ecj-10468	223	16	,	,	PUNCT
ecj-10468	223	17	filippeschi	filippeschi	PROPN
ecj-10468	223	18	c	c	X
ecj-10468	223	19	,	,	PUNCT
ecj-10468	223	20	et	et	PROPN
ecj-10468	223	21	al	al	PROPN
ecj-10468	223	22	.	.	PUNCT
ecj-10468	224	1	chilblain	chilblain	PROPN
ecj-10468	224	2	-	-	PUNCT
ecj-10468	224	3	like	like	ADJ
ecj-10468	224	4	lesions	lesion	NOUN
ecj-10468	224	5	during	during	ADP
ecj-10468	224	6	covid-19	covid-19	PROPN
ecj-10468	224	7	epidemic	epidemic	NOUN
ecj-10468	224	8	:	:	PUNCT
ecj-10468	224	9	a	a	DET
ecj-10468	224	10	preliminary	preliminary	ADJ
ecj-10468	224	11	study	study	NOUN
ecj-10468	224	12	on	on	ADP
ecj-10468	224	13	63	63	NUM
ecj-10468	224	14	patients	patient	NOUN
ecj-10468	224	15	.	.	PUNCT
ecj-10468	225	1	j	j	PROPN
ecj-10468	225	2	eur	eur	PROPN
ecj-10468	225	3	acad	acad	PROPN
ecj-10468	225	4	dermatol	dermatol	NOUN
ecj-10468	225	5	venereol	venereol	PROPN
ecj-10468	225	6	2020;34	2020;34	NUM
ecj-10468	225	7	:	:	PUNCT
ecj-10468	225	8	e291	e291	PROPN
ecj-10468	225	9	-	-	SYM
ecj-10468	225	10	3	3	NUM
ecj-10468	225	11	.	.	NUM
ecj-10468	225	12	42	42	NUM
ecj-10468	225	13	.	.	PUNCT
ecj-10468	226	1	proietti	proietti	PROPN
ecj-10468	226	2	i	i	PRON
ecj-10468	226	3	,	,	PUNCT
ecj-10468	226	4	tolino	tolino	NOUN
ecj-10468	226	5	e	e	PROPN
ecj-10468	226	6	,	,	PUNCT
ecj-10468	226	7	bernardini	bernardini	PROPN
ecj-10468	226	8	n	n	CCONJ
ecj-10468	226	9	,	,	PUNCT
ecj-10468	226	10	et	et	PROPN
ecj-10468	226	11	al	al	PROPN
ecj-10468	226	12	.	.	PROPN
ecj-10468	227	1	auricle	auricle	NOUN
ecj-10468	227	2	perniosis	perniosis	NOUN
ecj-10468	227	3	as	as	ADP
ecj-10468	227	4	a	a	DET
ecj-10468	227	5	manifestation	manifestation	NOUN
ecj-10468	227	6	of	of	ADP
ecj-10468	227	7	covid-19	covid-19	PROPN
ecj-10468	227	8	infection	infection	NOUN
ecj-10468	227	9	.	.	PUNCT
ecj-10468	228	1	dermatol	dermatol	NOUN
ecj-10468	228	2	ther	ther	ADV
ecj-10468	228	3	2020;33	2020;33	NUM
ecj-10468	228	4	:	:	PUNCT
ecj-10468	228	5	e14089	e14089	ADJ
ecj-10468	228	6	.	.	PUNCT
ecj-10468	229	1	43	43	NUM
ecj-10468	229	2	.	.	PUNCT
ecj-10468	230	1	navarro	navarro	PROPN
ecj-10468	230	2	l	l	PROPN
ecj-10468	230	3	,	,	PUNCT
ecj-10468	230	4	andina	andina	PROPN
ecj-10468	230	5	d	d	PROPN
ecj-10468	230	6	,	,	PUNCT
ecj-10468	230	7	noguera	noguera	NOUN
ecj-10468	230	8	-	-	PUNCT
ecj-10468	230	9	morel	morel	NOUN
ecj-10468	230	10	l	l	NOUN
ecj-10468	230	11	,	,	PUNCT
ecj-10468	231	1	et	et	PROPN
ecj-10468	231	2	al	al	PROPN
ecj-10468	231	3	.	.	PROPN
ecj-10468	231	4	demoscopy	demoscopy	PROPN
ecj-10468	231	5	features	feature	NOUN
ecj-10468	231	6	of	of	ADP
ecj-10468	231	7	covid-19	covid-19	PROPN
ecj-10468	231	8	-	-	PUNCT
ecj-10468	231	9	related	relate	VERB
ecj-10468	231	10	chilblains	chilblain	NOUN
ecj-10468	231	11	in	in	ADP
ecj-10468	231	12	children	child	NOUN
ecj-10468	231	13	and	and	CCONJ
ecj-10468	231	14	adolescents	adolescent	NOUN
ecj-10468	231	15	.	.	PUNCT
ecj-10468	232	1	j	j	PROPN
ecj-10468	232	2	eur	eur	PROPN
ecj-10468	232	3	acad	acad	PROPN
ecj-10468	232	4	dermatol	dermatol	NOUN
ecj-10468	232	5	venereol	venereol	PROPN
ecj-10468	232	6	2020;34	2020;34	NUM
ecj-10468	232	7	:	:	PUNCT
ecj-10468	232	8	e762	e762	PROPN
ecj-10468	232	9	-	-	PUNCT
ecj-10468	232	10	4	4	NUM
ecj-10468	232	11	.	.	NUM
ecj-10468	232	12	44	44	NUM
ecj-10468	232	13	.	.	PUNCT
ecj-10468	233	1	fernandez	fernandez	PROPN
ecj-10468	233	2	-	-	PUNCT
ecj-10468	233	3	nieto	nieto	PROPN
ecj-10468	233	4	d	d	PROPN
ecj-10468	233	5	,	,	PUNCT
ecj-10468	233	6	jimenez	jimenez	PROPN
ecj-10468	233	7	-	-	PUNCT
ecj-10468	233	8	cauhe	cauhe	PROPN
ecj-10468	233	9	j	j	PROPN
ecj-10468	233	10	,	,	PUNCT
ecj-10468	233	11	suarez	suarez	NOUN
ecj-10468	233	12	-	-	PUNCT
ecj-10468	233	13	valle	valle	PROPN
ecj-10468	233	14	a	a	NOUN
ecj-10468	233	15	,	,	PUNCT
ecj-10468	233	16	et	et	PROPN
ecj-10468	233	17	al	al	PROPN
ecj-10468	233	18	.	.	PROPN
ecj-10468	233	19	comment	comment	NOUN
ecj-10468	233	20	on	on	ADP
ecj-10468	233	21	"	"	PUNCT
ecj-10468	233	22	characterization	characterization	NOUN
ecj-10468	233	23	of	of	ADP
ecj-10468	233	24	acute	acute	PROPN
ecj-10468	233	25	acro	acro	NOUN
ecj-10468	233	26	-	-	ADJ
ecj-10468	233	27	ischemic	ischemic	ADJ
ecj-10468	233	28	lesions	lesion	NOUN
ecj-10468	233	29	in	in	ADP
ecj-10468	233	30	non	non	ADJ
ecj-10468	233	31	-	-	ADJ
ecj-10468	233	32	hospitalized	hospitalize	VERB
ecj-10468	233	33	patients	patient	NOUN
ecj-10468	233	34	:	:	PUNCT
ecj-10468	233	35	a	a	DET
ecj-10468	233	36	case	case	NOUN
ecj-10468	233	37	series	series	NOUN
ecj-10468	233	38	of	of	ADP
ecj-10468	233	39	132	132	NUM
ecj-10468	233	40	patients	patient	NOUN
ecj-10468	233	41	during	during	ADP
ecj-10468	233	42	the	the	DET
ecj-10468	233	43	covid-19	covid-19	PROPN
ecj-10468	233	44	outbreak	outbreak	NOUN
ecj-10468	233	45	"	"	PUNCT
ecj-10468	233	46	.	.	PUNCT
ecj-10468	234	1	j	j	PROPN
ecj-10468	234	2	am	be	AUX
ecj-10468	234	3	acad	acad	ADJ
ecj-10468	234	4	dermatol	dermatol	NOUN
ecj-10468	234	5	2020;83	2020;83	NUM
ecj-10468	234	6	:	:	PUNCT
ecj-10468	234	7	e241	e241	PROPN
ecj-10468	234	8	.	.	PUNCT
ecj-10468	235	1	45	45	NUM
ecj-10468	235	2	.	.	PUNCT
ecj-10468	236	1	kaya	kaya	PROPN
ecj-10468	236	2	g	g	PROPN
ecj-10468	236	3	,	,	PUNCT
ecj-10468	236	4	kaya	kaya	PROPN
ecj-10468	236	5	a	a	PROPN
ecj-10468	236	6	,	,	PUNCT
ecj-10468	236	7	saurat	saurat	PROPN
ecj-10468	236	8	jh	jh	PROPN
ecj-10468	236	9	.	.	PUNCT
ecj-10468	237	1	clinical	clinical	ADJ
ecj-10468	237	2	and	and	CCONJ
ecj-10468	237	3	histopathological	histopathological	ADJ
ecj-10468	237	4	features	feature	NOUN
ecj-10468	237	5	and	and	CCONJ
ecj-10468	237	6	potential	potential	ADJ
ecj-10468	237	7	pathological	pathological	ADJ
ecj-10468	237	8	mechanisms	mechanism	NOUN
ecj-10468	237	9	of	of	ADP
ecj-10468	237	10	skin	skin	NOUN
ecj-10468	237	11	lesions	lesion	NOUN
ecj-10468	237	12	in	in	ADP
ecj-10468	237	13	covid-19	covid-19	PROPN
ecj-10468	237	14	:	:	PUNCT
ecj-10468	237	15	review	review	NOUN
ecj-10468	237	16	of	of	ADP
ecj-10468	237	17	the	the	DET
ecj-10468	237	18	literature	literature	NOUN
ecj-10468	237	19	.	.	PUNCT
ecj-10468	238	1	dermatopathology	dermatopathology	NOUN
ecj-10468	238	2	(	(	PUNCT
ecj-10468	238	3	basel	basel	PROPN
ecj-10468	238	4	)	)	PUNCT
ecj-10468	238	5	2020;7:3	2020;7:3	PROPN
ecj-10468	238	6	-	-	SYM
ecj-10468	238	7	16	16	NUM
ecj-10468	238	8	.	.	PUNCT
ecj-10468	239	1	46	46	NUM
ecj-10468	239	2	.	.	PUNCT
ecj-10468	239	3	colmenero	colmenero	PROPN
ecj-10468	240	1	i	i	PRON
ecj-10468	240	2	,	,	PUNCT
ecj-10468	240	3	santonja	santonja	VERB
ecj-10468	240	4	c	c	NOUN
ecj-10468	240	5	,	,	PUNCT
ecj-10468	240	6	alonso	alonso	NOUN
ecj-10468	240	7	-	-	PUNCT
ecj-10468	240	8	riano	riano	NOUN
ecj-10468	240	9	m	m	PROPN
ecj-10468	240	10	,	,	PUNCT
ecj-10468	240	11	et	et	PROPN
ecj-10468	240	12	al	al	PROPN
ecj-10468	240	13	.	.	PUNCT
ecj-10468	241	1	sars	sars	PROPN
ecj-10468	241	2	-	-	PUNCT
ecj-10468	241	3	cov2	cov2	PROPN
ecj-10468	241	4	endothelial	endothelial	ADJ
ecj-10468	241	5	infection	infection	NOUN
ecj-10468	241	6	causes	cause	VERB
ecj-10468	241	7	covid-19	covid-19	PROPN
ecj-10468	241	8	chilblains	chilblain	VERB
ecj-10468	241	9	:	:	PUNCT
ecj-10468	242	1	mini	mini	ADJ
ecj-10468	242	2	review	review	NOUN
ecj-10468	242	3	[	[	X
ecj-10468	242	4	page	page	NOUN
ecj-10468	242	5	14	14	NUM
ecj-10468	242	6	]	]	PUNCT
ecj-10468	243	1	[	[	X
ecj-10468	243	2	emergency	emergency	NOUN
ecj-10468	243	3	care	care	NOUN
ecj-10468	243	4	journal	journal	NOUN
ecj-10468	243	5	2022	2022	NUM
ecj-10468	243	6	;	;	PUNCT
ecj-10468	243	7	18:10468	18:10468	NUM
ecj-10468	243	8	]	]	X
ecj-10468	243	9	non	non	ADJ
ecj-10468	243	10	-co	-co	PROPN
ecj-10468	243	11	mmerc	mmerc	PROPN
ecj-10468	243	12	ial	ial	PROPN
ecj-10468	243	13	us	us	PROPN
ecj-10468	243	14	e	e	NOUN
ecj-10468	243	15	o	o	NOUN
ecj-10468	243	16	nly	nly	ADV
ecj-10468	243	17	histopathological	histopathological	ADJ
ecj-10468	243	18	,	,	PUNCT
ecj-10468	243	19	immunohistochemical	immunohistochemical	ADJ
ecj-10468	243	20	and	and	CCONJ
ecj-10468	243	21	ultrastructural	ultrastructural	ADJ
ecj-10468	243	22	study	study	NOUN
ecj-10468	243	23	of	of	ADP
ecj-10468	243	24	seven	seven	NUM
ecj-10468	243	25	pediatric	pediatric	ADJ
ecj-10468	243	26	cases	case	NOUN
ecj-10468	243	27	.	.	PUNCT
ecj-10468	244	1	br	br	X
ecj-10468	244	2	j	j	PROPN
ecj-10468	244	3	dermatol	dermatol	NOUN
ecj-10468	244	4	2020;183:72937	2020;183:72937	NUM
ecj-10468	244	5	.	.	PUNCT
ecj-10468	245	1	47	47	NUM
ecj-10468	245	2	.	.	PUNCT
ecj-10468	246	1	griffiths	griffiths	PROPN
ecj-10468	246	2	c	c	PROPN
ecj-10468	246	3	,	,	PUNCT
ecj-10468	246	4	barker	barker	PROPN
ecj-10468	246	5	j	j	PROPN
ecj-10468	246	6	,	,	PUNCT
ecj-10468	246	7	bleiker	bleiker	PROPN
ecj-10468	246	8	t	t	PROPN
ecj-10468	246	9	,	,	PUNCT
ecj-10468	246	10	et	et	PROPN
ecj-10468	246	11	al	al	PROPN
ecj-10468	246	12	.	.	PROPN
ecj-10468	246	13	rook	rook	PROPN
ecj-10468	246	14	’s	’s	PART
ecj-10468	246	15	textbook	textbook	NOUN
ecj-10468	246	16	of	of	ADP
ecj-10468	246	17	dermatology	dermatology	NOUN
ecj-10468	246	18	.	.	PUNCT
ecj-10468	247	1	9th	9th	ADJ
ecj-10468	247	2	ed	ed	NOUN
ecj-10468	247	3	,	,	PUNCT
ecj-10468	247	4	rev	rev	PROPN
ecj-10468	247	5	.	.	PROPN
ecj-10468	248	1	hoboken	hoboken	PROPN
ecj-10468	248	2	:	:	PUNCT
ecj-10468	248	3	wiley	wiley	PROPN
ecj-10468	248	4	-	-	PUNCT
ecj-10468	248	5	blackwell	blackwell	PROPN
ecj-10468	248	6	;	;	PUNCT
ecj-10468	248	7	2016	2016	NUM
ecj-10468	248	8	.	.	PUNCT
ecj-10468	249	1	48	48	NUM
ecj-10468	249	2	.	.	PUNCT
ecj-10468	250	1	khalil	khalil	PROPN
ecj-10468	250	2	s	s	PROPN
ecj-10468	250	3	,	,	PUNCT
ecj-10468	250	4	hinds	hinds	PROPN
ecj-10468	250	5	br	br	PROPN
ecj-10468	250	6	,	,	PUNCT
ecj-10468	250	7	manalo	manalo	PROPN
ecj-10468	250	8	if	if	SCONJ
ecj-10468	250	9	,	,	PUNCT
ecj-10468	250	10	et	et	PROPN
ecj-10468	250	11	al	al	PROPN
ecj-10468	250	12	.	.	PROPN
ecj-10468	250	13	livedo	livedo	PROPN
ecj-10468	250	14	reticularis	reticularis	PROPN
ecj-10468	250	15	as	as	ADP
ecj-10468	250	16	a	a	DET
ecj-10468	250	17	presenting	presenting	NOUN
ecj-10468	250	18	sign	sign	NOUN
ecj-10468	250	19	of	of	ADP
ecj-10468	250	20	severe	severe	ADJ
ecj-10468	250	21	acute	acute	ADJ
ecj-10468	250	22	respiratory	respiratory	ADJ
ecj-10468	250	23	syndrome	syndrome	NOUN
ecj-10468	250	24	coronavirus	coronavirus	NOUN
ecj-10468	250	25	2	2	NUM
ecj-10468	250	26	infection	infection	NOUN
ecj-10468	250	27	.	.	PUNCT
ecj-10468	251	1	jaad	jaad	NOUN
ecj-10468	251	2	case	case	NOUN
ecj-10468	251	3	rep	rep	PROPN
ecj-10468	251	4	2020;6:871	2020;6:871	PROPN
ecj-10468	251	5	-	-	PUNCT
ecj-10468	251	6	4	4	NUM
ecj-10468	251	7	.	.	NUM
ecj-10468	251	8	49	49	NUM
ecj-10468	251	9	.	.	PUNCT
ecj-10468	252	1	magro	magro	PROPN
ecj-10468	252	2	cm	cm	PROPN
ecj-10468	252	3	,	,	PUNCT
ecj-10468	252	4	mulvey	mulvey	PROPN
ecj-10468	252	5	jj	jj	PROPN
ecj-10468	252	6	,	,	PUNCT
ecj-10468	252	7	laurence	laurence	PROPN
ecj-10468	252	8	j	j	PROPN
ecj-10468	252	9	,	,	PUNCT
ecj-10468	252	10	et	et	PROPN
ecj-10468	252	11	al	al	PROPN
ecj-10468	252	12	.	.	PUNCT
ecj-10468	253	1	the	the	DET
ecj-10468	253	2	differing	differ	VERB
ecj-10468	253	3	pathophysiologies	pathophysiologie	NOUN
ecj-10468	253	4	that	that	PRON
ecj-10468	253	5	underlie	underlie	VERB
ecj-10468	253	6	covid-19	covid-19	PROPN
ecj-10468	253	7	-	-	PUNCT
ecj-10468	253	8	associated	associate	VERB
ecj-10468	253	9	perniosis	perniosis	NOUN
ecj-10468	253	10	and	and	CCONJ
ecj-10468	253	11	thrombotic	thrombotic	ADJ
ecj-10468	253	12	retiform	retiform	NOUN
ecj-10468	253	13	purpura	purpura	NOUN
ecj-10468	253	14	:	:	PUNCT
ecj-10468	253	15	a	a	DET
ecj-10468	253	16	case	case	NOUN
ecj-10468	253	17	series	series	NOUN
ecj-10468	253	18	.	.	PUNCT
ecj-10468	254	1	br	br	PROPN
ecj-10468	254	2	j	j	PROPN
ecj-10468	254	3	dermatol	dermatol	NOUN
ecj-10468	254	4	2021;184:141	2021;184:141	NUM
ecj-10468	254	5	-	-	SYM
ecj-10468	254	6	50	50	NUM
ecj-10468	254	7	.	.	X
ecj-10468	255	1	50	50	NUM
ecj-10468	255	2	.	.	PUNCT
ecj-10468	256	1	cordoro	cordoro	PROPN
ecj-10468	256	2	km	km	PROPN
ecj-10468	256	3	,	,	PUNCT
ecj-10468	256	4	reynolds	reynolds	PROPN
ecj-10468	256	5	sd	sd	PROPN
ecj-10468	256	6	,	,	PUNCT
ecj-10468	256	7	wattier	wattier	NOUN
ecj-10468	256	8	r	r	NOUN
ecj-10468	256	9	,	,	PUNCT
ecj-10468	256	10	mc	mc	PROPN
ecj-10468	256	11	-	-	PUNCT
ecj-10468	256	12	calmont	calmont	PROPN
ecj-10468	256	13	th	th	PROPN
ecj-10468	256	14	.	.	PUNCT
ecj-10468	257	1	clustered	clustered	ADJ
ecj-10468	257	2	cases	case	NOUN
ecj-10468	257	3	of	of	ADP
ecj-10468	257	4	acral	acral	ADJ
ecj-10468	257	5	perniosis	perniosis	NOUN
ecj-10468	257	6	:	:	PUNCT
ecj-10468	257	7	clinical	clinical	ADJ
ecj-10468	257	8	features	feature	NOUN
ecj-10468	257	9	,	,	PUNCT
ecj-10468	257	10	histopathology	histopathology	NOUN
ecj-10468	257	11	,	,	PUNCT
ecj-10468	257	12	and	and	CCONJ
ecj-10468	257	13	relationship	relationship	NOUN
ecj-10468	257	14	to	to	ADP
ecj-10468	257	15	covid-19	covid-19	PROPN
ecj-10468	257	16	.	.	PUNCT
ecj-10468	258	1	pediatr	pediatr	ADJ
ecj-10468	258	2	dermatol	dermatol	NOUN
ecj-10468	258	3	2020;37:419	2020;37:419	NOUN
ecj-10468	258	4	-	-	SYM
ecj-10468	258	5	23	23	NUM
ecj-10468	258	6	.	.	PUNCT
ecj-10468	259	1	51	51	NUM
ecj-10468	259	2	.	.	PUNCT
ecj-10468	259	3	manalo	manalo	PROPN
ecj-10468	259	4	if	if	SCONJ
ecj-10468	259	5	,	,	PUNCT
ecj-10468	259	6	smith	smith	PROPN
ecj-10468	259	7	mk	mk	PROPN
ecj-10468	259	8	,	,	PUNCT
ecj-10468	259	9	cheeley	cheeley	PROPN
ecj-10468	259	10	j	j	PROPN
ecj-10468	259	11	,	,	PUNCT
ecj-10468	259	12	jacobs	jacobs	PROPN
ecj-10468	259	13	r.	r.	PROPN
ecj-10468	259	14	a	a	DET
ecj-10468	259	15	dermatologic	dermatologic	ADJ
ecj-10468	259	16	manifestation	manifestation	NOUN
ecj-10468	259	17	of	of	ADP
ecj-10468	259	18	covid-19	covid-19	PROPN
ecj-10468	259	19	:	:	PUNCT
ecj-10468	259	20	transient	transient	PROPN
ecj-10468	259	21	livedo	livedo	PROPN
ecj-10468	259	22	reticularis	reticularis	PROPN
ecj-10468	259	23	.	.	PUNCT
ecj-10468	260	1	j	j	PROPN
ecj-10468	260	2	am	be	AUX
ecj-10468	260	3	acad	acad	ADJ
ecj-10468	260	4	dermatol	dermatol	NOUN
ecj-10468	260	5	2020;83:700	2020;83:700	NOUN
ecj-10468	260	6	.	.	PROPN
ecj-10468	260	7	52	52	NUM
ecj-10468	260	8	.	.	PUNCT
ecj-10468	261	1	verheyden	verheyden	PROPN
ecj-10468	261	2	m	m	PROPN
ecj-10468	261	3	,	,	PUNCT
ecj-10468	261	4	grosber	grosber	PROPN
ecj-10468	261	5	m	m	PROPN
ecj-10468	261	6	,	,	PUNCT
ecj-10468	261	7	gutermuth	gutermuth	PROPN
ecj-10468	261	8	j	j	PROPN
ecj-10468	261	9	,	,	PUNCT
ecj-10468	261	10	velkeniers	velkenier	NOUN
ecj-10468	261	11	b.	b.	VERB
ecj-10468	261	12	relapsing	relapse	VERB
ecj-10468	261	13	symmetric	symmetric	ADJ
ecj-10468	261	14	livedo	livedo	PROPN
ecj-10468	261	15	reticularis	reticularis	PROPN
ecj-10468	261	16	in	in	ADP
ecj-10468	261	17	a	a	DET
ecj-10468	261	18	patient	patient	NOUN
ecj-10468	261	19	with	with	ADP
ecj-10468	261	20	covid-19	covid-19	PROPN
ecj-10468	261	21	infection	infection	NOUN
ecj-10468	261	22	.	.	PUNCT
ecj-10468	262	1	j	j	PROPN
ecj-10468	262	2	eur	eur	PROPN
ecj-10468	262	3	acad	acad	PROPN
ecj-10468	262	4	dermatol	dermatol	NOUN
ecj-10468	262	5	venereol	venereol	PROPN
ecj-10468	262	6	2020;34	2020;34	NUM
ecj-10468	262	7	:	:	PUNCT
ecj-10468	262	8	e684	e684	PROPN
ecj-10468	262	9	-	-	PUNCT
ecj-10468	262	10	6	6	NUM
ecj-10468	262	11	.	.	X
ecj-10468	262	12	53	53	NUM
ecj-10468	262	13	.	.	X
ecj-10468	263	1	chibane	chibane	VERB
ecj-10468	263	2	s	s	PROPN
ecj-10468	263	3	,	,	PUNCT
ecj-10468	263	4	gibeau	gibeau	PROPN
ecj-10468	263	5	g	g	PROPN
ecj-10468	263	6	,	,	PUNCT
ecj-10468	263	7	poulin	poulin	PROPN
ecj-10468	263	8	f	f	PROPN
ecj-10468	263	9	,	,	PUNCT
ecj-10468	264	1	et	et	PROPN
ecj-10468	264	2	al	al	PROPN
ecj-10468	264	3	.	.	PROPN
ecj-10468	264	4	hyperacute	hyperacute	PROPN
ecj-10468	264	5	multi	multi	ADJ
ecj-10468	264	6	-	-	ADJ
ecj-10468	264	7	organ	organ	ADJ
ecj-10468	264	8	thromboembolic	thromboembolic	NOUN
ecj-10468	264	9	storm	storm	NOUN
ecj-10468	264	10	in	in	ADP
ecj-10468	264	11	covid-19	covid-19	PROPN
ecj-10468	264	12	:	:	PUNCT
ecj-10468	264	13	a	a	DET
ecj-10468	264	14	case	case	NOUN
ecj-10468	264	15	report	report	NOUN
ecj-10468	264	16	.	.	PUNCT
ecj-10468	265	1	j	j	PROPN
ecj-10468	265	2	thromb	thromb	PROPN
ecj-10468	265	3	thrombolysis	thrombolysis	VERB
ecj-10468	265	4	2021;51:25	2021;51:25	NUM
ecj-10468	265	5	-	-	SYM
ecj-10468	265	6	8	8	NUM
ecj-10468	265	7	.	.	X
ecj-10468	266	1	54	54	NUM
ecj-10468	266	2	.	.	PUNCT
ecj-10468	267	1	droesch	droesch	VERB
ecj-10468	267	2	c	c	X
ecj-10468	267	3	,	,	PUNCT
ecj-10468	267	4	do	do	VERB
ecj-10468	267	5	mh	mh	PROPN
ecj-10468	267	6	,	,	PUNCT
ecj-10468	267	7	desancho	desancho	NOUN
ecj-10468	267	8	m	m	PROPN
ecj-10468	267	9	,	,	PUNCT
ecj-10468	268	1	et	et	PROPN
ecj-10468	268	2	al	al	PROPN
ecj-10468	268	3	.	.	PROPN
ecj-10468	268	4	livedoid	livedoid	PROPN
ecj-10468	268	5	and	and	CCONJ
ecj-10468	268	6	purpuric	purpuric	ADJ
ecj-10468	268	7	skin	skin	NOUN
ecj-10468	268	8	eruptions	eruption	NOUN
ecj-10468	268	9	associated	associate	VERB
ecj-10468	268	10	with	with	ADP
ecj-10468	268	11	coagulopathy	coagulopathy	ADJ
ecj-10468	268	12	in	in	ADP
ecj-10468	268	13	severe	severe	ADJ
ecj-10468	268	14	covid19	covid19	NOUN
ecj-10468	268	15	.	.	PUNCT
ecj-10468	269	1	jama	jama	PROPN
ecj-10468	269	2	dermato	dermato	PROPN
ecj-10468	269	3	2020;156:1	2020;156:1	NUM
ecj-10468	269	4	-	-	SYM
ecj-10468	269	5	3	3	NUM
ecj-10468	269	6	.	.	PUNCT
ecj-10468	269	7	erratum	erratum	PROPN
ecj-10468	269	8	in	in	ADP
ecj-10468	269	9	:	:	PUNCT
ecj-10468	269	10	jama	jama	X
ecj-10468	269	11	dermatol	dermatol	NOUN
ecj-10468	269	12	2020;156:1272	2020;156:1272	NUM
ecj-10468	269	13	.	.	PUNCT
ecj-10468	270	1	55	55	NUM
ecj-10468	270	2	.	.	PUNCT
ecj-10468	271	1	caputo	caputo	PROPN
ecj-10468	271	2	v	v	PROPN
ecj-10468	271	3	,	,	PUNCT
ecj-10468	271	4	schroeder	schroeder	PROPN
ecj-10468	271	5	j	j	PROPN
ecj-10468	271	6	,	,	PUNCT
ecj-10468	271	7	rongioletti	rongioletti	PROPN
ecj-10468	271	8	f.	f.	PROPN
ecj-10468	271	9	a	a	DET
ecj-10468	271	10	generalized	generalize	VERB
ecj-10468	271	11	purpuric	purpuric	ADJ
ecj-10468	271	12	eruption	eruption	NOUN
ecj-10468	271	13	with	with	ADP
ecj-10468	271	14	histopathologic	histopathologic	ADJ
ecj-10468	271	15	features	feature	NOUN
ecj-10468	271	16	of	of	ADP
ecj-10468	271	17	leucocytoclastic	leucocytoclastic	ADJ
ecj-10468	271	18	vasculitis	vasculitis	NOUN
ecj-10468	271	19	in	in	ADP
ecj-10468	271	20	a	a	DET
ecj-10468	271	21	patient	patient	NOUN
ecj-10468	271	22	severely	severely	ADV
ecj-10468	271	23	ill	ill	ADJ
ecj-10468	271	24	with	with	ADP
ecj-10468	271	25	covid-19	covid-19	PROPN
ecj-10468	271	26	.	.	PUNCT
ecj-10468	272	1	j	j	PROPN
ecj-10468	272	2	eur	eur	PROPN
ecj-10468	272	3	acad	acad	PROPN
ecj-10468	272	4	dermatol	dermatol	NOUN
ecj-10468	272	5	venereol	venereol	PROPN
ecj-10468	272	6	2020;34	2020;34	NUM
ecj-10468	272	7	:	:	PUNCT
ecj-10468	272	8	e579	e579	PROPN
ecj-10468	272	9	-	-	PUNCT
ecj-10468	272	10	81	81	NUM
ecj-10468	272	11	.	.	PUNCT
ecj-10468	272	12	56	56	NUM
ecj-10468	272	13	.	.	PUNCT
ecj-10468	273	1	karaca	karaca	PROPN
ecj-10468	273	2	z	z	PROPN
ecj-10468	273	3	,	,	PUNCT
ecj-10468	273	4	yayli	yayli	PROPN
ecj-10468	273	5	s	s	PROPN
ecj-10468	273	6	,	,	PUNCT
ecj-10468	273	7	çalışkan	çalışkan	PROPN
ecj-10468	273	8	o.	o.	PROPN
ecj-10468	273	9	a	a	DET
ecj-10468	273	10	unilateral	unilateral	ADJ
ecj-10468	273	11	purpuric	purpuric	ADJ
ecj-10468	273	12	rash	rash	NOUN
ecj-10468	273	13	in	in	ADP
ecj-10468	273	14	a	a	DET
ecj-10468	273	15	patient	patient	NOUN
ecj-10468	273	16	with	with	ADP
ecj-10468	273	17	covid-19	covid-19	PROPN
ecj-10468	273	18	infection	infection	NOUN
ecj-10468	273	19	.	.	PUNCT
ecj-10468	274	1	dermatol	dermatol	NOUN
ecj-10468	274	2	ther	ther	ADV
ecj-10468	274	3	2020;33	2020;33	NUM
ecj-10468	274	4	:	:	PUNCT
ecj-10468	274	5	e13798	e13798	ADJ
ecj-10468	274	6	.	.	PROPN
ecj-10468	274	7	57	57	NUM
ecj-10468	274	8	.	.	PUNCT
ecj-10468	274	9	garcía	garcía	ADJ
ecj-10468	274	10	-	-	PUNCT
ecj-10468	274	11	gil	gil	NOUN
ecj-10468	274	12	mf	mf	PROPN
ecj-10468	274	13	,	,	PUNCT
ecj-10468	274	14	monte	monte	PROPN
ecj-10468	274	15	serrano	serrano	PROPN
ecj-10468	274	16	j	j	PROPN
ecj-10468	274	17	,	,	PUNCT
ecj-10468	274	18	garcía	garcía	PROPN
ecj-10468	274	19	garcía	garcía	PROPN
ecj-10468	274	20	m	m	PROPN
ecj-10468	274	21	,	,	PUNCT
ecj-10468	274	22	et	et	PROPN
ecj-10468	274	23	al	al	PROPN
ecj-10468	274	24	.	.	PROPN
ecj-10468	275	1	acral	acral	PROPN
ecj-10468	275	2	purpuric	purpuric	ADJ
ecj-10468	275	3	lesions	lesion	NOUN
ecj-10468	275	4	associated	associate	VERB
ecj-10468	275	5	with	with	ADP
ecj-10468	275	6	coagulation	coagulation	NOUN
ecj-10468	275	7	disorders	disorder	NOUN
ecj-10468	275	8	during	during	ADP
ecj-10468	275	9	the	the	DET
ecj-10468	275	10	covid-19	covid-19	PROPN
ecj-10468	275	11	pandemic	pandemic	NOUN
ecj-10468	275	12	.	.	PUNCT
ecj-10468	276	1	int	int	NOUN
ecj-10468	276	2	j	j	PROPN
ecj-10468	276	3	dermatol	dermatol	NOUN
ecj-10468	276	4	2020;59:1151	2020;59:1151	NOUN
ecj-10468	276	5	-	-	SYM
ecj-10468	276	6	2	2	NUM
ecj-10468	276	7	.	.	NOUN
ecj-10468	276	8	58	58	NUM
ecj-10468	276	9	.	.	PUNCT
ecj-10468	277	1	del	del	PROPN
ecj-10468	277	2	giudice	giudice	PROPN
ecj-10468	277	3	p	p	PROPN
ecj-10468	277	4	,	,	PUNCT
ecj-10468	277	5	boudoumi	boudoumi	PROPN
ecj-10468	277	6	d	d	PROPN
ecj-10468	277	7	,	,	PUNCT
ecj-10468	277	8	le	le	X
ecj-10468	277	9	guen	guen	PROPN
ecj-10468	277	10	b	b	PROPN
ecj-10468	277	11	,	,	PUNCT
ecj-10468	277	12	et	et	PROPN
ecj-10468	277	13	al	al	PROPN
ecj-10468	277	14	.	.	PUNCT
ecj-10468	278	1	catastrophic	catastrophic	ADJ
ecj-10468	278	2	acute	acute	ADJ
ecj-10468	278	3	bilateral	bilateral	ADJ
ecj-10468	278	4	lower	low	ADJ
ecj-10468	278	5	limbs	limb	NOUN
ecj-10468	278	6	necrosis	necrosis	NOUN
ecj-10468	278	7	associated	associate	VERB
ecj-10468	278	8	with	with	ADP
ecj-10468	278	9	covid-19	covid-19	PROPN
ecj-10468	278	10	as	as	ADP
ecj-10468	278	11	a	a	DET
ecj-10468	278	12	likely	likely	ADJ
ecj-10468	278	13	consequence	consequence	NOUN
ecj-10468	278	14	of	of	ADP
ecj-10468	278	15	both	both	DET
ecj-10468	278	16	vasculitis	vasculitis	NOUN
ecj-10468	278	17	and	and	CCONJ
ecj-10468	278	18	coagulopathy	coagulopathy	ADJ
ecj-10468	278	19	.	.	PUNCT
ecj-10468	279	1	j	j	PROPN
ecj-10468	279	2	eur	eur	PROPN
ecj-10468	279	3	acad	acad	PROPN
ecj-10468	279	4	dermatol	dermatol	NOUN
ecj-10468	279	5	venereol	venereol	PROPN
ecj-10468	279	6	2020;34	2020;34	NUM
ecj-10468	279	7	:	:	PUNCT
ecj-10468	279	8	e679	e679	PROPN
ecj-10468	279	9	-	-	PUNCT
ecj-10468	279	10	80	80	NUM
ecj-10468	279	11	.	.	PUNCT
ecj-10468	280	1	59	59	NUM
ecj-10468	280	2	.	.	PUNCT
ecj-10468	281	1	larrondo	larrondo	PROPN
ecj-10468	281	2	j	j	PROPN
ecj-10468	281	3	,	,	PUNCT
ecj-10468	281	4	cabrera	cabrera	PROPN
ecj-10468	281	5	r	r	NOUN
ecj-10468	281	6	,	,	PUNCT
ecj-10468	281	7	gosch	gosch	ADJ
ecj-10468	281	8	m	m	PROPN
ecj-10468	281	9	,	,	PUNCT
ecj-10468	281	10	et	et	PROPN
ecj-10468	281	11	al	al	PROPN
ecj-10468	281	12	.	.	PUNCT
ecj-10468	282	1	papular	papular	ADJ
ecj-10468	282	2	-	-	PUNCT
ecj-10468	282	3	purpuric	purpuric	ADJ
ecj-10468	282	4	exanthem	exanthem	NOUN
ecj-10468	282	5	in	in	ADP
ecj-10468	282	6	a	a	DET
ecj-10468	282	7	covid-19	covid-19	PROPN
ecj-10468	282	8	patient	patient	NOUN
ecj-10468	282	9	:	:	PUNCT
ecj-10468	282	10	clinical	clinical	ADJ
ecj-10468	282	11	and	and	CCONJ
ecj-10468	282	12	dermoscopic	dermoscopic	ADJ
ecj-10468	282	13	description	description	NOUN
ecj-10468	282	14	.	.	PUNCT
ecj-10468	283	1	j	j	PROPN
ecj-10468	283	2	eur	eur	PROPN
ecj-10468	283	3	acad	acad	PROPN
ecj-10468	283	4	dermatol	dermatol	NOUN
ecj-10468	283	5	venereol	venereol	PROPN
ecj-10468	283	6	2020;34	2020;34	NUM
ecj-10468	283	7	:	:	PUNCT
ecj-10468	283	8	e570	e570	PROPN
ecj-10468	283	9	-	-	SYM
ecj-10468	283	10	2	2	NUM
ecj-10468	283	11	.	.	NOUN
ecj-10468	283	12	60	60	NUM
ecj-10468	283	13	.	.	PUNCT
ecj-10468	284	1	jimenez	jimenez	PROPN
ecj-10468	284	2	-	-	PUNCT
ecj-10468	284	3	cauhe	cauhe	PROPN
ecj-10468	284	4	j	j	PROPN
ecj-10468	284	5	,	,	PUNCT
ecj-10468	284	6	ortega	ortega	PROPN
ecj-10468	284	7	-	-	PUNCT
ecj-10468	284	8	quijano	quijano	PROPN
ecj-10468	284	9	d	d	NOUN
ecj-10468	284	10	,	,	PUNCT
ecj-10468	284	11	carretero	carretero	NOUN
ecj-10468	284	12	-	-	PUNCT
ecj-10468	284	13	barrio	barrio	NOUN
ecj-10468	284	14	i	i	PROPN
ecj-10468	284	15	,	,	PUNCT
ecj-10468	284	16	et	et	PROPN
ecj-10468	284	17	al	al	PROPN
ecj-10468	284	18	.	.	PROPN
ecj-10468	285	1	erythema	erythema	PROPN
ecj-10468	285	2	multiforme	multiforme	NOUN
ecj-10468	285	3	-	-	PUNCT
ecj-10468	285	4	like	like	ADJ
ecj-10468	285	5	eruption	eruption	NOUN
ecj-10468	285	6	in	in	ADP
ecj-10468	285	7	patients	patient	NOUN
ecj-10468	285	8	with	with	ADP
ecj-10468	285	9	covid-19	covid-19	PROPN
ecj-10468	285	10	infection	infection	NOUN
ecj-10468	285	11	:	:	PUNCT
ecj-10468	285	12	clinical	clinical	ADJ
ecj-10468	285	13	and	and	CCONJ
ecj-10468	285	14	histological	histological	ADJ
ecj-10468	285	15	findings	finding	NOUN
ecj-10468	285	16	.	.	PUNCT
ecj-10468	286	1	clin	clin	PROPN
ecj-10468	286	2	exp	exp	NOUN
ecj-10468	286	3	dermatol	dermatol	NOUN
ecj-10468	286	4	2020;45:892–5	2020;45:892–5	NUM
ecj-10468	286	5	.	.	PUNCT
ecj-10468	287	1	61	61	NUM
ecj-10468	287	2	.	.	PUNCT
ecj-10468	288	1	gupta	gupta	PROPN
ecj-10468	288	2	a	a	PRON
ecj-10468	288	3	,	,	PUNCT
ecj-10468	288	4	gill	gill	PROPN
ecj-10468	288	5	a	a	X
ecj-10468	288	6	,	,	PUNCT
ecj-10468	288	7	sharma	sharma	PROPN
ecj-10468	288	8	m	m	PROPN
ecj-10468	288	9	,	,	PUNCT
ecj-10468	288	10	garg	garg	PROPN
ecj-10468	288	11	m.	m.	NOUN
ecj-10468	288	12	multi	multi	ADJ
ecj-10468	288	13	-	-	ADJ
ecj-10468	288	14	system	system	ADJ
ecj-10468	288	15	inflammatory	inflammatory	ADJ
ecj-10468	288	16	syndrome	syndrome	NOUN
ecj-10468	288	17	in	in	ADP
ecj-10468	288	18	a	a	DET
ecj-10468	288	19	child	child	NOUN
ecj-10468	288	20	mimicking	mimic	VERB
ecj-10468	288	21	kawasaki	kawasaki	PROPN
ecj-10468	288	22	disease	disease	NOUN
ecj-10468	288	23	.	.	PUNCT
ecj-10468	289	1	j	j	PROPN
ecj-10468	289	2	trop	trop	X
ecj-10468	289	3	pediatr	pediatr	PROPN
ecj-10468	289	4	2021;67	2021;67	NUM
ecj-10468	289	5	:	:	PUNCT
ecj-10468	289	6	fmaa060	fmaa060	PROPN
ecj-10468	289	7	.	.	PROPN
ecj-10468	289	8	62	62	NUM
ecj-10468	289	9	.	.	PUNCT
ecj-10468	290	1	shanshal	shanshal	PROPN
ecj-10468	290	2	m.	m.	NOUN
ecj-10468	290	3	covid-19	covid-19	PROPN
ecj-10468	290	4	related	relate	VERB
ecj-10468	290	5	anagen	anagen	NOUN
ecj-10468	290	6	effluvium	effluvium	NOUN
ecj-10468	290	7	.	.	PUNCT
ecj-10468	291	1	j	j	PROPN
ecj-10468	291	2	dermatolog	dermatolog	PROPN
ecj-10468	291	3	treat	treat	VERB
ecj-10468	291	4	2020;16:1–2	2020;16:1–2	NUM
ecj-10468	291	5	.	.	PUNCT
ecj-10468	292	1	mini	mini	ADJ
ecj-10468	292	2	review	review	NOUN
ecj-10468	292	3	[	[	X
ecj-10468	292	4	emergency	emergency	NOUN
ecj-10468	292	5	care	care	NOUN
ecj-10468	292	6	journal	journal	NOUN
ecj-10468	292	7	2022	2022	NUM
ecj-10468	292	8	;	;	PUNCT
ecj-10468	292	9	18:10468	18:10468	NUM
ecj-10468	292	10	]	]	X
ecj-10468	292	11	[	[	X
ecj-10468	292	12	page	page	NOUN
ecj-10468	292	13	15	15	NUM
ecj-10468	292	14	]	]	X
ecj-10468	292	15	non	non	ADJ
ecj-10468	292	16	-co	-co	PROPN
ecj-10468	292	17	mmerc	mmerc	PROPN
ecj-10468	292	18	ial	ial	PROPN
ecj-10468	292	19	us	us	PROPN
ecj-10468	292	20	e	e	NOUN
ecj-10468	292	21	o	o	NOUN
ecj-10468	292	22	nly	nly	ADV